Courses & outcomes
Course descriptions and learning outcomes.
Interim Stream Review · Prototype
Stream Overview
What does learning in this stream look like across the program and within each year?
This workspace moves from a high-level orientation to an interactive curriculum portrait and then to searchable source records, helping reviewers understand the stream across the program, examine year-specific evidence, and verify the records behind the summary.
Evidence at a Glance
What curriculum evidence am I reviewing?
Teaching & topics
Sessions, topics, types, duration, and instructional characteristics.
Assessment
Assessment structure and available descriptions.
High-Level Overview of Learning
What does learning look like in this stream?
Overall focus
The Therapeutics stream documents extensive condition‑ and topic‑specific knowledge, clinical reasoning skills and professional attitudes across Years 1–3. Content includes self‑care and respiratory topics in Year 1, organ/system therapeutics in Year 2 (infectious disease, cardiology, endocrine, renal), and a broad array of complex topics, monitoring and therapeutic drug management in Year 3.
Development across years
Documented development moves from foundational self‑care and respiratory coverage in Year 1 to topic‑dense, clinically focused Year‑2 content, then to broader, higher‑complexity clinical topics and stronger practice‑skills application in Year 3. AFPC mappings in the packet show a dominant Care‑Provider emphasis across all years.
How to read this curriculum portrait
Top-line metrics summarize the selected academic cycle. Within each curriculum portrait figure, Years 1, 2 and 3 are shown separately so reviewers can compare the same program year across available academic cycles. No Overall distribution is shown.
What students learn
The Therapeutics stream documents condition‑focused clinical knowledge and applied therapeutic decision‑making across Years 1–3. Course outcomes cover self‑care and pulmonary topics; infectious disease, cardiology, renal and endocrine conditions; GI, dermatology and ophthalmology; oncology, neurology, pain, mental health, transplant, geriatrics and pediatrics; and vaccines/immunology. Skills include patient assessment, evidence‑based plan development, therapeutic drug monitoring, dosing adjustments, diagnostic interpretation, documentation and oral presentation; attitudes emphasize empathy, interdisciplinary care and lifelong learning.
204Documented learning outcomes
326Documented topics
7AFPC roles represented
55CCAPP categories represented
Learning-outcome and curriculum-framework profiles
Learning outcomes
KSAs are predominantly skills and knowledge: substantial clinical knowledge across organ systems paired with many applied clinical skills (assessment, monitoring, therapeutic planning); attitudes such as empathy, advocacy and professional caring are explicitly documented.
- Knowledge
- Skills
- Attitudes
Year 1
2025-2026n = 10
2024-2025n = 16
2023-2024n = 16
Year 2
2025-2026n = 79
2024-2025n = 81
2023-2024n = 81
Year 3
2025-2026n = 108
2024-2025n = 108
2023-2024n = 107
AFPC professional roles
AFPC mappings are dominated by the Care Provider role with Scholar mappings present, documenting curricular emphasis on clinical care competencies supported by scholarly reasoning and evidence appraisal.
- Care Provider
- Scholar
- Health Advocate
- Leader-Manager
- Communicator
- Other
Year 1
2025-2026n = 58
2024-2025n = 56
2023-2024n = 56
Year 2
2025-2026n = 208
2024-2025n = 214
2023-2024n = 214
Year 3
2025-2026n = 219
2024-2025n = 224
2023-2024n = 224
CCAPP curriculum topics
CCAPP mappings concentrate in clinical sciences: infectious disease, respirology, cardiology and multiple specialty areas, plus strong representation for patient assessment work‑ups — documenting extensive clinical topic coverage and hands‑on therapeutic reasoning training.
- infectious disease
- respirology
- patient assessment/pharmacotherapy work-up
- dermatology
- gastroenterology
- Other
Year 1
2025-2026n = 58
2024-2025n = 56
2023-2024n = 56
Year 2
2025-2026n = 208
2024-2025n = 214
2023-2024n = 214
Year 3
2025-2026n = 219
2024-2025n = 224
2023-2024n = 224
View all mapped CCAPP topic categories
Percentages are the governed CCAPP topic-category mapping proportions for the selected program-year perspective in each academic cycle. The denominator used for each cycle is shown in its column header.
| Topic category | 2025-2026 n = 294 | 2024-2025 n = 300 | 2023-2024 n = 300 |
|---|---|---|---|
| infectious disease | 41% | 41% | 41% |
| patient assessment/pharmacotherapy work-up | 16% | 30% | 32% |
| respirology | 25% | 28% | 28% |
| dermatology | 22% | 21% | 21% |
| cardiology | 22% | 18% | 18% |
| gastroenterology | 17% | 17% | 17% |
| conditions affecting head, eyes, ears, nose, throat (EENT) | 19% | 15% | 15% |
| psychiatric and mental health | 15% | 14% | 14% |
| endocrinology | 19% | 13% | 13% |
| pain | 18% | 12% | 12% |
| neurology | 13% | 12% | 12% |
| pathophysiology | 6% | 10% | 10% |
| sexual and reproductive health | 12% | 10% | 10% |
| microbiology | 3% | 10% | 10% |
| nephrology | 15% | 10% | 10% |
| nutrition | 8% | 9% | 9% |
| rheumatology | 8% | 8% | 8% |
| patient self-care and management of minor ailments | 10% | 10% | 8% |
| traditional, complementary, and alternative medicine | 5% | 8% | 8% |
| oncology | 9% | 8% | 8% |
| hematology | 8% | 7% | 7% |
| substance use disorders, dependency, and addiction | 6% | 6% | 6% |
| healthcare education | 4% | 6% | 6% |
| public health | 7% | 6% | 6% |
| pharmacokinetics | 4% | 5% | 5% |
| documentation of care | 1% | 5% | 5% |
| drugs in pregnancy and lactation | 2% | 5% | 5% |
| pharmacology | 6% | 5% | 5% |
| monitoring & follow-up | 6% | 4% | 4% |
| healthcare systems and health economics | 3% | 4% | 4% |
| urology | 3% | 3% | 3% |
| patient safety | 1% | 3% | 3% |
| physical assessment | 5% | 3% | 3% |
| collaborative care and shared decision-making | 1% | 3% | 3% |
| patient and professional communications | — | 3% | 3% |
| pharmacoepidemiology | — | 3% | 3% |
| quality improvement | 3% | 2% | 2% |
| pharmacy law and regulatory issues | 3% | 2% | 2% |
| administration of drugs by injection | 3% | 2% | 2% |
| care plan development | 2% | 2% | 2% |
| diagnostic and point-of-care testing | — | 1% | 1% |
| drug information provision | 4% | 1% | 1% |
| molecular and cell biology | 1% | 1% | 1% |
| physiology | 1% | 1% | 1% |
| immunology | 4% | 1% | 1% |
| professional identity formation | 3% | 1% | 1% |
| cultural diversity | 1% | 1% | 1% |
| best possible medication history and medication reconciliation | — | 1% | 1% |
| health equity and social determinants of health | 3% | 1% | 1% |
| prescriptive decision making (i.e. prescribing, deprescribing, adapting a prescription) | 3% | 1% | 1% |
| cultural safety, humility, and responsiveness | 2% | 1% | 1% |
| evidence-based decision making | 2% | 1% | 1% |
| health advocacy | 1% | 1% | 1% |
| pharmacist patient care process | 1% | 1% | 1% |
| care plan implementation | — | 1% | 1% |
| professional learning and development | 4% | — | — |
| digital health | 1% | — | — |
| health systems planning | 1% | — | — |
| professional wellbeing | 1% | — | — |
Relationships with other streams
These summaries identify documented areas of shared or adjacent curriculum with the other program streams.
BASE
Professional, regulatory and health-system context
Therapeutics connects around patient and professional communication, patient assessment/pharmacotherapy work‑up, evidence‑based decision making and drug information provision that align with BASE content. Across Years 1–3 the documented course outcomes, sessions and mappings additionally show overlap with BASE in patient safety, quality improvement, healthcare systems/public health, cultural safety/Indigenous health, and health advocacy.
Pharmaceutical Sciences
Scientific foundations for pharmacy practice
Therapeutics connects to Pharmaceutical Sciences through documented clinical applications that rely on pharmacology, PK/PD concepts, pharmaceutics/biopharmaceutics and toxicology fundamentals relevant to Therapeutics topics such as cardiology, infectious disease, neurology, pregnancy/lactation and substance use. The connection is evident in the two streams’ course outcomes, session lists, assessment weights and framework mappings provided for the 2023–24 academic cycle.
Practice Skills
Patient care, communication and applied practice
Therapeutics shares documented learning across Years 1–3 with Practice Skills in clinical assessment and management activities, including patient assessment/pharmacotherapy work‑up, documentation of care, monitoring and follow‑up, patient communication, and some injection administration training. The supplied Therapeutics course and session materials document condition‑focused therapeutic content together with practice‑skill topics that appear in Practice Skills course outcomes and session topics across the three‑year cycle.
These relationships reflect documented curriculum portraits and governed cross-stream evidence. They identify shared or adjacent curriculum territory but do not by themselves demonstrate intentional coordination, integration, sequencing quality or curriculum quality.
How learning is delivered
Instruction is mainly lecture‑based to convey disease‑specific knowledge, augmented by case/seminar blocks that concentrate active learning and team problem solving. Students learn diagnostic and therapeutic principles in concise lectures and then apply them in 110‑minute case seminars, PBL/TBL exercises and occasional lab‑format sessions for laboratory‑value interpretation. Distinctive activities include team‑based seminars on complex therapeutics (transplant, chronic pain), lab sessions interpreting lab values, and problem‑solving case debriefs that integrate pharmacology and clinical decision making.
Documented delivery mix
319Lecture
61Seminar
2Lab
10Other
- Lecture
- Seminar
- Lab
- Other
Year 1
2025-2026n = 46
2024-2025n = 44
2023-2024n = 44
Year 2
2025-2026n = 186
2024-2025n = 178
2023-2024n = 178
Year 3
2025-2026n = 188
2024-2025n = 170
2023-2024n = 170
How learning is assessed
Students are expected to exercise clinical reasoning, make therapeutic decisions, communicate recommendations and engage in case‑based work. Assessment typically uses proctored multiple‑choice midterms and finals to evaluate breadth and accuracy, supplemented by frequent pre‑seminar quizzes that check preparation. Applied learning is captured through care plans, group case presentations, documentation tasks and reflective assignments; seminar participation and small formative tasks support active learning. Peer review is used selectively to evaluate teamwork and individual contributions.
Assessment pattern
27Quiz
10Assignment/written work
10Final exam
10Midterm exam
1Participation/professionalism
- Quiz
- Assignment/written work
- Final exam
- Midterm exam
- Participation/professionalism
Year 1
2025-2026n = 4
2024-2025n = 4
2023-2024n = 6
Year 2
2025-2026n = 22
2024-2025n = 26
2023-2024n = 26
Year 3
2025-2026n = 35
2024-2025n = 26
2023-2024n = 26
Overall focus
The Therapeutics stream covers self‑care/CAM and pulmonary topics in Year 1, organ/system‑based therapeutics in Year 2 (infectious disease, cardiology, nephrology, endocrinology, etc.), and advanced, complex therapeutics in Year 3 (oncology, neurology, geriatrics, transplant, mental health and multimorbidity). Outcomes include knowledge, clinical reasoning skills and professional attitudes.
Development across years
Documented emphasis develops from Year 1 lecture‑based foundational content to increased seminar/case‑based and active‑learning formats in Years 2–3, with assessments shifting from midterm/final exams toward added applied assessments (pre‑seminar quizzes, care plans, group case work). The packet maps topical shifts from respirology/self‑care to infectious disease/cardiology and then to broader complex care.
How to read this curriculum portrait
Top-line metrics summarize the selected academic cycle. Within each curriculum portrait figure, Years 1, 2 and 3 are shown separately so reviewers can compare the same program year across available academic cycles. No Overall distribution is shown.
What students learn
The Therapeutics stream documents broad clinical knowledge and applied therapeutic reasoning across Years 1–3. Outcomes cover self‑care and respirology; infectious disease; fluid/electrolyte, renal and endocrine conditions; cardiology and hematology; GI, dermatology and ophthalmology; oncology; neurology; pain and mental health; transplant and vaccines; and population‑level considerations. Skills emphasized include patient assessment, evidence‑based management, guideline application, dosing adjustments, therapeutic drug monitoring, documentation and communication; attitudes include empathy, advocacy, interdisciplinary collaboration and lifelong learning.
205Documented learning outcomes
321Documented topics
7AFPC roles represented
55CCAPP categories represented
Learning-outcome and curriculum-framework profiles
Learning outcomes
KSAs combine extensive condition‑specific knowledge with robust applied skills in assessment, therapeutic planning and monitoring; attitudes such as empathy and advocacy are explicitly recorded across the curriculum.
- Knowledge
- Skills
- Attitudes
Year 1
2025-2026n = 10
2024-2025n = 16
2023-2024n = 16
Year 2
2025-2026n = 79
2024-2025n = 81
2023-2024n = 81
Year 3
2025-2026n = 108
2024-2025n = 108
2023-2024n = 107
AFPC professional roles
AFPC mappings are highly weighted to the Care Provider role with Scholar representations, documenting curriculum emphasis on clinical practice competencies supported by evidence‑oriented scholarship.
- Care Provider
- Scholar
- Health Advocate
- Leader-Manager
- Communicator
- Other
Year 1
2025-2026n = 58
2024-2025n = 56
2023-2024n = 56
Year 2
2025-2026n = 208
2024-2025n = 214
2023-2024n = 214
Year 3
2025-2026n = 219
2024-2025n = 224
2023-2024n = 224
CCAPP curriculum topics
CCAPP mappings concentrate in clinical sciences (respirology, infectious disease, cardiology, dermatology) and practice‑skills (patient assessment/work‑ups), documenting extensive clinical topic coverage and hands‑on therapeutic reasoning training.
- infectious disease
- respirology
- patient assessment/pharmacotherapy work-up
- dermatology
- gastroenterology
- Other
Year 1
2025-2026n = 58
2024-2025n = 56
2023-2024n = 56
Year 2
2025-2026n = 208
2024-2025n = 214
2023-2024n = 214
Year 3
2025-2026n = 219
2024-2025n = 224
2023-2024n = 224
View all mapped CCAPP topic categories
Percentages are the governed CCAPP topic-category mapping proportions for the selected program-year perspective in each academic cycle. The denominator used for each cycle is shown in its column header.
| Topic category | 2025-2026 n = 294 | 2024-2025 n = 300 | 2023-2024 n = 300 |
|---|---|---|---|
| infectious disease | 41% | 41% | 41% |
| patient assessment/pharmacotherapy work-up | 16% | 30% | 32% |
| respirology | 25% | 28% | 28% |
| dermatology | 22% | 21% | 21% |
| cardiology | 22% | 18% | 18% |
| gastroenterology | 17% | 17% | 17% |
| conditions affecting head, eyes, ears, nose, throat (EENT) | 19% | 15% | 15% |
| psychiatric and mental health | 15% | 14% | 14% |
| endocrinology | 19% | 13% | 13% |
| pain | 18% | 12% | 12% |
| neurology | 13% | 12% | 12% |
| pathophysiology | 6% | 10% | 10% |
| sexual and reproductive health | 12% | 10% | 10% |
| microbiology | 3% | 10% | 10% |
| nephrology | 15% | 10% | 10% |
| patient self-care and management of minor ailments | 10% | 10% | 8% |
| nutrition | 8% | 9% | 9% |
| rheumatology | 8% | 8% | 8% |
| traditional, complementary, and alternative medicine | 5% | 8% | 8% |
| oncology | 9% | 8% | 8% |
| hematology | 8% | 7% | 7% |
| substance use disorders, dependency, and addiction | 6% | 6% | 6% |
| healthcare education | 4% | 6% | 6% |
| public health | 7% | 6% | 6% |
| pharmacokinetics | 4% | 5% | 5% |
| documentation of care | 1% | 5% | 5% |
| drugs in pregnancy and lactation | 2% | 5% | 5% |
| pharmacology | 6% | 5% | 5% |
| monitoring & follow-up | 6% | 4% | 4% |
| healthcare systems and health economics | 3% | 4% | 4% |
| urology | 3% | 3% | 3% |
| patient safety | 1% | 3% | 3% |
| physical assessment | 5% | 3% | 3% |
| collaborative care and shared decision-making | 1% | 3% | 3% |
| patient and professional communications | — | 3% | 3% |
| pharmacoepidemiology | — | 3% | 3% |
| quality improvement | 3% | 2% | 2% |
| pharmacy law and regulatory issues | 3% | 2% | 2% |
| administration of drugs by injection | 3% | 2% | 2% |
| care plan development | 2% | 2% | 2% |
| diagnostic and point-of-care testing | — | 1% | 1% |
| drug information provision | 4% | 1% | 1% |
| molecular and cell biology | 1% | 1% | 1% |
| physiology | 1% | 1% | 1% |
| immunology | 4% | 1% | 1% |
| professional identity formation | 3% | 1% | 1% |
| cultural diversity | 1% | 1% | 1% |
| best possible medication history and medication reconciliation | — | 1% | 1% |
| health equity and social determinants of health | 3% | 1% | 1% |
| prescriptive decision making (i.e. prescribing, deprescribing, adapting a prescription) | 3% | 1% | 1% |
| cultural safety, humility, and responsiveness | 2% | 1% | 1% |
| evidence-based decision making | 2% | 1% | 1% |
| health advocacy | 1% | 1% | 1% |
| pharmacist patient care process | 1% | 1% | 1% |
| care plan implementation | — | 1% | 1% |
| professional learning and development | 4% | — | — |
| digital health | 1% | — | — |
| health systems planning | 1% | — | — |
| professional wellbeing | 1% | — | — |
Relationships with other streams
These summaries identify documented areas of shared or adjacent curriculum with the other program streams.
BASE
Professional, regulatory and health-system context
Across Years 1–3 Therapeutics connects around patient and professional communications, patient assessment/pharmacotherapy work‑up, evidence‑based therapeutic decision making and drug information that align with BASE content. The supplied course outcomes and mappings also indicate shared emphasis on healthcare systems/public health, patient safety and quality improvement, cultural safety/Indigenous health, leadership/management and health advocacy.
Pharmaceutical Sciences
Scientific foundations for pharmacy practice
Therapeutics across 2024–25 documents extensive clinical and practice‑skill content that aligns with Pharmaceutical Sciences fundamentals in pharmacology, PK/PD, pharmaceutics and toxicology relevant to clinical topics such as respirology, cardiology, infectious disease, neurology and oncology. This alignment is supported by the streams’ course outcomes, session lists, assessment weights and framework mappings in the 2024–25 documentation.
Practice Skills
Patient care, communication and applied practice
Across the 2024–25 cycle, Therapeutics documents extensive condition‑specific therapeutic knowledge and clinical reasoning that connects with Practice Skills in patient assessment/pharmacotherapy work‑up, documentation and care‑plan activities, monitoring/follow‑up, communication, and occasional injection administration. The supplied Therapeutics course portraits and session lists show topic blocks and case work that overlap with Practice Skills’ documented applied patient‑care sessions.
These relationships reflect documented curriculum portraits and governed cross-stream evidence. They identify shared or adjacent curriculum territory but do not by themselves demonstrate intentional coordination, integration, sequencing quality or curriculum quality.
How learning is delivered
The stream combines frequent lecture blocks for content delivery with scheduled longer seminars that prioritize applied case work and team problem solving. Students learn core therapeutic principles through concise lectures and then consolidate via PBL/TBL seminars, lab sessions for lab‑value interpretation, and focused debriefs. Distinctive learning activities include multidisciplinary case seminars, oncology and transplant case work, and practice interpreting laboratory data in clinical context.
Documented delivery mix
319Lecture
61Seminar
2Lab
10Other
- Lecture
- Seminar
- Lab
- Other
Year 1
2025-2026n = 46
2024-2025n = 44
2023-2024n = 44
Year 2
2025-2026n = 186
2024-2025n = 178
2023-2024n = 178
Year 3
2025-2026n = 188
2024-2025n = 170
2023-2024n = 170
How learning is assessed
Students are expected to apply therapeutic knowledge to patient cases, demonstrate clinical decision making, and communicate care plans. Assessment combines proctored multiple‑choice midterms and finals for summative judgement, frequent pre‑seminar quizzes to verify preparation, and applied assignments (care plans, documentation, group presentations) to evaluate reasoning and communication. Seminar assignments and small reflective tasks provide iterative feedback and a record of engagement. Peer review and clinic assignments are used where teamwork and practical exposure are required.
Assessment pattern
23Quiz
11Assignment/written work
10Final exam
10Midterm exam
2Participation/professionalism
- Quiz
- Assignment/written work
- Final exam
- Midterm exam
- Participation/professionalism
Year 1
2025-2026n = 4
2024-2025n = 4
2023-2024n = 6
Year 2
2025-2026n = 22
2024-2025n = 26
2023-2024n = 26
Year 3
2025-2026n = 35
2024-2025n = 26
2023-2024n = 26
Overall focus
The Therapeutics stream documents comprehensive, condition‑specific knowledge, clinical assessment and therapeutic planning across Years 1–3, spanning self‑care and respiratory topics through organ/system therapeutics and complex population care. Skills include patient assessment, guideline‑based plan development, therapeutic drug monitoring, literature appraisal and collaborative practice; attitudes emphasize equity, empathy and lifelong learning.
Development across years
Documented progression shifts from foundational/minor‑ailment topics in Year 1 to organ‑system and guideline‑based therapeutic knowledge in Year 2 and then to complex/population‑focused therapeutics in Year 3. Delivery and assessment documentation move from lecture‑dominant Year‑1 formats toward more seminar/case work, labs/clinic activities and varied applied assessments in later years.
How to read this curriculum portrait
Top-line metrics summarize the selected academic cycle. Within each curriculum portrait figure, Years 1, 2 and 3 are shown separately so reviewers can compare the same program year across available academic cycles. No Overall distribution is shown.
What students learn
The Therapeutics stream documents comprehensive condition‑specific knowledge and applied clinical skills across Years 1–3: self‑care and pulmonary conditions, infectious disease, cardiology, endocrinology, nephrology, GI, dermatology, oncology, neurology, pain, mental health, transplant, geriatrics/pediatrics and vaccines. Outcomes include epidemiology, pathophysiology, clinical presentation and assessment, pharmacology and PK/PD considerations, guideline‑based therapeutic approaches, therapeutic drug monitoring, diagnostic interpretation and care‑plan development; attitudes emphasize equity, inclusivity, empathy and lifelong learning.
197Documented learning outcomes
387Documented topics
7AFPC roles represented
54CCAPP categories represented
Learning-outcome and curriculum-framework profiles
Learning outcomes
Documented KSAs show extensive clinical knowledge paired with many applied skills for assessment, therapeutic planning and monitoring; attitudinal outcomes emphasize advocacy, inclusivity and professional caring.
- Knowledge
- Skills
- Attitudes
Year 1
2025-2026n = 10
2024-2025n = 16
2023-2024n = 16
Year 2
2025-2026n = 79
2024-2025n = 81
2023-2024n = 81
Year 3
2025-2026n = 108
2024-2025n = 108
2023-2024n = 107
AFPC professional roles
AFPC mappings overwhelmingly map to the Care Provider role with Scholar representation, documenting focus on patient care competencies supported by scholarly practice and evidence appraisal.
- Care Provider
- Scholar
- Health Advocate
- Professional
- Communicator
- Other
Year 1
2025-2026n = 58
2024-2025n = 56
2023-2024n = 56
Year 2
2025-2026n = 208
2024-2025n = 214
2023-2024n = 214
Year 3
2025-2026n = 219
2024-2025n = 224
2023-2024n = 224
CCAPP curriculum topics
CCAPP mappings emphasize infectious disease, cardiology, endocrinology and nephrology among many clinical categories, together with practice‑skill mappings for patient assessment and monitoring — documenting a curriculum concentrated on clinical conditions and therapeutic reasoning.
- infectious disease
- respirology
- dermatology
- conditions affecting head, eyes, ears, nose, throat (EENT)
- cardiology
- Other
Year 1
2025-2026n = 58
2024-2025n = 56
2023-2024n = 56
Year 2
2025-2026n = 208
2024-2025n = 214
2023-2024n = 214
Year 3
2025-2026n = 219
2024-2025n = 224
2023-2024n = 224
View all mapped CCAPP topic categories
Percentages are the governed CCAPP topic-category mapping proportions for the selected program-year perspective in each academic cycle. The denominator used for each cycle is shown in its column header.
| Topic category | 2025-2026 n = 294 | 2024-2025 n = 300 | 2023-2024 n = 300 |
|---|---|---|---|
| infectious disease | 41% | 41% | 41% |
| respirology | 25% | 28% | 28% |
| cardiology | 22% | 18% | 18% |
| dermatology | 22% | 21% | 21% |
| endocrinology | 19% | 13% | 13% |
| conditions affecting head, eyes, ears, nose, throat (EENT) | 19% | 15% | 15% |
| pain | 18% | 12% | 12% |
| gastroenterology | 17% | 17% | 17% |
| patient assessment/pharmacotherapy work-up | 16% | 30% | 32% |
| nephrology | 15% | 10% | 10% |
| psychiatric and mental health | 15% | 14% | 14% |
| neurology | 13% | 12% | 12% |
| sexual and reproductive health | 12% | 10% | 10% |
| patient self-care and management of minor ailments | 10% | 10% | 8% |
| oncology | 9% | 8% | 8% |
| nutrition | 8% | 9% | 9% |
| hematology | 8% | 7% | 7% |
| rheumatology | 8% | 8% | 8% |
| public health | 7% | 6% | 6% |
| monitoring & follow-up | 6% | 4% | 4% |
| pharmacology | 6% | 5% | 5% |
| substance use disorders, dependency, and addiction | 6% | 6% | 6% |
| pathophysiology | 6% | 10% | 10% |
| traditional, complementary, and alternative medicine | 5% | 8% | 8% |
| physical assessment | 5% | 3% | 3% |
| pharmacokinetics | 4% | 5% | 5% |
| healthcare education | 4% | 6% | 6% |
| professional learning and development | 4% | — | — |
| immunology | 4% | 1% | 1% |
| drug information provision | 4% | 1% | 1% |
| urology | 3% | 3% | 3% |
| professional identity formation | 3% | 1% | 1% |
| microbiology | 3% | 10% | 10% |
| health equity and social determinants of health | 3% | 1% | 1% |
| prescriptive decision making (i.e. prescribing, deprescribing, adapting a prescription) | 3% | 1% | 1% |
| quality improvement | 3% | 2% | 2% |
| healthcare systems and health economics | 3% | 4% | 4% |
| pharmacy law and regulatory issues | 3% | 2% | 2% |
| administration of drugs by injection | 3% | 2% | 2% |
| drugs in pregnancy and lactation | 2% | 5% | 5% |
| cultural safety, humility, and responsiveness | 2% | 1% | 1% |
| care plan development | 2% | 2% | 2% |
| evidence-based decision making | 2% | 1% | 1% |
| collaborative care and shared decision-making | 1% | 3% | 3% |
| health advocacy | 1% | 1% | 1% |
| pharmacist patient care process | 1% | 1% | 1% |
| molecular and cell biology | 1% | 1% | 1% |
| cultural diversity | 1% | 1% | 1% |
| documentation of care | 1% | 5% | 5% |
| patient safety | 1% | 3% | 3% |
| physiology | 1% | 1% | 1% |
| digital health | 1% | — | — |
| health systems planning | 1% | — | — |
| professional wellbeing | 1% | — | — |
| patient and professional communications | — | 3% | 3% |
| pharmacoepidemiology | — | 3% | 3% |
| diagnostic and point-of-care testing | — | 1% | 1% |
| best possible medication history and medication reconciliation | — | 1% | 1% |
| care plan implementation | — | 1% | 1% |
Relationships with other streams
These summaries identify documented areas of shared or adjacent curriculum with the other program streams.
BASE
Professional, regulatory and health-system context
Across Years 1–3 Therapeutics connects around pharmacy law and regulatory issues, patient and professional communication, evidence‑based therapeutic decision making and drug information that align with BASE content. The documented course outcomes, session listings and mappings additionally show shared emphasis on leadership/management, healthcare systems and economics, quality improvement, public health and health advocacy.
Pharmaceutical Sciences
Scientific foundations for pharmacy practice
Therapeutics in 2025–26 documents extensive clinical and practice‑skill content that aligns with Pharmaceutical Sciences fundamentals in pharmacology, PK/PD, pharmaceutics and toxicology across topics such as respirology, cardiology, infectious disease, oncology and neurology. The documented overlap is shown in course outcomes, session lists, assessment summaries and framework mappings supplied for the academic cycle.
Practice Skills
Patient care, communication and applied practice
Across the 2025–26 cycle, Therapeutics documents extensive condition‑focused knowledge and applied therapeutic decision‑making that connects with Practice Skills in patient assessment/pharmacotherapy work‑up, care‑plan development and monitoring, documentation, communication and some injection training. The stream‑level portraits and session inventories present Therapeutics topic blocks and assessments that overlap with Practice Skills’ applied labs and OSCE‑style evaluations.
These relationships reflect documented curriculum portraits and governed cross-stream evidence. They identify shared or adjacent curriculum territory but do not by themselves demonstrate intentional coordination, integration, sequencing quality or curriculum quality.
How learning is delivered
Learning is organized around in‑person lectures for content delivery and seminar/case sessions for applied problem solving, with some asynchronous materials and occasional clinic‑style activities. Students absorb disease‑specific knowledge in lectures and then practice management through PBL/TBL seminars, lab‑value interpretation exercises and integrated case presentations. Distinctive activities across years include an in‑person BP screening clinic, pre‑recorded preparatory content, and group presentations followed by expert debriefs.
Documented delivery mix
324Lecture
59Seminar
3Lab
34Other
- Lecture
- Seminar
- Lab
- Other
Year 1
2025-2026n = 46
2024-2025n = 44
2023-2024n = 44
Year 2
2025-2026n = 186
2024-2025n = 178
2023-2024n = 178
Year 3
2025-2026n = 188
2024-2025n = 170
2023-2024n = 170
How learning is assessed
Students are expected to demonstrate accurate therapeutic knowledge under timed conditions, consistent pre‑class preparation, and applied case management skills. The characteristic assessment mix includes proctored computer‑based midterms and finals with MCQ and short‑answer items, frequent seminar/quizzes with explicit windows and absence policies, and numerous applied artifacts—care plans, documentation uploads, brief seminar assignments and group presentations—that assess clinical reasoning and communication. Participation tasks and structured peer review capture professional engagement; some courses use explicit policies to reallocate marks for excused absences.
Assessment pattern
27Quiz
10Final exam
10Midterm exam
9Assignment/written work
5Participation/professionalism
- Quiz
- Final exam
- Midterm exam
- Assignment/written work
- Participation/professionalism
Year 1
2025-2026n = 4
2024-2025n = 4
2023-2024n = 6
Year 2
2025-2026n = 22
2024-2025n = 26
2023-2024n = 26
Year 3
2025-2026n = 35
2024-2025n = 26
2023-2024n = 26
Explore the Curriculum
What curriculum records sit behind this overview?
Use these searchable records to verify the course, session and assessment evidence behind the curriculum portrait. The browser supports inspection and verification rather than additional curriculum analysis.
Course Information
| PHARM 243 — PHARM 243 - Pharmacotherapy I | Y1 | Winter | 38 | 6 | 0 | Assignment/written work (3); Final exam (1); Midterm exam (1); Quiz (1) | — |
| PHARM 343 — PHARM 343 - Pharmacotherapy 2 | Y2 | Fall | 34 | 6 | 2 | Final exam (1); Midterm exam (1); Quiz (6) | — |
| PHARM 344 — PHARM 344 - Pharmacotherapy 3 | Y2 | Winter | 35 | 9 | 0 | Assignment/written work (1); Final exam (1); Midterm exam (1); Quiz (5) | — |
| PHARM 345 — PHARM 345 - Pharmacotherapy 4 | Y2 | Winter | 39 | 5 | 0 | Final exam (1); Midterm exam (1); Quiz (4) | — |
| PHARM 346 — PHARM 346 - Pharmacotherapy 5 | Y2 | Winter | 36 | 6 | 0 | Assignment/written work (1); Final exam (1); Midterm exam (1); Quiz (1) | — |
| PHARM 443 — PHARM 443 - Pharmacotherapy 6 | Y3 | Fall | 23 | 6 | 0 | Final exam (1); Midterm exam (1); Quiz (4) | — |
| PHARM 444 — PHARM 444 - Pharmacotherapy 7 | Y3 | Fall | 25 | 6 | 0 | Assignment/written work (2); Final exam (1); Midterm exam (1); Participation/professionalism (1); Quiz (2) | — |
| PHARM 445 — PHARM 445 - Pharmacotherapy 8 | Y3 | Fall | 37 | 6 | 0 | Assignment/written work (1); Final exam (1); Midterm exam (1); Quiz (2) | — |
| PHARM 446 — PHARM 446 - Pharmacotherapy 9 | Y3 | Winter | 25 | 6 | 0 | Final exam (1); Midterm exam (1); Quiz (1) | — |
| PHARM 448 — PHARM 448 - Pharmacotherapy 10 | Y3 | Winter | 27 | 5 | 0 | Assignment/written work (2); Final exam (1); Midterm exam (1); Quiz (1) | — |
Session Information
| PHARM 243 | Y1 | Winter | 2024-01-08 | Lecture | Lecture 1: CAM 1 | Review of course syllabus, Introduction to course assignments, , Introduction to CAM | P. Gill, D. Barnes |
| PHARM 243 | Y1 | Winter | 2024-01-10 | Lecture | Lecture 2: CAM 2 | Modalities and providers: Part I | D. Barnes |
| PHARM 243 | Y1 | Winter | 2024-01-12 | Lecture | Lecture 3: CAM 3 | Modalities and providers: Part II | D. Barnes |
| PHARM 243 | Y1 | Winter | 2024-01-15 | Lecture | Lecture 4: CAM 4 | Role of pharmacists in recommendations / referrals and collaboration, , , Natural Health Products, Regulations for drug information | D. Barnes |
| PHARM 243 | Y1 | Winter | 2024-01-17 | Lecture | Lecture 5: Eye | Eye Conditions, Dry Eye Disease, Contact Lens Care | D. Barnes |
| PHARM 243 | Y1 | Winter | 2024-01-19 | Lecture | Lecture 6: Ear | Otitis Externa, Minor Ear Pain, Impacted Ear Wax | D. Barnes |
| PHARM 243 | Y1 | Winter | 2024-01-22 | Lecture | Lecture 7 in AM: GI 1 | Hemorrhoids, Gastrointestinal Gas | D. Barnes |
| PHARM 243 | Y1 | Winter | 2024-01-22 | Lecture | Lecture 8 in PM: GI 2 | Heart Burn (Dyspepsia and GERD) | D. Barnes (See google calendar for lecture) |
| PHARM 243 | Y1 | Winter | 2024-01-23 | Seminar/case session | Seminar 1: Eye/Ear | Eye Cases, Ear Cases, O-P-E‚ÇÇ-N Presentation - "Over-the-counter Products related to Eyes, Ears, and NHP" | D. Barnes |
| PHARM 243 | Y1 | Winter | 2024-01-24 | Lecture | Lecture 9: Dental | Bad Breath (Halitosis), Dry Mouth (Xerostomia), Canker Sores (Oral Apthous Ulcers), | D. Barnes |
| PHARM 243 | Y1 | Winter | 2024-01-26 | Lecture | Lecture 10: Self Care Catch Up | Lecture 10: Self Care Catch Up | D. Barnes |
| PHARM 243 | Y1 | Winter | 2024-01-29 | Lecture | Lecture 11: Dermatological 1 | Intro to Derm, Physical Assessment, Hair, Skin, Nails, Sun Safety | R. Sanghera |
| PHARM 243 | Y1 | Winter | 2024-01-31 | Lecture | Lecture 12: Dermatological 2 | Lice & Scabies (Con't on Feb 1st) (Pediculosis) | R. Sanghera |
| PHARM 243 | Y1 | Winter | 2024-02-01 | Lecture | Lecture 13: Dermatological 3 | Corns/ Calluses / Bunions / Warts | R. Sanghera |
| PHARM 243 | Y1 | Winter | 2024-02-02 | Lecture | Lecture 14: Dermatological 4 | Dry Skin (Xerosis), Overview of Dermatitis, Dandruff/Seborrheic Dermatitis, Diaper Dermatitis | R. Sanghera |
| PHARM 243 | Y1 | Winter | 2024-02-05 | Lecture | Lecture 15: Dermatological 5 | Acne | R. Sanghera |
| PHARM 243 | Y1 | Winter | 2024-02-06 | Seminar/case session | Seminar 2: Dental and GI Cases | Seminar 2: Dental and GI Cases | D. Barnes |
| PHARM 243 | Y1 | Winter | 2024-02-07 | Lecture | Lecture 16: Dermatological 6 | Burns, Insect Bites and Stings, Minor Cuts and Wounds | R. Sanghera |
| PHARM 243 | Y1 | Winter | 2024-02-09 | Lecture | Lecture 17: Dermatological 7 | Heat-Related Illnesses, Perspiration and Body Odour | R. Sanghera |
| PHARM 243 | Y1 | Winter | 2024-02-12 | Lecture | Lecture 18: Acute Pain | Sports Injuries, Lower Back Pain, Tension-Type Headaches | D. Barnes |
| PHARM 243 | Y1 | Winter | 2024-02-14 | Seminar/case session | Seminar 3: Dermatology | Seminar 3: Dermatology | R. Sanghera |
| PHARM 243 | Y1 | Winter | 2024-02-26 | Lecture | Lecture 19: Acute Pain | Sports Injuries, Lower back pain, Tension Type Headaches | D. Barnes |
| PHARM 243 | Y1 | Winter | 2024-02-27 | Lecture | Lecture 20: Cough and Cold 1 | Assessment, Nonpharmacological management, Pharmacological management, Follow-up & Monitoring | D. Barnes |
| PHARM 243 | Y1 | Winter | 2024-02-28 | Lecture | Lecture 21: Allergic Rhinitis | Assessment, Non-pharmacological management | D. Barnes |
| PHARM 243 | Y1 | Winter | 2024-03-01 | Lecture | Lecture 22: Allergic Rhinitis | Pharmacotherapy, Monitoring & Follow-up | D. Barnes |
| PHARM 243 | Y1 | Winter | 2024-03-04 | Lecture | Lecture 23: Asthma | Pathophysiology, signs and symptoms, Epidemiology, Risk factors, triggers, and comorbidities, Diagnosis | P. Gill |
| PHARM 243 | Y1 | Winter | 2024-03-06 | Lecture | Lecture 24: Asthma 2 | Assessment, Asthma Management | P. Gill |
| PHARM 243 | Y1 | Winter | 2024-03-08 | Lecture | Lecture 25: Derm Complete | Completion of Derm Block | R. Sanghera |
| PHARM 243 | Y1 | Winter | 2024-03-11 | Lecture | Lecture 26: Asthma 3 | Asthma Management (Education and non-pharmacological approaches) | P. Gill |
| PHARM 243 | Y1 | Winter | 2024-03-12 | Seminar/case session | Seminar 4: Cough and Cold, Pain | Seminar 4: Cough and Cold, Pain | D. Barnes |
| PHARM 243 | Y1 | Winter | 2024-03-13 | Lecture | Lecture 27: Asthma 4 | Pharmacotherapy, Inhaled delivery devices | P. Gill |
| PHARM 243 | Y1 | Winter | 2024-03-15 | Lecture | Lecture 28: Asthma 5 | Pharmacotherapy, Inhaled delivery devices cont | P. Gill |
| PHARM 243 | Y1 | Winter | 2024-03-18 | Lecture | Lecture 29: Asthma 6 | Asthma exacerbations, Management of asthma exacerbations, Special populations (pediatric, pregnancy) | P. Gill |
| PHARM 243 | Y1 | Winter | 2024-03-20 | Lecture | Lecture 30: Asthma 7 | Special Populations | P. Gill |
| PHARM 243 | Y1 | Winter | 2024-03-22 | Lecture | Lecture 31: Asthma 8 | Asthma action plants, Monitoring & follow-up, Comparison between Asthma & COPD | P. Gill |
| PHARM 243 | Y1 | Winter | 2024-03-25 | Lecture | Lecture 32: COPD 1 | Epidemiology, risk factors, screening | P. Gill |
| PHARM 243 | Y1 | Winter | 2024-03-26 | Seminar/case session | Seminar 5: Asthma, Seasonal Allergies | Seminar 5: Asthma, Seasonal Allergies | P. Gill, D. Barnes |
| PHARM 243 | Y1 | Winter | 2024-03-27 | Lecture | Lecture 33: COPD 2 | Assessment, diagnosis, therapeutic approach | P. Gill |
| PHARM 243 | Y1 | Winter | 2024-04-03 | Lecture | Lecture 34: COPD 3 | Stable COPD, bronchodilators | P. Gill |
| PHARM 243 | Y1 | Winter | 2024-04-05 | Lecture | Lecture 35: COPD 4 | Acute exacerbations, antiinflammatories, COPD Action Plan | P. Gill |
| PHARM 243 | Y1 | Winter | 2024-04-08 | Lecture | Lecture 36: Tobacco Cessation 1 | Assessment, NRT | P. Gill |
| PHARM 243 | Y1 | Winter | 2024-04-09 | Seminar/case session | Seminar 6: COPD | Seminar 6: COPD | P. Gill |
| PHARM 243 | Y1 | Winter | 2024-04-10 | Lecture | Lecture 37: Tobacco Cessation 2 | Pharmacotherapy | P. Gill |
| PHARM 243 | Y1 | Winter | 2024-04-12 | Lecture | Lecture 38: Tobacco Cessation 3 | Pharmacotherapy and Alternate Products and Review | P. Gill |
| PHARM 343 | Y2 | Fall | 2023-09-06 | Lecture | Course overview & Conditions of Fluid Imbalance | Review principles of fluid homeostasis, Describe signs and symptoms of conditions of fluid imbalance, Describe an approach to management of conditions of fluid imbalance | Scot Simpson |
| PHARM 343 | Y2 | Fall | 2023-09-08 | Lecture | Conditions of Sodium Imbalance | Describe the signs and symptoms of electrolyte abnormalities, Describe management strategies for electrolyte abnormalities | Scot Simpson |
| PHARM 343 | Y2 | Fall | 2023-09-11 | Lecture | Conditions of Potassium and Magnesium Imbalance | Describe the signs and symptoms of electrolyte abnormalities, Describe management strategies for electrolyte abnormalities | Scot Simpson |
| PHARM 343 | Y2 | Fall | 2023-09-13 | Other exam/test | Laboratory Test Stewardship | Review the pharmacy practice standards related to laboratory testing, Describe issues related to ordering and interpreting laboratory tests, Describe basic principles and terminology related to laboratory testing, Highlight issues related to point of care testing | Scot Simpson |
| PHARM 343 | Y2 | Fall | 2023-09-14 | Seminar/case session | S-1 Fluid & Electrolyte Conditions | See below for details on Seminar format., Relevant Lectures: 1-3 | — |
| PHARM 343 | Y2 | Fall | 2023-09-15 | Laboratory | Endocrine and Cardiovascular Laboratory Values | Interpret the clinical implications of laboratory tests | Scot Simpson |
| PHARM 343 | Y2 | Fall | 2023-09-18 | Laboratory | Hematology, Liver, & GI Laboratory Values | Interpret the clinical implications of laboratory tests | Scot Simpson |
| PHARM 343 | Y2 | Fall | 2023-09-20 | Lecture | Acid/Base Disorders | Identify mechanisms that regulate acid-base balance, Describe 4 primary and secondary types of acid-base disorders, Describe management strategies for acid-base disorders | Joey Ton |
| PHARM 343 | Y2 | Fall | 2023-09-22 | Other exam/test | Introduction to Kidney Diseases & Renal Laboratory Tests | Describe basic kidney physiology and function, Differentiate between acute kidney injury and chronic kidney disease, Apply a systematic approach to assessing kidney function, Interpret the various laboratory tests used to assess kidney function | Rene Breault |
| PHARM 343 | Y2 | Fall | 2023-09-25 | Lecture | Chronic Kidney Disease-1 | Describe the risk factors, etiology, and pathophysiology of CKD, Identify stages of CKD, Explain the role of angiotensin II in the development of CKD, Demonstrate knowledge of factors leading to the progression of CKD, Assess a patient with CKD, Select appropriate management strategies to delay CKD progression | Rene Breault |
| PHARM 343 | Y2 | Fall | 2023-09-27 | Lecture | Chronic Kidney Disease-2 | Describe the risk factors, etiology, and pathophysiology of CKD, Identify stages of CKD, Explain the role of angiotensin II in the development of CKD, Demonstrate knowledge of factors leading to the progression of CKD, Assess a patient with CKD, Select appropriate management strategies to delay CKD progression | Rene Breault |
| PHARM 343 | Y2 | Fall | 2023-09-28 | Seminar/case session | S-2 Laboratory Values & Acid/Base Disorders | See below for details on Seminar format., Relevant Lectures: 4-7 | — |
| PHARM 343 | Y2 | Fall | 2023-09-29 | Lecture | Chronic Kidney Disease-Management of Complications 1 | Describe common complications associated with CKD, Recognize signs and symptoms of common complications associated with CKD, Describe management of common complications associated with CKD | Rene Breault |
| PHARM 343 | Y2 | Fall | 2023-10-02 | Lecture | Chronic Kidney Disease-Management of Complications 2 | Describe common complications associated with CKD, Recognize signs and symptoms of common complications associated with CKD, Describe management of common complications associated with CKD | Rene Breault |
| PHARM 343 | Y2 | Fall | 2023-10-04 | Lecture | Drug Dosing in Renal Impairment | Review effects of chronic kidney disease on pharmacokinetic parameters, Describe methods to estimate renal function, Describe an approach to adjusting drug dosage in renal impairment | Rene Breault |
| PHARM 343 | Y2 | Fall | 2023-10-06 | Lecture | Acute Kidney Injury-1 | Define acute kidney injury, Describe the different types of acute kidney injury, Explain an approach to assessment of patients with acute kidney injury, Identify causes of acute kidney injury, Describe management of acute kidney injury | Rene Breault |
| PHARM 343 | Y2 | Fall | 2023-10-11 | Lecture | Acute Kidney Injury-2 | Define acute kidney injury, Describe the different types of acute kidney injury, Explain an approach to assessment of patients with acute kidney injury, Identify causes of acute kidney injury, Describe management of acute kidney injury | Rene Breault |
| PHARM 343 | Y2 | Fall | 2023-10-12 | Seminar/case session | S-3 Chronic Kidney Disease & Drug Dosing in Renal Impairment | See below for details on Seminar format., Relevant Lectures: 8-12 | — |
| PHARM 343 | Y2 | Fall | 2023-10-13 | Lecture | Lower Urinary Tract Symptoms: Introduction | Describe the epidemiology, pathophysiology, and risk factors for urinary incontinence, Classify the types of incontinence based on clinical presentation | Cheryl Sadowski |
| PHARM 343 | Y2 | Fall | 2023-10-16 | Lecture | Lower Urinary Tract Symptoms: Non-pharmacologic | Identify conservative management approaches for urinary incontinence and pelvic organ prolapse, Describe the potential role of the community pharmacist in client education on management | Kathleen Hunter |
| PHARM 343 | Y2 | Fall | 2023-10-18 | Lecture | Lower Urinary Tract Symptoms: Pharmacologic | Identify appropriate drug therapy for each type of urinary incontinence, Describe safety considerations for each class of drug therapy, Select appropriate monitoring parameters for each drug therapy | Cheryl Sadowski |
| PHARM 343 | Y2 | Fall | 2023-10-20 | Lecture | Lower Urinary Tract Symptoms: Case Studies | Describe the components of a continence assessment, Identify drug-related problems related to LUTS case studies, Design a care plan for a given case involving LUTS, Contrast the roles of key interprofessional team members in assessment of urinary incontinence, Discuss the role of the pharmacist in assessment and referral for a patient with LUTS | Cheryl Sadowski and Kathleen Hunter |
| PHARM 343 | Y2 | Fall | 2023-10-23 | Lecture | Diabetes Epidemiology | Describe the epidemiology and common classifications of diabetes, List the diagnostic criteria for diabetes and prediabetes, Describe the screening recommendations and risk factors for diabetes, Explain how to choose a treatment target for diabetes | Scot Simpson |
| PHARM 343 | Y2 | Fall | 2023-10-25 | Lecture | Calcium Metabolism/PTH/Vit D | Identify the key hormones involved in the regulation of calcium phosphate and bone mineral metabolism, Describe disorders of calcium homeostasis, Describe treatment options and strategies for disorders of calcium homeostasis | Michael Doschak |
| PHARM 343 | Y2 | Fall | 2023-10-26 | Seminar/case session | S-4 Acute Kidney Injury | See below for details on Seminar format., Relevant Lectures: 13-15 | — |
| PHARM 343 | Y2 | Fall | 2023-10-27 | Lecture | Renal Replacement Therapies | Describe the fundamental concepts of dialysis therapy, Describe the different types of renal replacement therapy | Ravina Sanghera |
| PHARM 343 | Y2 | Fall | 2023-10-30 | Lecture | Type 1 Diabetes - Clinical Presentation & Rationale for Insulin Administration | Identify key features in the clinical presentation of type 1 diabetes, List risk factors associated with type 1 diabetes, Describe the goals of therapy for type 1 diabetes, Explain important differences between insulin formulations, Explain why a basal-bolus regimen is commonly used to treat type 1 diabetes | Scot Simpson |
| PHARM 343 | Y2 | Fall | 2023-11-01 | Midterm exam | MIDTERM | See below for details on Midterm., Relevant Lectures: 1-19,21,22 | — |
| PHARM 343 | Y2 | Fall | 2023-11-03 | Lecture | Treatment of Type 1 Diabetes | Review general considerations of insulin, Develop an initial insulin regimen for someone with type 1 diabetes, Interpret information from a blood glucose log to make an insulin dose adjustment, Describe common adverse effects associated with insulin | Scot Simpson |
| PHARM 343 | Y2 | Fall | 2023-11-06 | Lecture | Acute Complications of Diabetes | Describe reasons for self monitoring blood glucose, Explain the effects of different lifestyle choices (exercise, alcohol, travel, driving) on blood glucose management, Identify resources for diabetes management during Ramadan and other periods of fasting, Explain important considerations for sick day management | Scot Simpson |
| PHARM 343 | Y2 | Fall | 2023-11-08 | Lecture | Type 2 Diabetes - Prevention | Describe the impact of type 2 diabetes on the individual and healthcare system, Explain the pathophysiologic mechanisms contributing to development of type 2 diabetes, List the risk factors for type 2 diabetes, Describe evidence-based lifestyle interventions to prevent development of type 2 diabetes | Dean Eurich |
| PHARM 343 | Y2 | Fall | 2023-11-09 | Seminar/case session | S-5 Insulin Management | See below for details on Seminar format., Relevant Lectures: 20,23,25 (also 29,30) | — |
| PHARM 343 | Y2 | Fall | 2023-11-10 | Lecture | Type 2 Diabetes - Initial Oral Therapy | Describe evidence-based oral therapies to prevent development of type 2 diabetes, List the pharmacologic options for type 2 diabetes treatment, Introduce the Diabetes Canada clinical practice guideline recommendations for glycemic management in type 2 diabetes, Describe the evidence to support using metformin as a first line agent | Dean Eurich |
| PHARM 343 | Y2 | Fall | 2023-11-10 | Lecture | Type 2 Diabetes - Treatment Intensification Pt 1 | Explain why type 2 diabetes is considered a chronic, progressive disease, Explain factors to consider when selecting a second line antihyperglycemic agent, Highlight limitations of the evidence supporting intensive glycemic control in type 2 diabetes | Scot Simpson |
| PHARM 343 | Y2 | Fall | 2023-11-15 | Lecture | Type 2 Diabetes - Treatment Intensification Pt 2 | Explain how to initiate insulin in someone with type 2 diabetes, Describe key observations fro CVOTs that influence clinical practice, Describe other safety signals associated with antihyperglycemic agents, Explain how to initiate insulin in someone with type 2 diabetes | Scot Simpson |
| PHARM 343 | Y2 | Fall | 2023-11-20 | Lecture | Microvascular Complications of Diabetes | Explain why early, aggressive management of diabetes and related complications is necessary, Describe important considerations for diabetes-related microvascular complications | Scot Simpson |
| PHARM 343 | Y2 | Fall | 2023-11-22 | Lecture | Macrovascular Complications of Diabetes | Describe what the "metabolic syndrome" means for diabetes management, Describe important considerations for diabetes-related macrovascular complications, Highlight key components of the ABCDES3 of diabetes care | Scot Simpson |
| PHARM 343 | Y2 | Fall | 2023-11-23 | Seminar/case session | S-6 Treatment of Type 2 Diabetes | See below for details on Seminar format., Relevant Lectures: 26-33 | — |
| PHARM 343 | Y2 | Fall | 2023-11-24 | Lecture | Current Issues in Diabetes Management | Describe the implications of a low carbohydrate diet on diabetes management, Explain how deprescribing applies to diabetes management, Describe selected drug-disease interactions related to diabetes, Highlight selected point-of-care testing devices used for diabetes management, Describe issues related to glucose meter accuracy | Scot Simpson |
| PHARM 343 | Y2 | Fall | 2023-11-27 | Lecture | Pragmatic Tips for Diabetes Management | Discuss practical considerations and patient education tips for people living with diabetes | Randeep Birdi and Eleanor Leoni |
| PHARM 343 | Y2 | Fall | 2023-11-29 | Lecture | Diabetes and Pregnancy | Describe how to screen for gestational diabetes, Explain the implications of gestational diabetes to the mother and baby, Describe management strategies for gestational diabetes, Describe preconception planning for women with pre-existing diabetes | Rose Yeung |
| PHARM 343 | Y2 | Fall | 2023-12-01 | Lecture | Hypothalamus-Pituitary-Adrenal Axis Conditions | Explain management considerations for adrenocortical insufficiency, Explain management considerations for adrenal excess, Explain management considerations for hyperprolactinemia | Scot Simpson |
| PHARM 343 | Y2 | Fall | 2023-12-04 | Lecture | Thyroid Conditions-1: Hypothyroidism | Outline screening recommendations for thyroid disorders, Interpret laboratory tests in patients with thyroid disorders, Describe signs and symptoms, and goals of therapy for thyroid disorders, Develop an appropriate patient-specific treatment and monitoring plan for thyroid disorders, Identify drugs which may cause or interact with treatment of thyroid disorders | Christine Hughes |
| PHARM 343 | Y2 | Fall | 2023-12-06 | Lecture | Thyroid Conditions-2: Hyperthyroidism | Outline screening recommendations for thyroid disorders, Interpret laboratory tests in patients with thyroid disorders, Describe signs and symptoms, and goals of therapy for thyroid disorders, Develop an appropriate patient-specific treatment and monitoring plan for thyroid disorders, Identify drugs which may cause or interact with treatment of thyroid disorders | Christine Hughes |
| PHARM 343 | Y2 | Fall | 2023-12-08 | Lecture | Natural Health Products for Diabetes & Course Review | Identify common natural health products (NHPs) used to help people manage diabetes, Describe how NHPs used for diabetes management can affect blood glucose, Describe common drug interactions associated with NHPs used for diabetes management, Discuss the role of the pharmacist in patient safety surrounding NHP use | Scot Simpson |
| PHARM 344 | Y2 | Winter | 2024-01-08 | Lecture | Lecture 1: Overview of CVD and Hypertension | Orientation & Hypertension | A. Thompson |
| PHARM 344 | Y2 | Winter | 2024-01-10 | Lecture | Lecture 2: Hypertension | Hypertension | A. Thompson |
| PHARM 344 | Y2 | Winter | 2024-01-11 | Lecture | Lecture 3 & 4: Hypertension Parts 3 & 4 | Hypertension | A. Thompson |
| PHARM 344 | Y2 | Winter | 2024-01-12 | Seminar/case session | Seminar 1: Hypertension (PBL Rooms) | Patient Assessment Seminar | A. Thompson |
| PHARM 344 | Y2 | Winter | 2024-01-15 | Seminar/case session | Seminar 1 Debrief: Hypertension | Patient Assessment, Hypertension | A. Thompson |
| PHARM 344 | Y2 | Winter | 2024-01-17 | Lecture | Lecture 5: Dyslipidemia Part 1 | Dyslipidemia | G. Pearson |
| PHARM 344 | Y2 | Winter | 2024-01-19 | Lecture | Lecture 6: Dyslipidemia Part 2 | Dyslipidemia | G. Pearson |
| PHARM 344 | Y2 | Winter | 2024-01-22 | Lecture | Lecture 7: Dyslipidemia Part 3 | Dyslipidemia | G Pearson |
| PHARM 344 | Y2 | Winter | 2024-01-23 | Lecture | Lecture 8: Heart Failure Part 1 | Heart Failure | S. Koshman |
| PHARM 344 | Y2 | Winter | 2024-01-24 | Lecture | Lecture 9: Heart Failure Part 2 | Heart Failure | S. Koshman |
| PHARM 344 | Y2 | Winter | 2024-01-25 | Lecture | Lecture 10: Heart Failure Part 3 | Heart Failure | S. Koshman |
| PHARM 344 | Y2 | Winter | 2024-01-25 | Seminar/case session | Seminar 2: Risk Assessment and Primary Prevention | Risk Assessment & Primary Prevention Seminar | A. Thompson and G. Pearson |
| PHARM 344 | Y2 | Winter | 2024-01-26 | Lecture | Lecture 11: Heart Failure Part 4 | Heart Failure | S. Koshman |
| PHARM 344 | Y2 | Winter | 2024-01-29 | Lecture | Lecture 12: Patient Assessment Heart Failure (pre-recorded) | Patient Assessment - Heart Failure | S. Koshman |
| PHARM 344 | Y2 | Winter | 2024-01-31 | Lecture | Lecture 13: Patient Perspective: from Heart Failure to Heart Transplant and Beyond | Lecture 13: Patient Perspective: from Heart Failure to Heart Transplant and Beyond | M. Bains |
| PHARM 344 | Y2 | Winter | 2024-02-02 | Lecture | Lecture 14: Patient Assessment Chest Pain | Patient Assessment | S. Koshman |
| PHARM 344 | Y2 | Winter | 2024-02-05 | Lecture | Lecture 15 : Stable Ischemic Heart Disease Part 1 | Stable Ischemic Heart Disease/Stable Angina | A. Thompson |
| PHARM 344 | Y2 | Winter | 2024-02-07 | Lecture | Lecture 16: Stable Ischemic Heart Disease Part 2 | Stable Ischemic Heart Disease | A. Thompson |
| PHARM 344 | Y2 | Winter | 2024-02-08 | Seminar/case session | Seminar 3: Heart Failure | Heart Failure Seminar | A. Thompson and S. Koshman |
| PHARM 344 | Y2 | Winter | 2024-02-09 | Lecture | Lecture 17: ACS Part 1 | Acute Coronary Syndromes | M. Ackman |
| PHARM 344 | Y2 | Winter | 2024-02-12 | Lecture | Lecture 18: ACS 2 | Acute Coronary Syndromes | M. Ackman |
| PHARM 344 | Y2 | Winter | 2024-02-14 | Lecture | Lecture 19: ACS Part 3 | Acute Coronary Syndromes | M. Ackman |
| PHARM 344 | Y2 | Winter | 2024-02-16 | Midterm exam | Session 20: Midterm Exam | Session 20: Midterm Exam | A. Thompson |
| PHARM 344 | Y2 | Winter | 2024-02-26 | Lecture | Lecture 21: VTE Part 1 | Thromboembolism | T. Bungard |
| PHARM 344 | Y2 | Winter | 2024-02-28 | Lecture | Lecture 22: VTE Part 2 | Thromboembolism | T. Bungard |
| PHARM 344 | Y2 | Winter | 2024-02-29 | Seminar/case session | Seminar 4: ACS | Hypertension and Acute Coronary Syndromes Seminar, Acute Coronary Syndromes Seminar | A. Thompson and M. Ackman |
| PHARM 344 | Y2 | Winter | 2024-03-01 | Lecture | Lecture 23: VTE Part 3 | Thromboembolism | T. Bungard |
| PHARM 344 | Y2 | Winter | 2024-03-04 | Lecture | Lecture 24: VTE Part 4 | Thromboembolism | T. Bungard |
| PHARM 344 | Y2 | Winter | 2024-03-06 | Lecture | Lecture 25: Patient Assessment: Palpitations, Syncope and Pre-Syncope | Patient Assessment | S. Koshman |
| PHARM 344 | Y2 | Winter | 2024-03-08 | Lecture | Lecture 26: AFib Part 1 | Atrial Fibrillation | E. Cowley |
| PHARM 344 | Y2 | Winter | 2024-03-11 | Lecture | Lecture 27: AFib Part 2 | Atrial Fibrillation | E. Cowley |
| PHARM 344 | Y2 | Winter | 2024-03-13 | Lecture | Lecture 28: AFib Part 3 | Atrial Fibrillation | E. Cowley |
| PHARM 344 | Y2 | Winter | 2024-03-14 | Seminar/case session | Seminar 5: VTE | Thromboembolism Seminar | A. Thompson, T. Bungard |
| PHARM 344 | Y2 | Winter | 2024-03-15 | Lecture | Lecture 29: Stroke Part 1 | Stroke | M. Hodgson |
| PHARM 344 | Y2 | Winter | 2024-03-18 | Lecture | Lecture 30: Stroke Part 2 | Stroke | M. Hodgson |
| PHARM 344 | Y2 | Winter | 2024-03-20 | Lecture | Lecture 31: Optimizing Antiplatelets and Anticoagulants | Optimizing Antiplatelets and Anticoagulants | T. Eberhardt |
| PHARM 344 | Y2 | Winter | 2024-03-22 | Seminar/case session | Lecture 32: Optimizing Antiplatelets and Anticoagulants (seminar cases) | Heart Failure | T. Eberhardt |
| PHARM 344 | Y2 | Winter | 2024-03-25 | Lecture | Lecture 33: Debrief Antiplatalet/Anticoagulant Cases | Patient Experience - Stroke | T. Eberhardt |
| PHARM 344 | Y2 | Winter | 2024-03-27 | Lecture | Lecture 34: PGx Part 1 | Pharmacogenomics CV | D. El Sayed |
| PHARM 344 | Y2 | Winter | 2024-03-28 | Seminar/case session | Seminar 6: AFib and Stroke | Atrial Fibrillation and Stroke Seminar | A. Thompson & M. Hodgson |
| PHARM 344 | Y2 | Winter | 2024-04-03 | Lecture | Lecture 35: PGx Part 2 | Lecture 35: PGx Part 2 | D. El Sayed |
| PHARM 344 | Y2 | Winter | 2024-04-05 | Lecture | Lecture 36: Anemia Part 1 | Anemia | C. Hughes |
| PHARM 344 | Y2 | Winter | 2024-04-08 | Lecture | Lecture 37: Anemia Part 2 | Anemia | C. Hughes |
| PHARM 344 | Y2 | Winter | 2024-04-10 | Seminar/case session | Lecture 38: Anemia Cases (seminar format) | Anemia Cases | C. Hughes |
| PHARM 344 | Y2 | Winter | 2024-04-12 | Lecture | Lecture 39: Anemia Case Debrief | Anemia Cases Debrief | C. Hughes |
| PHARM 345 | Y2 | Winter | 2024-01-08 | Lecture | Lecture 1 | Introduction/Nausea and Vomiting | Dr. Leslie |
| PHARM 345 | Y2 | Winter | 2024-01-10 | Lecture | Lecture 2 | Nausea and Vomiting Cont | Dr. Leslie |
| PHARM 345 | Y2 | Winter | 2024-01-12 | Lecture | Lecture 3 | Treatment of Diarrhea | Dr. Leslie |
| PHARM 345 | Y2 | Winter | 2024-01-15 | Lecture | Lecture 4 | Treatment of Constipation Cont | Dr. Leslie |
| PHARM 345 | Y2 | Winter | 2024-01-17 | Lecture | Lecture 5 | Treatment of Constipation | Dr. Leslie |
| PHARM 345 | Y2 | Winter | 2024-01-18 | Seminar/case session | Seminar 1 | Constipation Cases | Dr. Leslie |
| PHARM 345 | Y2 | Winter | 2024-01-19 | Lecture | Lecture 6 | Irritable Bowel Syndrome (IBS) | Dr. Hall |
| PHARM 345 | Y2 | Winter | 2024-01-22 | Lecture | Lecture 7 | Inflammatory Bowel Disease (IBD) | Dr. Hall |
| PHARM 345 | Y2 | Winter | 2024-01-24 | Lecture | Lecture 8 | Inflammatory Bowel Disease (IBD) | Dr. Hall |
| PHARM 345 | Y2 | Winter | 2024-01-26 | Lecture | Lecture 9 | Inflammatory Bowel Disease (IBD) | Dr. Hall |
| PHARM 345 | Y2 | Winter | 2024-01-29 | Lecture | Lecture 10 | Inflammatory Bowel Disease (IBD) | Dr. Hall |
| PHARM 345 | Y2 | Winter | 2024-01-31 | Lecture | Lecture 11 | Liver Disease | Dr. Hall |
| PHARM 345 | Y2 | Winter | 2024-02-01 | Seminar/case session | Seminar 2 | IBD cases | Dr. Hall |
| PHARM 345 | Y2 | Winter | 2024-02-02 | Lecture | Lecture 12 | Liver disease | Dr. Hall |
| PHARM 345 | Y2 | Winter | 2024-02-02 | Lecture | Lecture 14 | Liver Disease Cont | Dr. Yuksel |
| PHARM 345 | Y2 | Winter | 2024-02-05 | Lecture | Lecture 13 | Peptic Ulcer Disease (PUD) | Dr. Makowsky |
| PHARM 345 | Y2 | Winter | 2024-02-07 | Lecture | Lecture 14 | gastrointestinal reflux | Dr. Makowsky |
| PHARM 345 | Y2 | Winter | 2024-02-09 | Lecture | Lecture 15 | Macronutrient Metabolism Overview | Dr. Ussher |
| PHARM 345 | Y2 | Winter | 2024-02-14 | Lecture | Lecture 17 | Macronutrient Metabolism Overview Cont | Dr. Ussher |
| PHARM 345 | Y2 | Winter | 2024-02-16 | Lecture | Lecture 18 | Canada Food Guide & Dietary Reference Intakes | Dr. Ussher |
| PHARM 345 | Y2 | Winter | 2024-02-26 | Lecture | Lecture 19 | Vitamins, Minerals & Other Supplements, Nutritional Deficiencies | Dr. Ussher |
| PHARM 345 | Y2 | Winter | 2024-02-28 | Lecture | Lecture 20 | Vitamins, Minerals & Other Supplements, Nutritional Deficiencies (Part 2) | Dr. Ussher |
| PHARM 345 | Y2 | Winter | 2024-03-01 | Lecture | Lecture 21 | Enteral Nutrition | Leanne Mulesa |
| PHARM 345 | Y2 | Winter | 2024-03-04 | Lecture | Lecture 22 | Parenteral Nutrition | Leanne Mulesa |
| PHARM 345 | Y2 | Winter | 2024-03-06 | Lecture | Lecture 23 | Specialty Diets (Specific medical conditions [e.g. Celiac disease] and Obesity) | Dr. Ussher |
| PHARM 345 | Y2 | Winter | 2024-03-07 | Seminar/case session | Seminar 3 | Brown Bag Nutritional Supplements | Dr. Ussher |
| PHARM 345 | Y2 | Winter | 2024-03-08 | Lecture | Lecture 24 | Specialty Diets & Obesity Cont | Dr. Ussher |
| PHARM 345 | Y2 | Winter | 2024-03-11 | Lecture | Lecture 25 | Nutrition in Pregnancy | Rhonda Bell |
| PHARM 345 | Y2 | Winter | 2024-03-13 | Lecture | Lecture 26 | Nutrition in Pediatrics | Dr. Sanghera |
| PHARM 345 | Y2 | Winter | 2024-03-15 | Lecture | Lecture 27 | Nutrition in Geriatrics/Cachexia | Heather Oga |
| PHARM 345 | Y2 | Winter | 2024-03-18 | Lecture | Lecture 28 | Eye Diseases 1: Infections and inflammation | Dr. Ton/Dr. Hong |
| PHARM 345 | Y2 | Winter | 2024-03-18 | Lecture | Lecture 29 | Eye Diseases 2 Infection and inflammation continued | Dr. Ton/Dr. Hong |
| PHARM 345 | Y2 | Winter | 2024-03-20 | Lecture | Lecture 30 | Glaucoma, Cataracts | Dr. Ton/Dr. Hong |
| PHARM 345 | Y2 | Winter | 2024-03-21 | Seminar/case session | Seminar 4 | Ophthalmology | Dr. Sadowski/Dr. Ton |
| PHARM 345 | Y2 | Winter | 2024-03-22 | Lecture | Lecture 31 | Age-related macular degeneration, Diabetic retinopathy | Dr. Ton/Dr. Hong |
| PHARM 345 | Y2 | Winter | 2024-03-25 | Lecture | Lecture 32 | Psoriasis | Dr. Sanghera |
| PHARM 345 | Y2 | Winter | 2024-03-27 | Lecture | Lecture 33 | Dermatitis | Dr. Sanghera |
| PHARM 345 | Y2 | Winter | 2024-04-03 | Lecture | Lecture 34 | Overview of Skin & Nail Infections (Bacterial, Viral) | Dr. Sanghera/Dr. Grewal |
| PHARM 345 | Y2 | Winter | 2024-04-03 | Lecture | Lecture 35 | Drug Induced Eruptions | Dr. Grewal |
| PHARM 345 | Y2 | Winter | 2024-04-04 | Seminar/case session | Seminar 5 | Psoriasis (Biologic Therapy Cases) | Dr. Sanghera |
| PHARM 345 | Y2 | Winter | 2024-04-05 | Lecture | Lecture 36 | Perioral dermatitis, Rosacea | Dr. Sanghera |
| PHARM 345 | Y2 | Winter | 2024-04-08 | Lecture | Lecture 37 | Chilblains, chronic idiopathic urticaria, Dermatology Mini Topics | Dr. Sanghera |
| PHARM 345 | Y2 | Winter | 2024-04-10 | Lecture | Lecture 38 | Assessment & Derm Manifestations in Skin of Colour | Dr. Sanghera |
| PHARM 345 | Y2 | Winter | 2024-04-12 | Lecture | Lecture 39 | Cosmetic Derm & Alopecia | Dr. Grewal/Dr. Sanghera |
| PHARM 346 | Y2 | Winter | 2024-01-08 | Lecture | Overview of ID and Antimicrobial Stewardship | Antimicrobial resistance, Antimicrobial selection considerations, Impact of antibacterials to care | Nathan Beahm |
| PHARM 346 | Y2 | Winter | 2024-01-10 | Lecture | Microbiology 1: Bacterial Pathogens | Clinical lab assays, Serology, Bacterial cultures | Nathan Zelyas |
| PHARM 346 | Y2 | Winter | 2024-01-10 | Lecture | Penicillins | Appropriate usage, Spectra of activity, Bacterial resistance mechanisms | Nathan Beahm |
| PHARM 346 | Y2 | Winter | 2024-01-12 | Lecture | Microbiology 2: Bacterial Pathogens | Antimicrobial susceptibility testing, Microbiology reports | Nathan Zelyas |
| PHARM 346 | Y2 | Winter | 2024-01-15 | Lecture | Upper Respiratory Tract Infections 1 | Otitis media | Nathan Beahm |
| PHARM 346 | Y2 | Winter | 2024-01-17 | Lecture | Upper Respiratory Tract Infections 2 | Sinusitis, Pharyngitis | Nathan Beahm |
| PHARM 346 | Y2 | Winter | 2024-01-18 | Seminar/case session | Seminar 1: URTI | URTI | Nathan Beahm |
| PHARM 346 | Y2 | Winter | 2024-01-19 | Lecture | Microbiology 3: Bacterial Pathogens | Gram positives (aerobes and anaerobes), Gram negatives (aerobes and anaerobes) | Nathan Zelyas |
| PHARM 346 | Y2 | Winter | 2024-01-22 | Other exam/test | Microbiology 4: Antimicrobial Identification and Susceptibility Testing | Cell wall deficient, Mycobacteria | Nathan Zelyas |
| PHARM 346 | Y2 | Winter | 2024-01-24 | Lecture | PK-PD of Antimicrobials 1 | PK-PD target attainment, PK-PD indices, Dose optimization | Nathan Beahm |
| PHARM 346 | Y2 | Winter | 2024-01-26 | Lecture | PK-PD of Antimicrobials 2 | PK-PD target attainment, PK-PD indices, Dose optimization | Nathan Beahm |
| PHARM 346 | Y2 | Winter | 2024-01-29 | Lecture | Lower Respiratory Tract Infections 1 | Clinical signs of infection, Community-acquired pneumonia | Nathan Beahm |
| PHARM 346 | Y2 | Winter | 2024-01-31 | Lecture | Lower Respiratory Tract Infections 2 | Aspiration pneumonia, Acute bronchitis, Hospital-acquired pneumonia, Ventilator-associated pneumonia | Nathan Beahm |
| PHARM 346 | Y2 | Winter | 2024-02-01 | Seminar/case session | Seminar 2: LRTI | LRTI | Nathan Beahm |
| PHARM 346 | Y2 | Winter | 2024-02-02 | Lecture | Cephalosporins | Appropriate usage, Spectra of activity, Bacterial resistance mechanisms | Nathan Beahm |
| PHARM 346 | Y2 | Winter | 2024-02-05 | Lecture | Carbapenems, Monobactams | Appropriate usage, Spectra of activity, Bacterial resistance mechanisms | Nathan Beahm |
| PHARM 346 | Y2 | Winter | 2024-02-07 | Other exam/test | Beta-lactam Cross-Sensitivity/Allergy Testing | Beta-lactam cross-reactivity, Allergy management, Hypersensitivity reactions, Skin testing | Nathan Beahm |
| PHARM 346 | Y2 | Winter | 2024-02-09 | Lecture | Macrolides, Clindamycin, Tetracyclines | Appropriate usage, Spectra of activity, Bacterial resistance mechanisms | Nathan Beahm |
| PHARM 346 | Y2 | Winter | 2024-02-12 | Lecture | Sepsis and Septic Shock | Assessment, Management | Nathan Beahm |
| PHARM 346 | Y2 | Winter | 2024-02-14 | Lecture | Skin and Soft Tissue Infections | Diabetic foot infections, Necrotizing fasciitis, Erysipelas, Cellulitis | Nathan Beahm |
| PHARM 346 | Y2 | Winter | 2024-02-15 | Seminar/case session | Seminar 3: SSTI | SSTI | Nathan Beahm |
| PHARM 346 | Y2 | Winter | 2024-02-16 | Lecture | Fluoroquinolones, Metronidazole | Appropriate usage, Spectra of activity, Bacterial resistance mechanisms | Nathan Beahm |
| PHARM 346 | Y2 | Winter | 2024-02-26 | Lecture | Glycopeptides | Appropriate usage, Spectra of activity, Bacterial resistance mechanisms | Nathan Beahm |
| PHARM 346 | Y2 | Winter | 2024-02-28 | Lecture | TMP/SMX, Fosfomycin, Nitrofurantoin | Appropriate usage, Spectra of activity, Bacterial resistance mechanisms | Nathan Beahm |
| PHARM 346 | Y2 | Winter | 2024-03-01 | Lecture | Oxazolidinones, Daptomycin, Chloramphenicol | Appropriate usage, Spectra of activity, Bacterial resistance mechanisms | Nathan Beahm |
| PHARM 346 | Y2 | Winter | 2024-03-04 | Lecture | Urinary Tract Infections 1 | Pyelonephritis, Assessment, Cystitis | Nathan Beahm |
| PHARM 346 | Y2 | Winter | 2024-03-06 | Lecture | Urinary Tract Infections 2 | Prostatitis, Treatment, Prevention | Nathan Beahm |
| PHARM 346 | Y2 | Winter | 2024-03-07 | Seminar/case session | Seminar 4: UTI | UTI | Nathan Beahm |
| PHARM 346 | Y2 | Winter | 2024-03-08 | Lecture | Aminoglycosides | Appropriate usage, Spectra of activity, Bacterial resistance mechanisms | Nathan Beahm |
| PHARM 346 | Y2 | Winter | 2024-03-11 | Lecture | Vancomycin TDM | Dose adjustment, Dosing, Monitoring | Tony Kiang |
| PHARM 346 | Y2 | Winter | 2024-03-13 | Lecture | Aminoglycoside TDM | Dose adjustment, Dosing, Monitoring | Tony Kiang |
| PHARM 346 | Y2 | Winter | 2024-03-15 | Lecture | Bone & Joint Infections | Septic arthritis, Osteomyelitis, Prosthetic Joint Infection | Nathan Beahm |
| PHARM 346 | Y2 | Winter | 2024-03-18 | Lecture | Tuberculosis and Antitubercular Agents 1 | Pharmacology of TB agents, Assessment, Diagnosis | Donna Chua |
| PHARM 346 | Y2 | Winter | 2024-03-20 | Lecture | Tuberculosis and Antitubercular Agents 2 | Active TB, Treatment regimens, Latent TB | Donna Chua |
| PHARM 346 | Y2 | Winter | 2024-03-21 | Seminar/case session | Seminar 5: Bone & Joint Infections | Bone & Joint Infections | Nathan Beahm |
| PHARM 346 | Y2 | Winter | 2024-03-22 | Lecture | Clostridioides difficile Infection | Treatment, Assessment, Prevention | Nathan Beahm |
| PHARM 346 | Y2 | Winter | 2024-03-25 | Lecture | Endocarditis | Prevention, Assessment, Treatment | Margaret Gray |
| PHARM 346 | Y2 | Winter | 2024-03-27 | Lecture | Endocarditis (Cases) | Endocarditis (Cases) | Margaret Gray |
| PHARM 346 | Y2 | Winter | 2024-04-03 | Lecture | Meningitis/Encephalitis | Meningitis/Encephalitis | Cecilia Lau |
| PHARM 346 | Y2 | Winter | 2024-04-04 | Seminar/case session | Seminar 6: Meningitis | Meningitis | Cecilia Lau, Nathan Beahm |
| PHARM 346 | Y2 | Winter | 2024-04-05 | Lecture | Intra-abdominal Infections | Peritoneal dialysis-related peritonitis, Primary peritonitis, Secondary peritonitis | Jackson Stewart |
| PHARM 346 | Y2 | Winter | 2024-04-08 | Lecture | Polymyxins, Bacitracin, Mupirocin, Fusidic Acid | Appropriate usage, Spectra of activity, Bacterial resistance mechanisms | Nathan Beahm |
| PHARM 346 | Y2 | Winter | 2024-04-10 | Lecture | Infection Prevention & Control | Personal protective equipment, Environmental control, Patient isolation, Hand hygiene | Melody Cordoviz |
| PHARM 346 | Y2 | Winter | 2024-04-12 | Lecture | Surgical Prophylaxis | Surgical wound classification, Antimicrobial options for prophylaxis | Nathan Beahm |
| PHARM 443 | Y3 | Fall | 2023-09-05 | Lecture | Introduction to Sexual and ReprodIntroduction to the Course; Contraception Part I: General and Part II: Combined hormonal contraceptives | Introduction to the Course, Contraception Part I and Part II | Torok-Both |
| PHARM 443 | Y3 | Fall | 2023-09-07 | Lecture | Contraception Part II: Combined Hormonal Contraceptives; progestin only contraceptives | Combined Hormonal Contraception, Progestin only contraceptive | Torok-Both |
| PHARM 443 | Y3 | Fall | 2023-09-12 | Lecture | Contraception Part II con't | Combined Hormonal Contraceptives; Progestin only contraceptives | Torok-Both |
| PHARM 443 | Y3 | Fall | 2023-09-14 | Lecture | Contraception Part III LARC; Contraception Part IV: Non-hormonal contraceptives | LARC, Non-hormonal contraceptives | Torok-Both |
| PHARM 443 | Y3 | Fall | 2023-09-14 | Seminar/case session | Seminar 1: Contraception: Prescribing of Combined Hormonal Contraceptive Cases and LARC Cases | Case Based Seminar: Contraception: Prescribing of CHC and LARC Cases | Torok-Both |
| PHARM 443 | Y3 | Fall | 2023-09-19 | Lecture | Emergency Contraception; Medical Abortion | Emergency Contraception, Medical Abortion | Biggs |
| PHARM 443 | Y3 | Fall | 2023-09-21 | Lecture | Menstrual Related Disorders (dysmenorrhea/AUB); PMS/PMDD | Menstrual Related Disorders (Dysmenorrhea, AUB); PMS/PMDD | Torok-Both |
| PHARM 443 | Y3 | Fall | 2023-09-26 | Lecture | Endometriosis | Endometriosis | Torok-Both |
| PHARM 443 | Y3 | Fall | 2023-09-28 | Lecture | Menopause Part 1: Pathophysiology; Menopause Part 2: Role of Menopausal Hormone Therapy and Management of Menopause | Menopause Pathophysiology, Signs and Symptoms, Management of Menopause, Role of Menopausal Hormone Therapy | Torok-Both |
| PHARM 443 | Y3 | Fall | 2023-10-03 | Lecture | Erectile Dysfunction | Erectile Dysfunction | Sadowski |
| PHARM 443 | Y3 | Fall | 2023-10-05 | Lecture | Menopause Part 2 con't; Part 3: Therapeutic Options | Management of Menopause, Role of Menopausal Hormone Therapy, Therapeutic Options | Torok-Both |
| PHARM 443 | Y3 | Fall | 2023-10-12 | Lecture | Hypogonadism | Hypogonadism and testosterone in men | Sadowski |
| PHARM 443 | Y3 | Fall | 2023-10-12 | Seminar/case session | Seminar 2: Menopause Cases | Case based seminar: Management of menopause and hormone therapy prescribing | Torok-Both |
| PHARM 443 | Y3 | Fall | 2023-10-17 | Midterm exam | Midterm Exam | Midterm Exam | Hall/Torok-Both |
| PHARM 443 | Y3 | Fall | 2023-10-19 | Lecture | Polycystic Ovarian Syndrome | Polycystic Ovarian Syndrome | Torok-Both |
| PHARM 443 | Y3 | Fall | 2023-10-24 | Other exam/test | Pregnancy and ovulation testing/Treatment of Infertility | Pregnancy and Ovulation Testing, Treatment of Infertility | Yuksel |
| PHARM 443 | Y3 | Fall | 2023-10-26 | Lecture | Female Sexual Dysfunction; Drugs in Pregnancy and Lactation | Female Sexual Dysfunction, Drugs in Pregnancy and Lactation | Yuksel |
| PHARM 443 | Y3 | Fall | 2023-10-26 | Seminar/case session | Seminar 3: Care of the SOGIE Client/Transgender Care | Full Class Seminar: Pharmaceutical Care of the SOGIE (Sexual, Orientation, Gender, Identity, Expression) Client | TBA |
| PHARM 443 | Y3 | Fall | 2023-10-31 | Lecture | Physiologic Changes in Pregnancy/Treatment in Pregnancy | Physiologic Changes in Pregnancy, Treatment in Pregnancy | Torok-Both |
| PHARM 443 | Y3 | Fall | 2023-11-02 | Lecture | Treatment Issues in Pregnancy; Postpartum Care/Postpartum Depression | Treatment Issues in Pregnancy, Postpartum Care/Postpartum Depression | Torok-Both |
| PHARM 443 | Y3 | Fall | 2023-11-07 | Lecture | Gout | Gout | Hall |
| PHARM 443 | Y3 | Fall | 2023-11-09 | Lecture | Osteoarthritis | Osteoarthritis | Beahm |
| PHARM 443 | Y3 | Fall | 2023-11-09 | Seminar/case session | Seminar 4: Gout/Osteoarthritis | Case Based Seminar: Musculoskeletal Cases, Gout and Osteoarthritis | Hall |
| PHARM 443 | Y3 | Fall | 2023-11-16 | Lecture | Fibromyalgia | Fibromyalgia (self directed learning) | Hall |
| PHARM 443 | Y3 | Fall | 2023-11-21 | Lecture | Rheumatoid Arthritis (RA) I | Rheumatoid Arthritis: Pathophsiology, Assessment | Hall |
| PHARM 443 | Y3 | Fall | 2023-11-23 | Lecture | RA II | Rheumatoid Arthritis: Management of Rheumatoid Arthritis | Hall |
| PHARM 443 | Y3 | Fall | 2023-11-23 | Seminar/case session | Seminar 5: Rheumatoid Arthritis | Case Based Seminar: Rheumatoid Arthritis Cases | Hall |
| PHARM 443 | Y3 | Fall | 2023-11-28 | Lecture | Osteoporosis Part I | Osteoporosis: Pathophysiology, Assessment | Biggs |
| PHARM 443 | Y3 | Fall | 2023-11-30 | Lecture | Osteoporosis Part II | Osteoporosis: Management of Osteoporosis | Biggs |
| PHARM 443 | Y3 | Fall | 2023-12-05 | Lecture | Spondyloarthropathies/Lupus | Spondyloarthropathies , Lupus | Hall |
| PHARM 443 | Y3 | Fall | 2023-12-07 | Final exam | (Optional Attendance) Fibromyalgia Unit Debrief; Final Exam Q&A | Optional Attendance: Fibromyalgia Unit Debrief; Final Exam Q&A | Hall |
| PHARM 443 | Y3 | Fall | 2023-12-07 | Seminar/case session | Musculoskeletal Imaging (seminar/discussion); Class Evaluations | Musculoskeletal Imaging, Final exam review | Clifford/Dillon/Hall |
| PHARM 444 | Y3 | Fall | 2023-09-05 | Lecture | Course Introduction and Oncology Introduction | Hallmarks of Cancer | Tara Leslie & Sherif Mahmoud |
| PHARM 444 | Y3 | Fall | 2023-09-07 | Lecture | Colon Cancer | Colon Cancer | Tara Leslie |
| PHARM 444 | Y3 | Fall | 2023-09-07 | Seminar/case session | Seminar #1 - Oncology Basics Module/Quiz | Oncology Introduction Case Oncology Basics Modules and Quiz | Tara Leslie |
| PHARM 444 | Y3 | Fall | 2023-09-12 | Lecture | Radiotherapy and Breast Cancer 1 | Radiotherapy | Tara Leslie |
| PHARM 444 | Y3 | Fall | 2023-09-14 | Lecture | Breast Cancer 2 | Breast Cancer | Tara Leslie |
| PHARM 444 | Y3 | Fall | 2023-09-19 | Lecture | Supportive Care 1 - AINV, Hand&Foot, Mucositis, etc | Supportive Care 1 (AINV) | Tara Leslie |
| PHARM 444 | Y3 | Fall | 2023-09-21 | Lecture | Lung Cancer 1 | Lung Cancer | Tara Leslie |
| PHARM 444 | Y3 | Fall | 2023-09-21 | Seminar/case session | Seminar 2 - Breast Cancer and Supportive Care Seminar | Breast Cancer with Supportive Care Seminar | Tara Leslie |
| PHARM 444 | Y3 | Fall | 2023-09-26 | Lecture | Lung Cancer 2 and Supportive Care 2 (Other Chemotherapy Toxicitiies) | Supportive Care 2 (Hand/Foot, mucositis, clots, cardiotoxicity hair loss) | Tara Leslie |
| PHARM 444 | Y3 | Fall | 2023-09-28 | Lecture | Prostate Cancer | Prostate Cancer | Tara Leslie |
| PHARM 444 | Y3 | Fall | 2023-10-03 | Lecture | Hematologic Malignancy Part 1 (Lymphoma and Multiple Myeloma) | Hematology (Lymphoma and Multiple Myeloma include hypercalcemia) | Tara Leslie |
| PHARM 444 | Y3 | Fall | 2023-10-05 | Lecture | Hematologic Malignancy Part 2 (Leukemias) and Supportive Care 4 (TLS) | Hematology (Leukemias) + Supportive Care 4 (TLS) | Tara Leslie |
| PHARM 444 | Y3 | Fall | 2023-10-05 | Seminar/case session | Seminar #3 - Drug Interactions and Survive and Thrive | Drug Interactions Seminar and Survive and Thrive | Tara Leslie |
| PHARM 444 | Y3 | Fall | 2023-10-12 | Lecture | Palliative Care | Palliative Care | Vincent Ha |
| PHARM 444 | Y3 | Fall | 2023-10-17 | Lecture | Supportive Care 3 (Myelosuppression and FN) | Supportive Care #3 (Myelosuppression and FN) | Tara Leslie |
| PHARM 444 | Y3 | Fall | 2023-10-19 | Lecture | Peripheral Neuropathies | Supportive Care 5 (FN and myelosuppression) | Sherif Mahmoud |
| PHARM 444 | Y3 | Fall | 2023-10-26 | Lecture | Seizures and Epilepsy 1 | Seizures and Epilepsy 1 | Sherif Mahmoud |
| PHARM 444 | Y3 | Fall | 2023-10-31 | Lecture | Seizures and Epilepsy 2 | Seizures and Epilepsy 2 | Sherif Mahmoud |
| PHARM 444 | Y3 | Fall | 2023-11-02 | Lecture | Seizures and Epilepsy 3 | Seizures and Epilepsy 3 | Sherif Mahmoud |
| PHARM 444 | Y3 | Fall | 2023-11-02 | Seminar/case session | Seminar 4 - Seizures and Epilepsy | Seizures and Epilepsy Seminar | Sherif Mahmoud |
| PHARM 444 | Y3 | Fall | 2023-11-07 | Lecture | Headache Disorders 1 | Headache Disorders 1 | Sherif Mahmoud |
| PHARM 444 | Y3 | Fall | 2023-11-09 | Lecture | Headache Disorders 2 | Headache Disorders 2 | Sherif Mahmoud |
| PHARM 444 | Y3 | Fall | 2023-11-16 | Lecture | Multiple Sclerosis | Multiple Sclerosis | Penny Smyth |
| PHARM 444 | Y3 | Fall | 2023-11-16 | Seminar/case session | Seminar 5 - Headache Seminar | Headache Seminar | Sherif Mahmoud |
| PHARM 444 | Y3 | Fall | 2023-11-21 | Lecture | Movement Disorders 1 | Movement Disorders 1 | Cheryl Sadowski |
| PHARM 444 | Y3 | Fall | 2023-11-21 | Lecture | Movement Disorders 2 | Movement Disorders 2 | Cheryl Sadowski |
| PHARM 444 | Y3 | Fall | 2023-11-28 | Lecture | Cognitive Impairment 1 | Dementia | Cheryl Sadowski |
| PHARM 444 | Y3 | Fall | 2023-11-30 | Lecture | Cognitive Impairment 2 | Delirium and behavioral disorders | Cheryl Sadowski |
| PHARM 444 | Y3 | Fall | 2023-11-30 | Seminar/case session | Seminar 6 - A day in the life of a neurology pharmacist | A day in the life of a Neurology Pharmacist | Sherif Mahmoud |
| PHARM 444 | Y3 | Fall | 2023-12-05 | Lecture | Dizziness | Dizziness | Cheryl Sadowski |
| PHARM 444 | Y3 | Fall | 2023-12-07 | Lecture | Traumatic Brain Injury /Course Review | Traumatic Brain Injury /Course Review | Sherif Mahmoud |
| PHARM 445 | Y3 | Fall | 2023-09-06 | Lecture | Course Intro, Pain Types, General Pain Assessment | Pain types, Pain management strategies | Nathan Beahm |
| PHARM 445 | Y3 | Fall | 2023-09-06 | Lecture | General Pain Assessment | Pain types, pain assessment strategies, pain assessment tools | Nathan Beahm |
| PHARM 445 | Y3 | Fall | 2023-09-11 | Lecture | Opioid Management | Initiating, titrating, rotating, weaning, and monitoring of opioids | Nathan Beahm |
| PHARM 445 | Y3 | Fall | 2023-09-13 | Lecture | Opioid Management | Initiating, titrating, rotating, weaning, and monitoring of opioids | Nathan Beahm |
| PHARM 445 | Y3 | Fall | 2023-09-15 | Lecture | Acute Pain | Pathophysiology, epidemiology, patient assessment, and management strategies | Nathan Beahm |
| PHARM 445 | Y3 | Fall | 2023-09-18 | Lecture | Acute Pain | Pathophysiology, epidemiology, patient assessment, and management strategies | Nathan Beahm |
| PHARM 445 | Y3 | Fall | 2023-09-18 | Seminar/case session | Seminar 1: Acute Pain | Seminar 1: Acute Pain | Nathan Beahm |
| PHARM 445 | Y3 | Fall | 2023-09-20 | Lecture | Cannabinoids | Pharmacology, drug interactions, clinical evidence, and clinical use of cannabinoids for pain | Nathan Beahm |
| PHARM 445 | Y3 | Fall | 2023-09-21 | Lecture | Chronic Pain | Pathophysiology, epidemiology, patient assessment, and management strategies | Nathan Beahm |
| PHARM 445 | Y3 | Fall | 2023-09-25 | Lecture | Chronic Pain | Pathophysiology, epidemiology, patient assessment, and management strategies | Nathan Beahm |
| PHARM 445 | Y3 | Fall | 2023-09-27 | Lecture | Pain Management in Palliative Care | Pathophysiology, epidemiology, patient assessment, and management strategies | Serena Rix |
| PHARM 445 | Y3 | Fall | 2023-09-29 | Lecture | Pain Management in Palliative Care | Pathophysiology, epidemiology, patient assessment, and management strategies | Serena Rix |
| PHARM 445 | Y3 | Fall | 2023-10-02 | Lecture | Methadone for Pain Management | Pharmacology, drug interactions, initiating, titrating, rotating (to/from), and monitoring of methadone | Serena Rix |
| PHARM 445 | Y3 | Fall | 2023-10-02 | Seminar/case session | Seminar 2: Chronic Pain and Palliative | Chronic Pain and Palliative | Nathan Beahm |
| PHARM 445 | Y3 | Fall | 2023-10-04 | Lecture | Neuropathic Pain | Pathophysiology, epidemiology, patient assessment, and management strategies | Nathan Beahm |
| PHARM 445 | Y3 | Fall | 2023-10-06 | Lecture | Neuropathic Pain | Pathophysiology, epidemiology, patient assessment, and management strategies | Nathan Beahm |
| PHARM 445 | Y3 | Fall | 2023-10-11 | Lecture | Mental Health Intro | Introduction to mental health module; epidemiology and population impact of mental health disorders | Dylan Moulton |
| PHARM 445 | Y3 | Fall | 2023-10-13 | Lecture | Major Depressive Disorder | Major Depressive Disorder | Dylan Moulton |
| PHARM 445 | Y3 | Fall | 2023-10-16 | Lecture | Major Depressive Disorder | Major Depressive Disorder, epidemiology, assessment, management strategies | Dylan Moulton |
| PHARM 445 | Y3 | Fall | 2023-10-18 | Lecture | Psychotropic Drugs I | epidemiology, assessment, management strategies | Dylan Moulton |
| PHARM 445 | Y3 | Fall | 2023-10-20 | Lecture | Anxiety Disorders | Anxiety Disorders | Dylan Moulton |
| PHARM 445 | Y3 | Fall | 2023-10-23 | Lecture | Anxiety Disorders | epidemiology, assessment, management strategies | Dylan Moulton |
| PHARM 445 | Y3 | Fall | 2023-10-23 | Seminar/case session | Seminar 3: Major Depressive Disorder | Major Depressive Disorder | Dylan Moulton |
| PHARM 445 | Y3 | Fall | 2023-10-25 | Lecture | Other Mental Disorders | Panic Disorder/OCD/PTSD | Dylan Moulton |
| PHARM 445 | Y3 | Fall | 2023-10-27 | Lecture | Sleep-Wake Disorders | Sleep Disorders | Dylan Moulton |
| PHARM 445 | Y3 | Fall | 2023-11-01 | Lecture | Bipolar disorder | Bipolar disorder | TBD |
| PHARM 445 | Y3 | Fall | 2023-11-03 | Lecture | Bipolar Disorder | Bipolar disorder | TBD |
| PHARM 445 | Y3 | Fall | 2023-11-06 | Lecture | Psychotropic Drugs II | Antipsychotics- monitoring and safety considerations | TBD |
| PHARM 445 | Y3 | Fall | 2023-11-06 | Seminar/case session | Seminar 4: Bipolar Disorder Seminar | Seminar 4: Bipolar Disorder Seminar | TBD |
| PHARM 445 | Y3 | Fall | 2023-11-08 | Lecture | Attention-Deficit/Hyperactivity Disorder | Attention-Deficit/Hyperactivity Disorder | Dylan Moulton |
| PHARM 445 | Y3 | Fall | 2023-11-10 | Lecture | Attention-Deficit/Hyperactivity Disorder | Attention-Deficit/Hyperactivity Disorder | Dylan Moulton |
| PHARM 445 | Y3 | Fall | 2023-11-15 | Lecture | Substance Use Disorders Intro | Substance Use Disorders [introduction, pathophysiology] | Essi Salokangas |
| PHARM 445 | Y3 | Fall | 2023-11-17 | Lecture | Opioid Use Disorder | Substance Use Disorders [opioid use disorder] | Essi Salokangas |
| PHARM 445 | Y3 | Fall | 2023-11-20 | Lecture | Opioid Use Disorder | Substance Use Disorders [opioid use disorder] | Essi Salokangas |
| PHARM 445 | Y3 | Fall | 2023-11-22 | Lecture | Alcohol Use Disorder | Substance Use Disorders [alcohol use disorder] | Essi Salokagas |
| PHARM 445 | Y3 | Fall | 2023-11-23 | Seminar/case session | Seminar 6: TBD | Seminar 6: TBD | TBD |
| PHARM 445 | Y3 | Fall | 2023-11-24 | Lecture | Alcohol Use Disorder | Substance Use Disorders [alcohol use disorder] | Essi Salokangas |
| PHARM 445 | Y3 | Fall | 2023-11-27 | Lecture | Lived Experience | Substance Use Disorders [lived experience] | Essi Salokangas |
| PHARM 445 | Y3 | Fall | 2023-11-27 | Seminar/case session | Seminar 5: Complex Applied Case (pain, mental health disorders, substance use disorders, ID) | Complex Applied Case (pain, mental health disorders, substance use disorders, ID) | Nathan Beahm, Essi Salokangas |
| PHARM 445 | Y3 | Fall | 2023-11-29 | Lecture | Schizophrenia | Schizophrenia | Chris Evernden |
| PHARM 445 | Y3 | Fall | 2023-12-01 | Lecture | Schizophrenia | Schizophrenia | Chris Evernden |
| PHARM 445 | Y3 | Fall | 2023-12-04 | Lecture | Psychotropic Drugs III | Schizophrenia | Chris Evernden |
| PHARM 445 | Y3 | Fall | 2023-12-06 | Lecture | Pharmacogenomics and the Management of Analgesics and Psychotropics | Pharmacogenomics and the Management of Psychotropics, PGx and management of analgesics | Dalia Hamdy |
| PHARM 445 | Y3 | Fall | 2023-12-08 | Final exam | Mental Health Application / Final Exam Review | Pharmacogenomics | Dylan Moulton / Nathan Beahm |
| PHARM 446 | Y3 | Winter | 2024-01-09 | Lecture | Lecture 1 (Course introduction Public Health and the Canadian Immunization System) | Course introduction Public Health and the Canadian Immunization System | Dr. Tony Kiang, Mr. Pierre Danis |
| PHARM 446 | Y3 | Winter | 2024-01-11 | Lecture | Lecture 2 (Immunology overview and types of immunizing agents) | Immunology Overview and types of immunizing agents | Mr. Pierre Danis |
| PHARM 446 | Y3 | Winter | 2024-01-16 | Lecture | Lecture 3 (Vaccine Preventable Diseases) | Vaccine Preventable Diseases | Mr. Pierre Danis |
| PHARM 446 | Y3 | Winter | 2024-01-18 | Lecture | Lecture 4 (Vaccine Preventable Diseases) | Vaccine Preventable Diseases | Mr. Pierre Danis |
| PHARM 446 | Y3 | Winter | 2024-01-23 | Lecture | Lecture 5 (Vaccine Preventable Diseases Vaccine Assessment & Screening) | Vaccine Preventable Diseases Vaccine Assessment & Screening | Mr. Pierre Danis |
| PHARM 446 | Y3 | Winter | 2024-01-23 | Seminar/case session | Seminar 1 (Vaccination Cases) | Vaccination cases | Mr. Pierre Danis |
| PHARM 446 | Y3 | Winter | 2024-01-25 | Lecture | Lecture 6 (Pharmacy-Based Immunization program: adverse events, documentation, storage and handling) | Pharmacy-Based Immunization program: adverse events, documentation, storage and handling | Mr. Pierre Danis |
| PHARM 446 | Y3 | Winter | 2024-01-30 | Lecture | Lecture 7 (Virology introduction: structure of viruses, classification, and replication) | Virology introduction: structure of viruses, classification, and replication | Ruwandi Kariyawasam |
| PHARM 446 | Y3 | Winter | 2024-02-01 | Lecture | Lecture 8 (Herpes Zoster Virus: Therapeutics) | Herpes Simplex Viruses: Therapeutics | Dr. Christine Hughes |
| PHARM 446 | Y3 | Winter | 2024-02-06 | Lecture | Lecture 9 (Herpes Simplex Viruses: Therapeutics) | Herpes Simplex Viruses: Therapeutics | Dr. Christine Hughes |
| PHARM 446 | Y3 | Winter | 2024-02-06 | Seminar/case session | Seminar 2 (Herpes Zoster Case) | Herpes Zoster Case | Dr. Christine Hughes |
| PHARM 446 | Y3 | Winter | 2024-02-08 | Lecture | Lecture 10 (Viral Hepatitis: Therapeutics) | Viral Hepatitis: Therapeutics | Dr. Christine Hughes |
| PHARM 446 | Y3 | Winter | 2024-02-13 | Lecture | Lecture 11 (HIV) | HIV | Dr. Christine Hughes |
| PHARM 446 | Y3 | Winter | 2024-02-15 | Lecture | Lecture 12 (HIV) | HIV | Dr. Christine Hughes |
| PHARM 446 | Y3 | Winter | 2024-02-27 | Lecture | Lecture 13 (HIV and opportunistic infections) | Opportunistic infections in HIV | Dr. Christine Hughes, Ms. Caitlin Olatunbosun |
| PHARM 446 | Y3 | Winter | 2024-02-27 | Seminar/case session | Seminar 3 (Viral Hepatitis Case) | Viral Hepatitis | Dr. Christine Hughes |
| PHARM 446 | Y3 | Winter | 2024-02-29 | Lecture | Lecture 14 (Influenza: Therapeutics) | Influenza: Therapeutics | Jackson Stewart |
| PHARM 446 | Y3 | Winter | 2024-03-05 | Lecture | Lecture 15 Sexually transmitted infections | Sexually transmitted infections | Jackson Stewart |
| PHARM 446 | Y3 | Winter | 2024-03-07 | Lecture | Lecture 16 (Sexually transmitted infections) | Sexually transmitted infections | Mr. Jackson Stewart |
| PHARM 446 | Y3 | Winter | 2024-03-12 | Lecture | Lecture 17 (Vaginal candidiasis: Therapeutics) | Vaginal candidiasis: Therapeutics | Ms. Eleanor Leoni |
| PHARM 446 | Y3 | Winter | 2024-03-12 | Seminar/case session | Seminar 4 (HIV case) | HIV | Dr. Christine Hughes, Ms. Caitlin Olatunbosun |
| PHARM 446 | Y3 | Winter | 2024-03-14 | Lecture | Lecture 18 (Dermatophytoses) | Dermatophytoses (Athlete’s foot, Jock itch, Ringworm, Fungal Nail Infections): Therapeutics Course evaluations Review and final exam preparation | Dr. Tony Kiang, Ms. Eleanor Leoni |
| PHARM 446 | Y3 | Winter | 2024-03-19 | Lecture | Lecture 19 (Systemic fungal infections: Therapeutics) | Systemic fungal infections: Therapeutics | Mr. Jackson Stewart |
| PHARM 446 | Y3 | Winter | 2024-03-21 | Seminar/case session | Seminar 5 (Organ donation and transplantation) | Transplant Seminar – Transplant Team (lecture theatre) | Dr. Tony Kiang |
| PHARM 446 | Y3 | Winter | 2024-03-26 | Lecture | Lecture 20 (Traveller's Health) | Traveller’s Health | Mr. Pierre Denis |
| PHARM 446 | Y3 | Winter | 2024-03-28 | Lecture | Lecture 21 (Traveller’s Health / COVID-19 pharmacotherapy, Pinworms: Therapeutics (pre-recorded)) | Traveller's Health, Pinworms: therapeutics | Dr. Christine Hughes, Mr. Pierre Denis |
| PHARM 446 | Y3 | Winter | 2024-04-02 | Lecture | Lecture 22 (history on transplantation; key concepts; mechanisms of rejection) | history on transplantation; key concepts; mechanisms of rejection | Dr. Tony Kiang |
| PHARM 446 | Y3 | Winter | 2024-04-04 | Lecture | Lecture 23 (Pharmacology/ pharmacokinetics of immunosuppressants) | Pharmacology/ pharmacokinetics of immunosuppressants (small molecule drugs 1) | Dr. Tony Kiang |
| PHARM 446 | Y3 | Winter | 2024-04-09 | Lecture | Lecture 24 (Pharmacology/Pharmacokinetics of immunosuppressants (small molecule drugs) | Pharmacology/Pharmacokinetics of immunosuppressants (small molecule drugs 2) | Dr. Tony Kiang |
| PHARM 446 | Y3 | Winter | 2024-04-09 | Seminar/case session | Seminar 6 (Renal transplant cases) | Renal Transplant cases | Dr. Tony Kiang |
| PHARM 446 | Y3 | Winter | 2024-04-11 | Lecture | Lecture 25 (Opportunistic infections in transplant) | Opportunistic infections in transplant | Dr. Tony Kiang |
| PHARM 448 | Y3 | Winter | 2024-01-09 | Lecture | Course Introduction - Advanced Therapeutics Principles I | Practice Integrated Case(s) | Sherif Mahmoud |
| PHARM 448 | Y3 | Winter | 2024-01-11 | Lecture | Advanced Therapeutics Principles II | Dealing with Complex Patients | Sherif Mahmoud |
| PHARM 448 | Y3 | Winter | 2024-01-16 | Lecture | Advanced Therapeutics - Practice Cases | Advanced Therapeutics - Practice Cases | Sherif Mahmoud |
| PHARM 448 | Y3 | Winter | 2024-01-16 | Seminar/case session | Case 1 | Case 1 | Sherif Mahmoud, Cheryl Sadowski |
| PHARM 448 | Y3 | Winter | 2024-01-18 | Lecture | Case 1 - Debrief | Case debrief | Sherif Mahmoud, Cheryl Sadowski |
| PHARM 448 | Y3 | Winter | 2024-01-23 | Lecture | Advanced Therapeutics Principles III | Decision making with no or limited evidence | Sherif Mahmoud |
| PHARM 448 | Y3 | Winter | 2024-01-25 | Lecture | Geriatrics - Part 1 | Changes with aging and implications for medication use and safety , Challenges in care delivery | Cheryl Sadowski |
| PHARM 448 | Y3 | Winter | 2024-01-30 | Lecture | Geriatrics - Part 2 | Geriatric Syndromes , Medication related problems encountered in older adults | Cheryl Sadowski |
| PHARM 448 | Y3 | Winter | 2024-02-02 | Lecture | Case 2 - Pediatrics (Acute care) | Pediatric case: acute care, Documentation: note to MD on hospital chart | Cheryl Sadowski / Pediatrics Team (D Dersch-Mills, M Romanick, J Wichart, A Chan |
| PHARM 448 | Y3 | Winter | 2024-02-09 | Lecture | Case 3 - Primary Care | Middle aged man, Comorbidities: HTN; Chronic Pain; Constipation, Documentation: Care Plan | Sherif Mahmoud |
| PHARM 448 | Y3 | Winter | 2024-02-13 | Lecture | Case 3 - Geriatrics | A geriatric patient case • Documentation: Clinic Note for NetCare | Cheryl Sadowski |
| PHARM 448 | Y3 | Winter | 2024-02-14 | Lecture | Case 3 - Debrief | Case 3 - Debrief | Sherif Mahmoud |
| PHARM 448 | Y3 | Winter | 2024-02-28 | Lecture | Case 4 - Acute Care | Middle aged woman, Comorbidities: depression; DM2; Osteoporosis; Headache. Documentation: Pharmacist discharge plan | Sherif Mahmoud/ Cheryl Sadowski |
| PHARM 448 | Y3 | Winter | 2024-02-28 | Seminar/case session | Seminar 4: A day in a life of a hospital pharmacist | Prioritizing in hospital pharmacy practice, Providing care in a complex and busy environment | Sherif Mahmoud |
| PHARM 448 | Y3 | Winter | 2024-03-02 | Lecture | Case 4 Debrief | Debrief | Sherif Mahmoud |
| PHARM 448 | Y3 | Winter | 2024-03-12 | Lecture | Pediatrics - Introduction | Pediatrics - Principles and Process of Care | Cheryl Sadowski / Pediatrics Team (D Dersch-Mills, M Romanick, J Wichart, A Chan |
| PHARM 448 | Y3 | Winter | 2024-03-14 | Lecture | Elder Abuse | Workshop/Case discussions | Cheryl Sadowski / Kitty Choi |
| PHARM 448 | Y3 | Winter | 2024-03-14 | Lecture | Pediatrics - Lecture 2 | Pediatric Therapeutics | Bharti Thomas |
| PHARM 448 | Y3 | Winter | 2024-03-14 | Seminar/case session | Seminar 5: Psychosocial Issues in Older Adults | Communication and ageism , Geriatrics Toolbox for Challenging Cases (hot topics, debates) | Cheryl Sadowski/ Sheree Kwong-See |
| PHARM 448 | Y3 | Winter | 2024-03-16 | Lecture | Case 5 - Geriatrics | Geriatric Syndromes -supportive living, Documentation: Assessment note to MD | Cheryl Sadowski |
| PHARM 448 | Y3 | Winter | 2024-03-16 | Lecture | Case 5 - Geriatrics (Acute Care) | Geriatric Syndromes, Documentation: Assessment note to MD | Cheryl Sadowski |
| PHARM 448 | Y3 | Winter | 2024-03-19 | Lecture | Case 5 - Pediatrics | Pediatric case | Bharti Thomas/ Cheryl Sadowski |
| PHARM 448 | Y3 | Winter | 2024-03-19 | Lecture | Pediatrics - Lecture 1 | Introduction to age groups, newborn care, prematurity | Cheryl Sadowski / Deonne Dersch-Mills |
| PHARM 448 | Y3 | Winter | 2024-03-21 | Lecture | Case 5 - Debrief | Debrief | Cheryl Sadowski/Bharti Thomas |
| PHARM 448 | Y3 | Winter | 2024-03-21 | Lecture | Case 5 - debrief | Introduction to age groups, classification; Newborn care, Prematurity and implications | Bharti Thomas/ Cheryl Sadowski |
| PHARM 448 | Y3 | Winter | 2024-03-28 | Lecture | Case 6 debrief | Debrief | Cheryl Sadowski |
| PHARM 448 | Y3 | Winter | 2024-03-28 | Seminar/case session | Child Maltreatment | Child Maltreatment | Jillian Poppel / Cheryl Sadowski |
| PHARM 448 | Y3 | Winter | 2024-03-28 | Seminar/case session | Seminar 6: A day in a life of Pharmacist in a correctional facility | Approach to Pediatric Care | Stewart MacLennan Correctional facility team |
| PHARM 448 | Y3 | Winter | 2024-03-30 | Lecture | Case 7 - Correctional Facility Care | Middle aged adult in incarceration, Comorbidities: COPD; Epilepsy; GERD; Liver; Anxiety. Documentation: summary note given to patient | Stewart MacLennan/Correctional facility team |
| PHARM 448 | Y3 | Winter | 2024-04-04 | Lecture | Case 7 Debrief | Debrief | Stewart MacLennan Correctional facility team |
| PHARM 448 | Y3 | Winter | 2024-04-09 | Lecture | Autism Spectrum Disorder | Care, complications and case studies | Lonnie Zwaigenbaum |
| PHARM 448 | Y3 | Winter | 2024-04-11 | Lecture | Critical Care | Case 8 - ICU • Documentation: DAP note | Sherif Mahmoud |
Assessment Information
| PHARM 243 | Y1 | Health Aisle Assignment | Assignment/written work | 5.0% | — |
| PHARM 243 | Y1 | Reflection on Pulmonary Case | Assignment/written work | 2.0% | — |
| PHARM 243 | Y1 | Reflection on Pulmonary Case Revisited | Assignment/written work | 5.0% | — |
| PHARM 243 | Y1 | Final | Final exam | 43.0% | — |
| PHARM 243 | Y1 | Midterm | Midterm exam | 33.0% | — |
| PHARM 243 | Y1 | Lecture, Assigned Readings, and Seminar Quizzes | Quiz | 12.0% | — |
| PHARM 343 | Y2 | Final | Final exam | 55.0% | — |
| PHARM 343 | Y2 | Midterm | Midterm exam | 30.0% | — |
| PHARM 343 | Y2 | Pre-Seminar Quiz #1: Fluid & Electrolyte Conditions | Quiz | 2.5% | — |
| PHARM 343 | Y2 | Pre-Seminar Quiz #2: Laboratory Values & Acid/Base Conditions | Quiz | 2.5% | — |
| PHARM 343 | Y2 | Pre-Seminar Quiz #3: Chronic Kidney Disease | Quiz | 2.5% | — |
| PHARM 343 | Y2 | Pre-Seminar Quiz #4: Drug Dosing in Renal Impairment & Acute Kidney Injury | Quiz | 2.5% | — |
| PHARM 343 | Y2 | Pre-Seminar Quiz #5: Insulin Management | Quiz | 2.5% | — |
| PHARM 343 | Y2 | Pre-Seminar Quiz #6: Type 2 Diabetes Management | Quiz | 2.5% | — |
| PHARM 344 | Y2 | Care Plan and Peer Review Assignment | Assignment/written work | 5.0% | — |
| PHARM 344 | Y2 | Final | Final exam | 45.0% | — |
| PHARM 344 | Y2 | Midterm | Midterm exam | 30.0% | — |
| PHARM 344 | Y2 | Quiz #1 | Quiz | 4.0% | — |
| PHARM 344 | Y2 | Quiz #2 | Quiz | 4.0% | — |
| PHARM 344 | Y2 | Quiz #3 | Quiz | 4.0% | — |
| PHARM 344 | Y2 | Quiz #4 | Quiz | 4.0% | — |
| PHARM 344 | Y2 | Quiz #5 | Quiz | 4.0% | — |
| PHARM 345 | Y2 | Final Exam | Final exam | 55.0% | — |
| PHARM 345 | Y2 | Midterm Exam | Midterm exam | 33.0% | — |
| PHARM 345 | Y2 | Seminar 4 Quiz | Quiz | 3.0% | — |
| PHARM 345 | Y2 | Seminar Quiz 1 | Quiz | 3.0% | — |
| PHARM 345 | Y2 | Seminar Quiz 2 | Quiz | 3.0% | — |
| PHARM 345 | Y2 | Seminar Quiz 5 | Quiz | 3.0% | — |
| PHARM 346 | Y2 | Assignments | Assignment/written work | 6.0% | — |
| PHARM 346 | Y2 | Final Exam | Final exam | 50.0% | — |
| PHARM 346 | Y2 | Midterm Exam | Midterm exam | 40.0% | — |
| PHARM 346 | Y2 | Quizzes | Quiz | 4.0% | — |
| PHARM 443 | Y3 | Final | Final exam | 50.0% | — |
| PHARM 443 | Y3 | Midterm | Midterm exam | 35.0% | — |
| PHARM 443 | Y3 | Seminar #1 | Quiz | 5.0% | — |
| PHARM 443 | Y3 | Seminar #2 | Quiz | 5.0% | — |
| PHARM 443 | Y3 | Seminar #4 | Quiz | 3.0% | — |
| PHARM 443 | Y3 | Seminar #5 | Quiz | 5.0% | — |
| PHARM 444 | Y3 | Rare Neurologic Disorders Assignment | Assignment/written work | 5.0% | — |
| PHARM 444 | Y3 | Survive and Thrive Documentary Reflection Assignment | Assignment/written work | 4.0% | — |
| PHARM 444 | Y3 | FINAL | Final exam | 40.0% | — |
| PHARM 444 | Y3 | Midterm | Midterm exam | 40.0% | — |
| PHARM 444 | Y3 | Seminar Participation | Participation/professionalism | 4.0% | — |
| PHARM 444 | Y3 | Oncology Basics Quiz | Quiz | 4.0% | — |
| PHARM 444 | Y3 | Rare Neurologic Disorders Quiz | Quiz | 3.0% | — |
| PHARM 445 | Y3 | Seminar Assignments | Assignment/written work | 7.5% | — |
| PHARM 445 | Y3 | Final Exam | Final exam | 45.0% | — |
| PHARM 445 | Y3 | Midterm Exam | Midterm exam | 35.0% | — |
| PHARM 445 | Y3 | Pre-Class Review Quizzes | Quiz | 7.5% | — |
| PHARM 445 | Y3 | Seminar Quizzes | Quiz | 5.0% | — |
| PHARM 446 | Y3 | Final | Final exam | 40.0% | — |
| PHARM 446 | Y3 | Midterm | Midterm exam | 30.0% | — |
| PHARM 446 | Y3 | Pre-Seminar Quizs | Quiz | 30.0% | — |
| PHARM 448 | Y3 | Case Presentations (Group) | Assignment/written work | 4.0% | — |
| PHARM 448 | Y3 | Documentation (Group) | Assignment/written work | 40.0% | — |
| PHARM 448 | Y3 | Final Exam | Final exam | 20.0% | — |
| PHARM 448 | Y3 | Midterm Exam | Midterm exam | 20.0% | — |
| PHARM 448 | Y3 | Case-related Quizzes | Quiz | 16.0% | — |
Use these searchable records to verify the course, session and assessment evidence behind the curriculum portrait. The browser supports inspection and verification rather than additional curriculum analysis.
Course Information
| PHARM 243 — PHARM 243 - Pharmacotherapy I | Y1 | Winter | 38 | 6 | 0 | Assignment/written work (1); Final exam (1); Midterm exam (1); Quiz (1) | — |
| PHARM 343 — PHARM 343 - Pharmacotherapy 2 | Y2 | Fall | 34 | 6 | 2 | Final exam (1); Midterm exam (1); Quiz (6) | — |
| PHARM 344 — PHARM 344 - Pharmacotherapy 3 | Y2 | Winter | 35 | 9 | 0 | Assignment/written work (3); Final exam (1); Midterm exam (1); Quiz (1) | — |
| PHARM 345 — PHARM 345 - Pharmacotherapy 4 | Y2 | Winter | 39 | 5 | 0 | Final exam (1); Midterm exam (1); Participation/professionalism (1); Quiz (4) | — |
| PHARM 346 — PHARM 346 - Pharmacotherapy 5 | Y2 | Winter | 36 | 6 | 0 | Assignment/written work (2); Final exam (1); Midterm exam (1); Quiz (1) | — |
| PHARM 443 — PHARM 443 - Pharmacotherapy 6 | Y3 | Fall | 23 | 6 | 0 | Final exam (1); Midterm exam (1); Quiz (4) | — |
| PHARM 444 — PHARM 444 - Pharmacotherapy 7 | Y3 | Fall | 25 | 6 | 0 | Assignment/written work (2); Final exam (1); Midterm exam (1); Participation/professionalism (1); Quiz (2) | — |
| PHARM 445 — PHARM 445 - Pharmacotherapy 8 | Y3 | Fall | 37 | 6 | 0 | Assignment/written work (1); Final exam (1); Midterm exam (1); Quiz (2) | — |
| PHARM 446 — PHARM 446 - Pharmacotherapy 9 | Y3 | Winter | 25 | 6 | 0 | Final exam (1); Midterm exam (1); Quiz (1) | — |
| PHARM 448 — PHARM 448 - Pharmacotherapy 10 | Y3 | Winter | 27 | 5 | 0 | Assignment/written work (2); Final exam (1); Midterm exam (1); Quiz (1) | — |
Session Information
| PHARM 243 | Y1 | Winter | 2024-01-08 | Lecture | Lecture 1: CAM 1 | Review of course syllabus, Introduction to course assignments, , Introduction to CAM | P. Gill, D. Barnes |
| PHARM 243 | Y1 | Winter | 2024-01-10 | Lecture | Lecture 2: CAM 2 | , Modalities and providers: Part I | D. Barnes |
| PHARM 243 | Y1 | Winter | 2024-01-12 | Lecture | Lecture 3: CAM 3 | , Modalities and providers: Part II | D. Barnes |
| PHARM 243 | Y1 | Winter | 2024-01-15 | Lecture | Lecture 4: CAM 4 | Role of pharmacists in recommendations / referrals and collaboration, , , Natural Health Products, Regulations for drug information | D. Barnes |
| PHARM 243 | Y1 | Winter | 2024-01-17 | Lecture | Lecture 5: Eye | , , Eye Conditions, Dry Eye Disease, Contact Lens Care | D. Barnes |
| PHARM 243 | Y1 | Winter | 2024-01-19 | Lecture | Lecture 6: Ear | , Otitis Externa, Minor Ear Pain, Impacted Ear Wax | D. Barnes |
| PHARM 243 | Y1 | Winter | 2024-01-22 | Lecture | Lecture 7 in AM: GI 1 | , Hemorrhoids, Gastrointestinal Gas | D. Barnes |
| PHARM 243 | Y1 | Winter | 2024-01-22 | Lecture | Lecture 8 in PM: GI 2 | Heart Burn (Dyspepsia and GERD) | D. Barnes (See google calendar for lecture) |
| PHARM 243 | Y1 | Winter | 2024-01-23 | Seminar/case session | Seminar 1: Eye/Ear | Eye Cases, Ear Cases, O-P-E‚ÇÇ-N Presentation - "Over-the-counter Products related to Eyes, Ears, and NHP" | D. Barnes |
| PHARM 243 | Y1 | Winter | 2024-01-24 | Lecture | Lecture 9: Dental | Bad Breath (Halitosis), Dry Mouth (Xerostomia), Canker Sores (Oral Apthous Ulcers), | D. Barnes |
| PHARM 243 | Y1 | Winter | 2024-01-26 | Lecture | Lecture 10: Self Care Catch Up | Lecture 10: Self Care Catch Up | D. Barnes |
| PHARM 243 | Y1 | Winter | 2024-01-29 | Lecture | Lecture 11: Dermatological 1 | , Intro to Derm, Physical Assessment, Hair, Skin, Nails, Sun Safety | R. Sanghera |
| PHARM 243 | Y1 | Winter | 2024-01-31 | Lecture | Lecture 12: Dermatological 2 | , Lice & Scabies (Con't on Feb 1st) (Pediculosis) | R. Sanghera |
| PHARM 243 | Y1 | Winter | 2024-02-01 | Lecture | Lecture 13: Dermatological 3 | , Corns/ Calluses / Bunions / Warts | R. Sanghera |
| PHARM 243 | Y1 | Winter | 2024-02-02 | Lecture | Lecture 14: Dermatological 4 | , Dry Skin (Xerosis), Overview of Dermatitis, Dandruff/Seborrheic Dermatitis, Diaper Dermatitis | R. Sanghera |
| PHARM 243 | Y1 | Winter | 2024-02-05 | Lecture | Lecture 15: Dermatological 5 | , Acne | R. Sanghera |
| PHARM 243 | Y1 | Winter | 2024-02-06 | Seminar/case session | Seminar 2: Dental and GI Cases | Seminar 2: Dental and GI Cases | D. Barnes |
| PHARM 243 | Y1 | Winter | 2024-02-07 | Lecture | Lecture 16: Dermatological 6 | , Burns, Insect Bites and Stings, Minor Cuts and Wounds | R. Sanghera |
| PHARM 243 | Y1 | Winter | 2024-02-09 | Lecture | Lecture 17: Dermatological 7 | , Heat-Related Illnesses, Perspiration and Body Odour | R. Sanghera |
| PHARM 243 | Y1 | Winter | 2024-02-12 | Lecture | Lecture 18: Acute Pain | , Sports Injuries, Lower Back Pain, Tension-Type Headaches | D. Barnes |
| PHARM 243 | Y1 | Winter | 2024-02-14 | Seminar/case session | Seminar 3: Dermatology | Seminar 3: Dermatology | R. Sanghera |
| PHARM 243 | Y1 | Winter | 2024-02-26 | Lecture | Lecture 19: Acute Pain | , Sports Injuries, Lower back pain, Tension Type Headaches | D. Barnes |
| PHARM 243 | Y1 | Winter | 2024-02-27 | Lecture | Lecture 20: Cough and Cold 1 | , Assessment, Nonpharmacological management, Pharmacological management, Follow-up & Monitoring | D. Barnes |
| PHARM 243 | Y1 | Winter | 2024-02-28 | Lecture | Lecture 21: Allergic Rhinitis | Assessment, Non-pharmacological management | D. Barnes |
| PHARM 243 | Y1 | Winter | 2024-03-01 | Lecture | Lecture 22: Allergic Rhinitis | , Pharmacotherapy, Monitoring & Follow-up | D. Barnes |
| PHARM 243 | Y1 | Winter | 2024-03-04 | Lecture | Lecture 23: Asthma | Pathophysiology, signs and symptoms, Epidemiology, Risk factors, triggers, and comorbidities, Diagnosis | P. Gill |
| PHARM 243 | Y1 | Winter | 2024-03-06 | Lecture | Lecture 24: Asthma 2 | , Assessment, Asthma Management | P. Gill |
| PHARM 243 | Y1 | Winter | 2024-03-08 | Lecture | Lecture 25: Derm Complete | , Completion of Derm Block | R. Sanghera |
| PHARM 243 | Y1 | Winter | 2024-03-11 | Lecture | Lecture 26: Asthma 3 | , Asthma Management (Education and non-pharmacological approaches) | P. Gill |
| PHARM 243 | Y1 | Winter | 2024-03-12 | Seminar/case session | Seminar 4: Cough and Cold, Pain | Seminar 4: Cough and Cold, Pain | D. Barnes |
| PHARM 243 | Y1 | Winter | 2024-03-13 | Lecture | Lecture 27: Asthma 4 | , Pharmacotherapy, Inhaled delivery devices | P. Gill |
| PHARM 243 | Y1 | Winter | 2024-03-15 | Lecture | Lecture 28: Asthma 5 | , Pharmacotherapy, Inhaled delivery devices cont | P. Gill |
| PHARM 243 | Y1 | Winter | 2024-03-18 | Lecture | Lecture 29: Asthma 6 | , Asthma exacerbations, Management of asthma exacerbations, Special populations (pediatric, pregnancy) | P. Gill |
| PHARM 243 | Y1 | Winter | 2024-03-20 | Lecture | Lecture 30: Asthma 7 | , Special Populations | P. Gill |
| PHARM 243 | Y1 | Winter | 2024-03-22 | Lecture | Lecture 31: Asthma 8 | Asthma action plants, Monitoring & follow-up, Comparison between Asthma & COPD | P. Gill |
| PHARM 243 | Y1 | Winter | 2024-03-25 | Lecture | Lecture 32: COPD 1 | , Epidemiology, risk factors, screening | P. Gill |
| PHARM 243 | Y1 | Winter | 2024-03-26 | Seminar/case session | Seminar 5: Asthma, Seasonal Allergies | Seminar 5: Asthma, Seasonal Allergies | P. Gill, D. Barnes |
| PHARM 243 | Y1 | Winter | 2024-03-27 | Lecture | Lecture 33: COPD 2 | , Assessment, diagnosis, therapeutic approach | P. Gill |
| PHARM 243 | Y1 | Winter | 2024-04-03 | Lecture | Lecture 34: COPD 3 | , Stable COPD, bronchodilators | P. Gill |
| PHARM 243 | Y1 | Winter | 2024-04-05 | Lecture | Lecture 35: COPD 4 | , Acute exacerbations, antiinflammatories, COPD Action Plan | P. Gill |
| PHARM 243 | Y1 | Winter | 2024-04-08 | Lecture | Lecture 36: Tobacco Cessation 1 | , Assessment, NRT | P. Gill |
| PHARM 243 | Y1 | Winter | 2024-04-09 | Seminar/case session | Seminar 6: COPD | Seminar 6: COPD | P. Gill |
| PHARM 243 | Y1 | Winter | 2024-04-10 | Lecture | Lecture 37: Tobacco Cessation 2 | , Pharmacotherapy | P. Gill |
| PHARM 243 | Y1 | Winter | 2024-04-12 | Lecture | Lecture 38: Tobacco Cessation 3 | , Pharmacotherapy and Alternate Products and Review | P. Gill |
| PHARM 343 | Y2 | Fall | 2024-09-04 | Lecture | Course overview & Conditions of Fluid Imbalance | Review principles of fluid homeostasis, Describe signs and symptoms of conditions of fluid imbalance, Describe an approach to management of conditions of fluid imbalance | Scot Simpson |
| PHARM 343 | Y2 | Fall | 2024-09-06 | Lecture | Conditions of Sodium Imbalance | Describe the signs and symptoms of electrolyte abnormalities, Describe management strategies for electrolyte abnormalities | Scot Simpson |
| PHARM 343 | Y2 | Fall | 2024-09-09 | Lecture | Conditions of Potassium and Magnesium Imbalance | Describe the signs and symptoms of electrolyte abnormalities, Describe management strategies for electrolyte abnormalities | Scot Simpson |
| PHARM 343 | Y2 | Fall | 2024-09-11 | Other exam/test | Laboratory Test Stewardship | Review the pharmacy practice standards related to laboratory testing, Describe issues related to ordering and interpreting laboratory tests, Describe basic principles and terminology related to laboratory testing, Highlight issues related to point of care testing | Scot Simpson |
| PHARM 343 | Y2 | Fall | 2024-09-12 | Seminar/case session | S-1 Fluid & Electrolyte Conditions | See below for details on Seminar format. | Scot H. Simpson, BSP, PharmD, MSc, Joey Ton, BScPharm, PharmD, Rene Breault, BScPharm, PharmD, Cheryl Sadowski, BSc(Pharm), PharmD, Michael Doschak, PhD, Ravina Sanghera, BSc Pharm, PharmD, Dean Eurich, BSP, PhD, Christine Hughes, BScPharm, PharmD |
| PHARM 343 | Y2 | Fall | 2024-09-13 | Laboratory | Endocrine and Cardiovascular Laboratory Values | Interpret the clinical implications of laboratory tests | Scot Simpson |
| PHARM 343 | Y2 | Fall | 2024-09-16 | Laboratory | Hematology, Liver, & GI Laboratory Values | Interpret the clinical implications of laboratory tests | Scot Simpson |
| PHARM 343 | Y2 | Fall | 2024-09-18 | Lecture | Acid/Base Disorders | Identify mechanisms that regulate acid-base balance, Describe 4 primary and secondary types of acid-base disorders, Describe management strategies for acid-base disorders | Joey Ton |
| PHARM 343 | Y2 | Fall | 2024-09-20 | Other exam/test | Introduction to Kidney Diseases & Renal Laboratory Tests | Describe basic kidney physiology and function, Differentiate between acute kidney injury and chronic kidney disease, Apply a systematic approach to assessing kidney function, Interpret the various laboratory tests used to assess kidney function | Rene Breault |
| PHARM 343 | Y2 | Fall | 2024-09-23 | Lecture | Chronic Kidney Disease-1 | Describe the risk factors, etiology, and pathophysiology of CKD, Identify stages of CKD, Explain the role of angiotensin II in the development of CKD, Demonstrate knowledge of factors leading to the progression of CKD, Assess a patient with CKD, Select appropriate management strategies to delay CKD progression | Rupam Arora |
| PHARM 343 | Y2 | Fall | 2024-09-25 | Lecture | Chronic Kidney Disease-2 | Describe the risk factors, etiology, and pathophysiology of CKD, Identify stages of CKD, Explain the role of angiotensin II in the development of CKD, Demonstrate knowledge of factors leading to the progression of CKD, Assess a patient with CKD, Select appropriate management strategies to delay CKD progression | Rupam Arora |
| PHARM 343 | Y2 | Fall | 2024-09-26 | Seminar/case session | S-2 Laboratory Values & Acid/Base Disorders | See below for details on Seminar format. | Scot H. Simpson, BSP, PharmD, MSc, Joey Ton, BScPharm, PharmD, Rene Breault, BScPharm, PharmD, Cheryl Sadowski, BSc(Pharm), PharmD, Michael Doschak, PhD, Ravina Sanghera, BSc Pharm, PharmD, Dean Eurich, BSP, PhD, Christine Hughes, BScPharm, PharmD |
| PHARM 343 | Y2 | Fall | 2024-09-27 | Lecture | Chronic Kidney Disease-Management of Complications 1 | Describe common complications associated with CKD, Recognize signs and symptoms of common complications associated with CKD, Describe management of common complications associated with CKD | Peter Yoeun |
| PHARM 343 | Y2 | Fall | 2024-10-02 | Lecture | Chronic Kidney Disease-Management of Complications 2 | Describe common complications associated with CKD, Recognize signs and symptoms of common complications associated with CKD, Describe management of common complications associated with CKD | Peter Yoeun |
| PHARM 343 | Y2 | Fall | 2024-10-04 | Lecture | Drug Dosing in Renal Impairment | Review effects of chronic kidney disease on pharmacokinetic parameters, Describe methods to estimate renal function, Describe an approach to adjusting drug dosage in renal impairment | Peter Yoeun |
| PHARM 343 | Y2 | Fall | 2024-10-07 | Lecture | Acute Kidney Injury-1 | Define acute kidney injury, Describe the different types of acute kidney injury, Explain an approach to assessment of patients with acute kidney injury, Identify causes of acute kidney injury, Describe management of acute kidney injury | Rene Breault |
| PHARM 343 | Y2 | Fall | 2024-10-09 | Lecture | Acute Kidney Injury-2 | Define acute kidney injury, Describe the different types of acute kidney injury, Explain an approach to assessment of patients with acute kidney injury, Identify causes of acute kidney injury, Describe management of acute kidney injury | Rene Breault |
| PHARM 343 | Y2 | Fall | 2024-10-10 | Seminar/case session | S-3 Chronic Kidney Disease & Drug Dosing in Renal Impairment | See below for details on Seminar format. | Scot H. Simpson, BSP, PharmD, MSc, Joey Ton, BScPharm, PharmD, Rene Breault, BScPharm, PharmD, Cheryl Sadowski, BSc(Pharm), PharmD, Michael Doschak, PhD, Ravina Sanghera, BSc Pharm, PharmD, Dean Eurich, BSP, PhD, Christine Hughes, BScPharm, PharmD |
| PHARM 343 | Y2 | Fall | 2024-10-11 | Lecture | Lower Urinary Tract Symptoms: Introduction | Describe the epidemiology, pathophysiology, and risk factors for urinary incontinence, Classify the types of incontinence based on clinical presentation | Cheryl Sadowski |
| PHARM 343 | Y2 | Fall | 2024-10-16 | Lecture | Lower Urinary Tract Symptoms: Non-pharmacologic | Identify conservative management approaches for urinary incontinence and pelvic organ prolapse, Describe the potential role of the community pharmacist in client education on management | Cheryl Sadowski |
| PHARM 343 | Y2 | Fall | 2024-10-18 | Lecture | Lower Urinary Tract Symptoms: Pharmacologic | Identify appropriate drug therapy for each type of urinary incontinence, Describe safety considerations for each class of drug therapy, Select appropriate monitoring parameters for each drug therapy | Cheryl Sadowski |
| PHARM 343 | Y2 | Fall | 2024-10-21 | Lecture | Lower Urinary Tract Symptoms: Case Studies | Describe the components of a continence assessment, Identify drug-related problems related to LUTS case studies, Design a care plan for a given case involving LUTS, Contrast the roles of key interprofessional team members in assessment of urinary incontinence, Discuss the role of the pharmacist in assessment and referral for a patient with LUTS | Cheryl Sadowski |
| PHARM 343 | Y2 | Fall | 2024-10-23 | Lecture | Calcium Metabolism/PTH/Vit D | Identify the key hormones involved in the regulation of calcium phosphate and bone mineral metabolism, Describe disorders of calcium homeostasis, Describe treatment options and strategies for disorders of calcium homeostasis | Michael Doschak |
| PHARM 343 | Y2 | Fall | 2024-10-24 | Seminar/case session | S-4 Acute Kidney Injury | See below for details on Seminar format. | Scot H. Simpson, BSP, PharmD, MSc, Joey Ton, BScPharm, PharmD, Rene Breault, BScPharm, PharmD, Cheryl Sadowski, BSc(Pharm), PharmD, Michael Doschak, PhD, Ravina Sanghera, BSc Pharm, PharmD, Dean Eurich, BSP, PhD, Christine Hughes, BScPharm, PharmD |
| PHARM 343 | Y2 | Fall | 2024-10-25 | Lecture | Renal Replacement Therapies | Describe the fundamental concepts of dialysis therapy, Describe the different types of renal replacement therapy | Ravina Sanghera |
| PHARM 343 | Y2 | Fall | 2024-10-28 | Lecture | Diabetes Epidemiology | Describe the epidemiology and common classifications of diabetes, List the diagnostic criteria for diabetes and prediabetes, Describe the screening recommendations and risk factors for diabetes, Explain how to choose a treatment target for diabetes | Scot Simpson |
| PHARM 343 | Y2 | Fall | 2024-10-30 | Midterm exam | MIDTERM | See below for details on Midterm. | Scot H. Simpson, BSP, PharmD, MSc, Joey Ton, BScPharm, PharmD, Rene Breault, BScPharm, PharmD, Cheryl Sadowski, BSc(Pharm), PharmD, Michael Doschak, PhD, Ravina Sanghera, BSc Pharm, PharmD, Dean Eurich, BSP, PhD, Christine Hughes, BScPharm, PharmD |
| PHARM 343 | Y2 | Fall | 2024-11-01 | Lecture | Type 1 Diabetes - Clinical Presentation & Rationale for Insulin Administration | Identify key features in the clinical presentation of type 1 diabetes, List risk factors associated with type 1 diabetes, Describe the goals of therapy for type 1 diabetes, Explain important differences between insulin formulations, Explain why a basal-bolus regimen is commonly used to treat type 1 diabetes | Scot Simpson |
| PHARM 343 | Y2 | Fall | 2024-11-04 | Lecture | Treatment of Type 1 Diabetes | Review general considerations of insulin, Develop an initial insulin regimen for someone with type 1 diabetes, Interpret information from a blood glucose log to make an insulin dose adjustment, Describe common adverse effects associated with insulin | Scot Simpson |
| PHARM 343 | Y2 | Fall | 2024-11-06 | Lecture | Acute Complications of Diabetes | Describe reasons for self monitoring blood glucose, Explain the effects of different lifestyle choices (exercise, alcohol, travel, driving) on blood glucose management, Identify resources for diabetes management during Ramadan and other periods of fasting, Explain important considerations for sick day management | Scot Simpson |
| PHARM 343 | Y2 | Fall | 2024-11-07 | Seminar/case session | S-5 Insulin Management | See below for details on Seminar format. | Scot H. Simpson, BSP, PharmD, MSc, Joey Ton, BScPharm, PharmD, Rene Breault, BScPharm, PharmD, Cheryl Sadowski, BSc(Pharm), PharmD, Michael Doschak, PhD, Ravina Sanghera, BSc Pharm, PharmD, Dean Eurich, BSP, PhD, Christine Hughes, BScPharm, PharmD |
| PHARM 343 | Y2 | Fall | 2024-11-13 | Lecture | Type 2 Diabetes - Prevention | Describe the impact of type 2 diabetes on the individual and healthcare system, Explain the pathophysiologic mechanisms contributing to development of type 2 diabetes, List the risk factors for type 2 diabetes, Describe evidence-based lifestyle interventions to prevent development of type 2 diabetes | Dean Eurich |
| PHARM 343 | Y2 | Fall | 2024-11-15 | Lecture | Type 2 Diabetes - Initial Oral Therapy | Describe evidence-based oral therapies to prevent development of type 2 diabetes, List the pharmacologic options for type 2 diabetes treatment, Introduce the Diabetes Canada clinical practice guideline recommendations for glycemic management in type 2 diabetes, Describe the evidence to support using metformin as a first line agent | Dean Eurich |
| PHARM 343 | Y2 | Fall | 2024-11-18 | Lecture | Type 2 Diabetes - Treatment Intensification Pt 1 | Explain why type 2 diabetes is considered a chronic, progressive disease, Explain factors to consider when selecting a second line antihyperglycemic agent, Highlight limitations of the evidence supporting intensive glycemic control in type 2 diabetes | Scot Simpson |
| PHARM 343 | Y2 | Fall | 2024-11-19 | Lecture | Type 2 Diabetes - Treatment Intensification Pt 2 | Explain how to initiate insulin in someone with type 2 diabetes, Describe key observations fro CVOTs that influence clinical practice, Describe other safety signals associated with antihyperglycemic agents, Explain how to initiate insulin in someone with type 2 diabetes | Scot Simpson |
| PHARM 343 | Y2 | Fall | 2024-11-20 | Lecture | Microvascular Complications of Diabetes | Explain why early, aggressive management of diabetes and related complications is necessary, Describe important considerations for diabetes-related microvascular complications | Scot Simpson |
| PHARM 343 | Y2 | Fall | 2024-11-21 | Seminar/case session | S-6 Treatment of Type 2 Diabetes | See below for details on Seminar format. | Scot H. Simpson, BSP, PharmD, MSc, Joey Ton, BScPharm, PharmD, Rene Breault, BScPharm, PharmD, Cheryl Sadowski, BSc(Pharm), PharmD, Michael Doschak, PhD, Ravina Sanghera, BSc Pharm, PharmD, Dean Eurich, BSP, PhD, Christine Hughes, BScPharm, PharmD |
| PHARM 343 | Y2 | Fall | 2024-11-22 | Lecture | Macrovascular Complications of Diabetes | Describe what the "metabolic syndrome" means for diabetes management, Describe important considerations for diabetes-related macrovascular complications, Highlight key components of the ABCDES3 of diabetes care | Scot Simpson |
| PHARM 343 | Y2 | Fall | 2024-11-25 | Lecture | Current Issues in Diabetes Management | Describe the implications of a low carbohydrate diet on diabetes management, Explain how deprescribing applies to diabetes management, Describe selected drug-disease interactions related to diabetes, Highlight selected point-of-care testing devices used for diabetes management, Describe issues related to glucose meter accuracy | Scot Simpson |
| PHARM 343 | Y2 | Fall | 2024-11-27 | Lecture | Pragmatic Tips for Diabetes Management | Discuss practical considerations and patient education tips for people living with diabetes | Eleanor Leoni and Ayush Chadha |
| PHARM 343 | Y2 | Fall | 2024-11-29 | Lecture | Diabetes and Pregnancy | Describe how to screen for gestational diabetes, Explain the implications of gestational diabetes to the mother and baby, Describe management strategies for gestational diabetes, Describe preconception planning for women with pre-existing diabetes | Scot Simpson |
| PHARM 343 | Y2 | Fall | 2024-12-02 | Lecture | Hypothalamus-Pituitary-Adrenal Axis Conditions | Explain management considerations for adrenocortical insufficiency, Explain management considerations for adrenal excess, Explain management considerations for hyperprolactinemia | TBD |
| PHARM 343 | Y2 | Fall | 2024-12-04 | Lecture | Thyroid Conditions-1: Hypothyroidism | Outline screening recommendations for thyroid disorders, Interpret laboratory tests in patients with thyroid disorders, Describe signs and symptoms, and goals of therapy for thyroid disorders, Develop an appropriate patient-specific treatment and monitoring plan for thyroid disorders, Identify drugs which may cause or interact with treatment of thyroid disorders | Christine Hughes |
| PHARM 343 | Y2 | Fall | 2024-12-06 | Lecture | Thyroid Conditions-2: Hyperthyroidism | Outline screening recommendations for thyroid disorders, Interpret laboratory tests in patients with thyroid disorders, Describe signs and symptoms, and goals of therapy for thyroid disorders, Develop an appropriate patient-specific treatment and monitoring plan for thyroid disorders, Identify drugs which may cause or interact with treatment of thyroid disorders | Christine Hughes |
| PHARM 343 | Y2 | Fall | 2024-12-09 | Lecture | Natural Health Products for Diabetes & Course Review | Identify common natural health products (NHPs) used to help people manage diabetes, Describe how NHPs used for diabetes management can affect blood glucose, Describe common drug interactions associated with NHPs used for diabetes management, Discuss the role of the pharmacist in patient safety surrounding NHP use | TBD |
| PHARM 344 | Y2 | Winter | 2024-01-08 | Lecture | Lecture 1: Overview of CVD and Hypertension | Orientation & Hypertension | A. Thompson |
| PHARM 344 | Y2 | Winter | 2024-01-10 | Lecture | Lecture 2: Hypertension | Hypertension | A. Thompson |
| PHARM 344 | Y2 | Winter | 2024-01-11 | Lecture | Lecture 3 & 4: Hypertension Parts 3 & 4 | Hypertension | A. Thompson |
| PHARM 344 | Y2 | Winter | 2024-01-12 | Seminar/case session | Seminar 1: Hypertension (PBL Rooms) | Patient Assessment Seminar | A. Thompson |
| PHARM 344 | Y2 | Winter | 2024-01-15 | Seminar/case session | Seminar 1 Debrief: Hypertension | Patient Assessment, Hypertension | A. Thompson |
| PHARM 344 | Y2 | Winter | 2024-01-17 | Lecture | Lecture 5: Dyslipidemia Part 1 | Dyslipidemia | G. Pearson |
| PHARM 344 | Y2 | Winter | 2024-01-19 | Lecture | Lecture 6: Dyslipidemia Part 2 | Dyslipidemia | G. Pearson |
| PHARM 344 | Y2 | Winter | 2024-01-22 | Lecture | Lecture 7: Dyslipidemia Part 3 | Dyslipidemia | G Pearson |
| PHARM 344 | Y2 | Winter | 2024-01-23 | Lecture | Lecture 8: Heart Failure Part 1 | Heart Failure | S. Koshman |
| PHARM 344 | Y2 | Winter | 2024-01-24 | Lecture | Lecture 9: Heart Failure Part 2 | Heart Failure | S. Koshman |
| PHARM 344 | Y2 | Winter | 2024-01-25 | Lecture | Lecture 10: Heart Failure Part 3 | Heart Failure | S. Koshman |
| PHARM 344 | Y2 | Winter | 2024-01-25 | Seminar/case session | Seminar 2: Risk Assessment and Primary Prevention | Risk Assessment & Primary Prevention Seminar | A. Thompson and G. Pearson |
| PHARM 344 | Y2 | Winter | 2024-01-26 | Lecture | Lecture 11: Heart Failure Part 4 | Heart Failure | S. Koshman |
| PHARM 344 | Y2 | Winter | 2024-01-29 | Lecture | Lecture 12: Patient Assessment Heart Failure (pre-recorded) | Patient Assessment - Heart Failure | S. Koshman |
| PHARM 344 | Y2 | Winter | 2024-01-31 | Lecture | Lecture 13: Patient Perspective: from Heart Failure to Heart Transplant and Beyond | Lecture 13: Patient Perspective: from Heart Failure to Heart Transplant and Beyond | M. Bains |
| PHARM 344 | Y2 | Winter | 2024-02-02 | Lecture | Lecture 14: Patient Assessment Chest Pain | Patient Assessment | S. Koshman |
| PHARM 344 | Y2 | Winter | 2024-02-05 | Lecture | Lecture 15 : Stable Ischemic Heart Disease Part 1 | Stable Ischemic Heart Disease/Stable Angina | A. Thompson |
| PHARM 344 | Y2 | Winter | 2024-02-07 | Lecture | Lecture 16: Stable Ischemic Heart Disease Part 2 | Stable Ischemic Heart Disease | A. Thompson |
| PHARM 344 | Y2 | Winter | 2024-02-08 | Seminar/case session | Seminar 3: Heart Failure | Heart Failure Seminar | A. Thompson and S. Koshman |
| PHARM 344 | Y2 | Winter | 2024-02-09 | Lecture | Lecture 17: ACS Part 1 | Acute Coronary Syndromes | M. Ackman |
| PHARM 344 | Y2 | Winter | 2024-02-12 | Lecture | Lecture 18: ACS 2 | Acute Coronary Syndromes | M. Ackman |
| PHARM 344 | Y2 | Winter | 2024-02-14 | Lecture | Lecture 19: ACS Part 3 | Acute Coronary Syndromes | M. Ackman |
| PHARM 344 | Y2 | Winter | 2024-02-16 | Midterm exam | Session 20: Midterm Exam | Session 20: Midterm Exam | A. Thompson |
| PHARM 344 | Y2 | Winter | 2024-02-26 | Lecture | Lecture 21: VTE Part 1 | Thromboembolism | T. Bungard |
| PHARM 344 | Y2 | Winter | 2024-02-28 | Lecture | Lecture 22: VTE Part 2 | Thromboembolism | T. Bungard |
| PHARM 344 | Y2 | Winter | 2024-02-29 | Seminar/case session | Seminar 4: ACS | Hypertension and Acute Coronary Syndromes Seminar, Acute Coronary Syndromes Seminar | A. Thompson and M. Ackman |
| PHARM 344 | Y2 | Winter | 2024-03-01 | Lecture | Lecture 23: VTE Part 3 | Thromboembolism | T. Bungard |
| PHARM 344 | Y2 | Winter | 2024-03-04 | Lecture | Lecture 24: VTE Part 4 | Thromboembolism | T. Bungard |
| PHARM 344 | Y2 | Winter | 2024-03-06 | Lecture | Lecture 25: Patient Assessment: Palpitations, Syncope and Pre-Syncope | Patient Assessment | S. Koshman |
| PHARM 344 | Y2 | Winter | 2024-03-08 | Lecture | Lecture 26: AFib Part 1 | Atrial Fibrillation | E. Cowley |
| PHARM 344 | Y2 | Winter | 2024-03-11 | Lecture | Lecture 27: AFib Part 2 | Atrial Fibrillation | E. Cowley |
| PHARM 344 | Y2 | Winter | 2024-03-13 | Lecture | Lecture 28: AFib Part 3 | Atrial Fibrillation | E. Cowley |
| PHARM 344 | Y2 | Winter | 2024-03-14 | Seminar/case session | Seminar 5: VTE | Thromboembolism Seminar | A. Thompson, T. Bungard |
| PHARM 344 | Y2 | Winter | 2024-03-15 | Lecture | Lecture 29: Stroke Part 1 | Stroke | M. Hodgson |
| PHARM 344 | Y2 | Winter | 2024-03-18 | Lecture | Lecture 30: Stroke Part 2 | Stroke | M. Hodgson |
| PHARM 344 | Y2 | Winter | 2024-03-20 | Lecture | Lecture 31: Optimizing Antiplatelets and Anticoagulants | Optimizing Antiplatelets and Anticoagulants | T. Eberhardt |
| PHARM 344 | Y2 | Winter | 2024-03-22 | Seminar/case session | Lecture 32: Optimizing Antiplatelets and Anticoagulants (seminar cases) | Heart Failure | T. Eberhardt |
| PHARM 344 | Y2 | Winter | 2024-03-25 | Lecture | Lecture 33: Debrief Antiplatalet/Anticoagulant Cases | Patient Experience - Stroke | T. Eberhardt |
| PHARM 344 | Y2 | Winter | 2024-03-27 | Lecture | Lecture 34: PGx Part 1 | Pharmacogenomics CV | D. El Sayed |
| PHARM 344 | Y2 | Winter | 2024-03-28 | Seminar/case session | Seminar 6: AFib and Stroke | Atrial Fibrillation and Stroke Seminar | A. Thompson & M. Hodgson |
| PHARM 344 | Y2 | Winter | 2024-04-03 | Lecture | Lecture 35: PGx Part 2 | Lecture 35: PGx Part 2 | D. El Sayed |
| PHARM 344 | Y2 | Winter | 2024-04-05 | Lecture | Lecture 36: Anemia Part 1 | Anemia | C. Hughes |
| PHARM 344 | Y2 | Winter | 2024-04-08 | Lecture | Lecture 37: Anemia Part 2 | Anemia | C. Hughes |
| PHARM 344 | Y2 | Winter | 2024-04-10 | Seminar/case session | Lecture 38: Anemia Cases (seminar format) | Anemia Cases | C. Hughes |
| PHARM 344 | Y2 | Winter | 2024-04-12 | Lecture | Lecture 39: Anemia Case Debrief | Anemia Cases Debrief | C. Hughes |
| PHARM 345 | Y2 | Winter | 2024-01-10 | Lecture | Lecture 3 | Treatment of Diarrhea | Dr. Breault |
| PHARM 345 | Y2 | Winter | 2024-02-02 | Lecture | Lecture 14 | Liver Disease Cont | Dr. Yuksel |
| PHARM 345 | Y2 | Winter | 2024-02-09 | Lecture | Lecture 15 | Macronutrient Metabolism Overview | Dr. Ussher |
| PHARM 345 | Y2 | Winter | 2024-02-14 | Lecture | Lecture 17 | Macronutrient Metabolism Overview Cont | Dr. Ussher |
| PHARM 345 | Y2 | Winter | 2024-02-16 | Lecture | Lecture 18 | Canada Food Guide & Dietary Reference Intakes | Dr. Ussher |
| PHARM 345 | Y2 | Winter | 2024-02-26 | Lecture | Lecture 19 | Vitamins, Minerals & Other Supplements, Nutritional Deficiencies | Dr. Ussher |
| PHARM 345 | Y2 | Winter | 2024-02-28 | Lecture | Lecture 20 | Vitamins, Minerals & Other Supplements, Nutritional Deficiencies (Part 2) | Dr. Ussher |
| PHARM 345 | Y2 | Winter | 2024-03-01 | Lecture | Lecture 21 | Enteral Nutrition | Leanne Mulesa |
| PHARM 345 | Y2 | Winter | 2024-03-04 | Lecture | Lecture 22 | Parenteral Nutrition | Leanne Mulesa |
| PHARM 345 | Y2 | Winter | 2024-03-06 | Lecture | Lecture 23 | Specialty Diets (Specific medical conditions [e.g. Celiac disease] and Obesity) | Dr. Ussher |
| PHARM 345 | Y2 | Winter | 2024-03-07 | Seminar/case session | Seminar 3 | Brown Bag Nutritional Supplements | Dr. Ussher |
| PHARM 345 | Y2 | Winter | 2024-03-08 | Lecture | Lecture 24 | Specialty Diets & Obesity Cont | Dr. Ussher |
| PHARM 345 | Y2 | Winter | 2024-03-11 | Lecture | Lecture 25 | Nutrition in Pregnancy | Rhonda Bell |
| PHARM 345 | Y2 | Winter | 2024-03-13 | Lecture | Lecture 26 | Nutrition in Pediatrics | Dr. Sanghera |
| PHARM 345 | Y2 | Winter | 2024-03-15 | Lecture | Lecture 27 | Nutrition in Geriatrics/Cachexia | Heather Oga |
| PHARM 345 | Y2 | Winter | 2024-03-18 | Lecture | Lecture 28 | Eye Diseases 1: Infections and inflammation | Dr. Ton/Dr. Hong |
| PHARM 345 | Y2 | Winter | 2024-03-18 | Lecture | Lecture 29 | Eye Diseases 2 Infection and inflammation continued | Dr. Ton/Dr. Hong |
| PHARM 345 | Y2 | Winter | 2024-03-20 | Lecture | Lecture 30 | Glaucoma, Cataracts | Dr. Ton/Dr. Hong |
| PHARM 345 | Y2 | Winter | 2024-03-21 | Seminar/case session | Seminar 4 | Ophthalmology | Dr. Sadowski/Dr. Ton |
| PHARM 345 | Y2 | Winter | 2024-03-22 | Lecture | Lecture 31 | Age-related macular degeneration, Diabetic retinopathy | Dr. Ton/Dr. Hong |
| PHARM 345 | Y2 | Winter | 2024-03-25 | Lecture | Lecture 32 | Psoriasis | Dr. Sanghera |
| PHARM 345 | Y2 | Winter | 2024-03-27 | Lecture | Lecture 33 | Dermatitis | Dr. Sanghera |
| PHARM 345 | Y2 | Winter | 2024-04-03 | Lecture | Lecture 34 | Overview of Skin & Nail Infections (Bacterial, Viral) | Dr. Sanghera/Dr. Grewal |
| PHARM 345 | Y2 | Winter | 2024-04-03 | Lecture | Lecture 35 | Drug Induced Eruptions | Dr. Grewal |
| PHARM 345 | Y2 | Winter | 2024-04-04 | Seminar/case session | Seminar 5 | Psoriasis (Biologic Therapy Cases) | Dr. Sanghera |
| PHARM 345 | Y2 | Winter | 2024-04-05 | Lecture | Lecture 36 | Perioral dermatitis, Rosacea | Dr. Sanghera |
| PHARM 345 | Y2 | Winter | 2024-04-08 | Lecture | Lecture 37 | Chilblains, chronic idiopathic urticaria, Dermatology Mini Topics | Dr. Sanghera |
| PHARM 345 | Y2 | Winter | 2024-04-10 | Lecture | Lecture 38 | Assessment & Derm Manifestations in Skin of Colour | Dr. Sanghera |
| PHARM 345 | Y2 | Winter | 2024-04-12 | Lecture | Lecture 39 | Cosmetic Derm & Alopecia | Dr. Grewal/Dr. Sanghera |
| PHARM 345 | Y2 | Winter | 2025-01-01 | Seminar/case session | Seminar 2 | IBD cases | Dr. Hall |
| PHARM 345 | Y2 | Winter | 2025-01-02 | Lecture | Lecture 14 | gastrointestinal reflux | Dr. Makowsky |
| PHARM 345 | Y2 | Winter | 2025-01-06 | Lecture | Lecture 1 | Introduction/Nausea and Vomiting | Dr. Breault |
| PHARM 345 | Y2 | Winter | 2025-01-08 | Lecture | Lecture 2 | Nausea and Vomiting Cont | Dr. Breault |
| PHARM 345 | Y2 | Winter | 2025-01-13 | Lecture | Lecture 4 | Treatment of Constipation Cont | Dr. Breault |
| PHARM 345 | Y2 | Winter | 2025-01-15 | Lecture | Lecture 5 | Treatment of Constipation | Dr. Breault |
| PHARM 345 | Y2 | Winter | 2025-01-16 | Seminar/case session | Seminar 1 | Constipation Cases | Dr. Breault |
| PHARM 345 | Y2 | Winter | 2025-01-17 | Lecture | Lecture 6 | Irritable Bowel Syndrome (IBS) | Dr. Breault |
| PHARM 345 | Y2 | Winter | 2025-01-20 | Lecture | Lecture 7 | Inflammatory Bowel Disease (IBD) | Dr. Hall |
| PHARM 345 | Y2 | Winter | 2025-01-22 | Lecture | Lecture 8 | Inflammatory Bowel Disease (IBD) | Dr. Hall |
| PHARM 345 | Y2 | Winter | 2025-01-24 | Lecture | Lecture 9 | Inflammatory Bowel Disease (IBD) | Dr. Hall |
| PHARM 345 | Y2 | Winter | 2025-01-27 | Lecture | Lecture 10 | Inflammatory Bowel Disease (IBD) | Dr. Hall |
| PHARM 345 | Y2 | Winter | 2025-01-29 | Lecture | Lecture 13 | Peptic Ulcer Disease (PUD) | Dr. Makowsky |
| PHARM 345 | Y2 | Winter | 2025-02-03 | Lecture | Lecture 11 | Liver Disease | Dr. Breault |
| PHARM 345 | Y2 | Winter | 2025-02-05 | Lecture | Lecture 12 | Liver disease | Dr. Breault |
| PHARM 346 | Y2 | Winter | 2024-01-08 | Lecture | Overview of ID and Antimicrobial Stewardship | Antimicrobial resistance, Antimicrobial selection considerations, Impact of antibacterials to care | Nathan Beahm |
| PHARM 346 | Y2 | Winter | 2024-01-10 | Lecture | Microbiology 1: Bacterial Pathogens | Clinical lab assays, Serology, Bacterial cultures | Nathan Zelyas |
| PHARM 346 | Y2 | Winter | 2024-01-10 | Lecture | Penicillins | Appropriate usage, Spectra of activity, Bacterial resistance mechanisms | Nathan Beahm |
| PHARM 346 | Y2 | Winter | 2024-01-12 | Lecture | Microbiology 2: Bacterial Pathogens | Antimicrobial susceptibility testing, Microbiology reports | Nathan Zelyas |
| PHARM 346 | Y2 | Winter | 2024-01-15 | Lecture | Upper Respiratory Tract Infections 1 | Otitis media | Nathan Beahm |
| PHARM 346 | Y2 | Winter | 2024-01-17 | Lecture | Upper Respiratory Tract Infections 2 | Sinusitis, Pharyngitis | Nathan Beahm |
| PHARM 346 | Y2 | Winter | 2024-01-18 | Seminar/case session | Seminar 1: URTI | URTI | Nathan Beahm |
| PHARM 346 | Y2 | Winter | 2024-01-19 | Lecture | Microbiology 3: Bacterial Pathogens | Gram positives (aerobes and anaerobes), Gram negatives (aerobes and anaerobes) | Nathan Zelyas |
| PHARM 346 | Y2 | Winter | 2024-01-22 | Other exam/test | Microbiology 4: Antimicrobial Identification and Susceptibility Testing | Cell wall deficient, Mycobacteria | Nathan Zelyas |
| PHARM 346 | Y2 | Winter | 2024-01-24 | Lecture | PK-PD of Antimicrobials 1 | PK-PD target attainment, PK-PD indices, Dose optimization | Nathan Beahm |
| PHARM 346 | Y2 | Winter | 2024-01-26 | Lecture | PK-PD of Antimicrobials 2 | PK-PD target attainment, PK-PD indices, Dose optimization | Nathan Beahm |
| PHARM 346 | Y2 | Winter | 2024-01-29 | Lecture | Lower Respiratory Tract Infections 1 | Clinical signs of infection, Community-acquired pneumonia | Nathan Beahm |
| PHARM 346 | Y2 | Winter | 2024-01-31 | Lecture | Lower Respiratory Tract Infections 2 | Aspiration pneumonia, Acute bronchitis, Hospital-acquired pneumonia, Ventilator-associated pneumonia | Nathan Beahm |
| PHARM 346 | Y2 | Winter | 2024-02-01 | Seminar/case session | Seminar 2: LRTI | LRTI | Nathan Beahm |
| PHARM 346 | Y2 | Winter | 2024-02-02 | Lecture | Cephalosporins | Appropriate usage, Spectra of activity, Bacterial resistance mechanisms | Nathan Beahm |
| PHARM 346 | Y2 | Winter | 2024-02-05 | Lecture | Carbapenems, Monobactams | Appropriate usage, Spectra of activity, Bacterial resistance mechanisms | Nathan Beahm |
| PHARM 346 | Y2 | Winter | 2024-02-07 | Other exam/test | Beta-lactam Cross-Sensitivity/Allergy Testing | Beta-lactam cross-reactivity, Allergy management, Hypersensitivity reactions, Skin testing | Nathan Beahm |
| PHARM 346 | Y2 | Winter | 2024-02-09 | Lecture | Macrolides, Clindamycin, Tetracyclines | Appropriate usage, Spectra of activity, Bacterial resistance mechanisms | Nathan Beahm |
| PHARM 346 | Y2 | Winter | 2024-02-12 | Lecture | Sepsis and Septic Shock | Assessment, Management | Nathan Beahm |
| PHARM 346 | Y2 | Winter | 2024-02-14 | Lecture | Skin and Soft Tissue Infections | Diabetic foot infections, Necrotizing fasciitis, Erysipelas, Cellulitis | Nathan Beahm |
| PHARM 346 | Y2 | Winter | 2024-02-15 | Seminar/case session | Seminar 3: SSTI | SSTI | Nathan Beahm |
| PHARM 346 | Y2 | Winter | 2024-02-16 | Lecture | Fluoroquinolones, Metronidazole | Appropriate usage, Spectra of activity, Bacterial resistance mechanisms | Nathan Beahm |
| PHARM 346 | Y2 | Winter | 2024-02-26 | Lecture | Glycopeptides | Appropriate usage, Spectra of activity, Bacterial resistance mechanisms | Nathan Beahm |
| PHARM 346 | Y2 | Winter | 2024-02-28 | Lecture | TMP/SMX, Fosfomycin, Nitrofurantoin | Appropriate usage, Spectra of activity, Bacterial resistance mechanisms | Nathan Beahm |
| PHARM 346 | Y2 | Winter | 2024-03-01 | Lecture | Oxazolidinones, Daptomycin, Chloramphenicol | Appropriate usage, Spectra of activity, Bacterial resistance mechanisms | Nathan Beahm |
| PHARM 346 | Y2 | Winter | 2024-03-04 | Lecture | Urinary Tract Infections 1 | Pyelonephritis, Assessment, Cystitis | Nathan Beahm |
| PHARM 346 | Y2 | Winter | 2024-03-06 | Lecture | Urinary Tract Infections 2 | Prostatitis, Treatment, Prevention | Nathan Beahm |
| PHARM 346 | Y2 | Winter | 2024-03-07 | Seminar/case session | Seminar 4: UTI | UTI | Nathan Beahm |
| PHARM 346 | Y2 | Winter | 2024-03-08 | Lecture | Aminoglycosides | Appropriate usage, Spectra of activity, Bacterial resistance mechanisms | Nathan Beahm |
| PHARM 346 | Y2 | Winter | 2024-03-11 | Lecture | Vancomycin TDM | Dose adjustment, Dosing, Monitoring | Tony Kiang |
| PHARM 346 | Y2 | Winter | 2024-03-13 | Lecture | Aminoglycoside TDM | Dose adjustment, Dosing, Monitoring | Tony Kiang |
| PHARM 346 | Y2 | Winter | 2024-03-15 | Lecture | Bone & Joint Infections | Septic arthritis, Osteomyelitis, Prosthetic Joint Infection | Nathan Beahm |
| PHARM 346 | Y2 | Winter | 2024-03-18 | Lecture | Tuberculosis and Antitubercular Agents 1 | Pharmacology of TB agents, Assessment, Diagnosis | Donna Chua |
| PHARM 346 | Y2 | Winter | 2024-03-20 | Lecture | Tuberculosis and Antitubercular Agents 2 | Active TB, Treatment regimens, Latent TB | Donna Chua |
| PHARM 346 | Y2 | Winter | 2024-03-21 | Seminar/case session | Seminar 5: Bone & Joint Infections | Bone & Joint Infections | Nathan Beahm |
| PHARM 346 | Y2 | Winter | 2024-03-22 | Lecture | Clostridioides difficile Infection | Treatment, Assessment, Prevention | Nathan Beahm |
| PHARM 346 | Y2 | Winter | 2024-03-25 | Lecture | Endocarditis | Prevention, Assessment, Treatment | Margaret Gray |
| PHARM 346 | Y2 | Winter | 2024-03-27 | Lecture | Endocarditis (Cases) | Endocarditis (Cases) | Margaret Gray |
| PHARM 346 | Y2 | Winter | 2024-04-03 | Lecture | Meningitis/Encephalitis | Meningitis/Encephalitis | Cecilia Lau |
| PHARM 346 | Y2 | Winter | 2024-04-04 | Seminar/case session | Seminar 6: Meningitis | Meningitis | Cecilia Lau, Nathan Beahm |
| PHARM 346 | Y2 | Winter | 2024-04-05 | Lecture | Intra-abdominal Infections | Peritoneal dialysis-related peritonitis, Primary peritonitis, Secondary peritonitis | Jackson Stewart |
| PHARM 346 | Y2 | Winter | 2024-04-08 | Lecture | Polymyxins, Bacitracin, Mupirocin, Fusidic Acid | Appropriate usage, Spectra of activity, Bacterial resistance mechanisms | Nathan Beahm |
| PHARM 346 | Y2 | Winter | 2024-04-10 | Lecture | Infection Prevention & Control | Personal protective equipment, Environmental control, Patient isolation, Hand hygiene | Melody Cordoviz |
| PHARM 346 | Y2 | Winter | 2024-04-12 | Lecture | Surgical Prophylaxis | Surgical wound classification, Antimicrobial options for prophylaxis | Nathan Beahm |
| PHARM 443 | Y3 | Fall | 2023-09-05 | Lecture | Introduction to Sexual and ReprodIntroduction to the Course; Contraception Part I: General and Part II: Combined hormonal contraceptives | Introduction to the Course, Contraception Part I and Part II | Torok-Both |
| PHARM 443 | Y3 | Fall | 2023-09-07 | Lecture | Contraception Part II: Combined Hormonal Contraceptives; progestin only contraceptives | Combined Hormonal Contraception, Progestin only contraceptive | Torok-Both |
| PHARM 443 | Y3 | Fall | 2023-09-12 | Lecture | Contraception Part II con't | Combined Hormonal Contraceptives; Progestin only contraceptives | Torok-Both |
| PHARM 443 | Y3 | Fall | 2023-09-14 | Lecture | Contraception Part III LARC; Contraception Part IV: Non-hormonal contraceptives | LARC, Non-hormonal contraceptives | Torok-Both |
| PHARM 443 | Y3 | Fall | 2023-09-14 | Seminar/case session | Seminar 1: Contraception: Prescribing of Combined Hormonal Contraceptive Cases and LARC Cases | Case Based Seminar: Contraception: Prescribing of CHC and LARC Cases | Torok-Both |
| PHARM 443 | Y3 | Fall | 2023-09-19 | Lecture | Emergency Contraception; Medical Abortion | Emergency Contraception, Medical Abortion | Biggs |
| PHARM 443 | Y3 | Fall | 2023-09-21 | Lecture | Menstrual Related Disorders (dysmenorrhea/AUB); PMS/PMDD | Menstrual Related Disorders (Dysmenorrhea, AUB); PMS/PMDD | Torok-Both |
| PHARM 443 | Y3 | Fall | 2023-09-26 | Lecture | Endometriosis | Endometriosis | Torok-Both |
| PHARM 443 | Y3 | Fall | 2023-09-28 | Lecture | Menopause Part 1: Pathophysiology; Menopause Part 2: Role of Menopausal Hormone Therapy and Management of Menopause | Menopause Pathophysiology, Signs and Symptoms, Management of Menopause, Role of Menopausal Hormone Therapy | Torok-Both |
| PHARM 443 | Y3 | Fall | 2023-10-03 | Lecture | Erectile Dysfunction | Erectile Dysfunction | Sadowski |
| PHARM 443 | Y3 | Fall | 2023-10-05 | Lecture | Menopause Part 2 con't; Part 3: Therapeutic Options | Management of Menopause, Role of Menopausal Hormone Therapy, Therapeutic Options | Torok-Both |
| PHARM 443 | Y3 | Fall | 2023-10-12 | Lecture | Hypogonadism | Hypogonadism and testosterone in men | Sadowski |
| PHARM 443 | Y3 | Fall | 2023-10-12 | Seminar/case session | Seminar 2: Menopause Cases | Case based seminar: Management of menopause and hormone therapy prescribing | Torok-Both |
| PHARM 443 | Y3 | Fall | 2023-10-17 | Midterm exam | Midterm Exam | Midterm Exam | Hall/Torok-Both |
| PHARM 443 | Y3 | Fall | 2023-10-19 | Lecture | Polycystic Ovarian Syndrome | Polycystic Ovarian Syndrome | Torok-Both |
| PHARM 443 | Y3 | Fall | 2023-10-24 | Other exam/test | Pregnancy and ovulation testing/Treatment of Infertility | Pregnancy and Ovulation Testing, Treatment of Infertility | Yuksel |
| PHARM 443 | Y3 | Fall | 2023-10-26 | Lecture | Female Sexual Dysfunction; Drugs in Pregnancy and Lactation | Female Sexual Dysfunction, Drugs in Pregnancy and Lactation | Yuksel |
| PHARM 443 | Y3 | Fall | 2023-10-26 | Seminar/case session | Seminar 3: Care of the SOGIE Client/Transgender Care | Full Class Seminar: Pharmaceutical Care of the SOGIE (Sexual, Orientation, Gender, Identity, Expression) Client | TBA |
| PHARM 443 | Y3 | Fall | 2023-10-31 | Lecture | Physiologic Changes in Pregnancy/Treatment in Pregnancy | Physiologic Changes in Pregnancy, Treatment in Pregnancy | Torok-Both |
| PHARM 443 | Y3 | Fall | 2023-11-02 | Lecture | Treatment Issues in Pregnancy; Postpartum Care/Postpartum Depression | Treatment Issues in Pregnancy, Postpartum Care/Postpartum Depression | Torok-Both |
| PHARM 443 | Y3 | Fall | 2023-11-07 | Lecture | Gout | Gout | Hall |
| PHARM 443 | Y3 | Fall | 2023-11-09 | Lecture | Osteoarthritis | Osteoarthritis | Beahm |
| PHARM 443 | Y3 | Fall | 2023-11-09 | Seminar/case session | Seminar 4: Gout/Osteoarthritis | Case Based Seminar: Musculoskeletal Cases, Gout and Osteoarthritis | Hall |
| PHARM 443 | Y3 | Fall | 2023-11-16 | Lecture | Fibromyalgia | Fibromyalgia (self directed learning) | Hall |
| PHARM 443 | Y3 | Fall | 2023-11-21 | Lecture | Rheumatoid Arthritis (RA) I | Rheumatoid Arthritis: Pathophsiology, Assessment | Hall |
| PHARM 443 | Y3 | Fall | 2023-11-23 | Lecture | RA II | Rheumatoid Arthritis: Management of Rheumatoid Arthritis | Hall |
| PHARM 443 | Y3 | Fall | 2023-11-23 | Seminar/case session | Seminar 5: Rheumatoid Arthritis | Case Based Seminar: Rheumatoid Arthritis Cases | Hall |
| PHARM 443 | Y3 | Fall | 2023-11-28 | Lecture | Osteoporosis Part I | Osteoporosis: Pathophysiology, Assessment | Biggs |
| PHARM 443 | Y3 | Fall | 2023-11-30 | Lecture | Osteoporosis Part II | Osteoporosis: Management of Osteoporosis | Biggs |
| PHARM 443 | Y3 | Fall | 2023-12-05 | Lecture | Spondyloarthropathies/Lupus | Spondyloarthropathies , Lupus | Hall |
| PHARM 443 | Y3 | Fall | 2023-12-07 | Final exam | (Optional Attendance) Fibromyalgia Unit Debrief; Final Exam Q&A | Optional Attendance: Fibromyalgia Unit Debrief; Final Exam Q&A | Hall |
| PHARM 443 | Y3 | Fall | 2023-12-07 | Seminar/case session | Musculoskeletal Imaging (seminar/discussion); Class Evaluations | Musculoskeletal Imaging, Final exam review | Clifford/Dillon/Hall |
| PHARM 444 | Y3 | Fall | 2023-09-05 | Lecture | Course Introduction and Oncology Introduction | Hallmarks of Cancer | Tara Leslie & Sherif Mahmoud |
| PHARM 444 | Y3 | Fall | 2023-09-07 | Lecture | Colon Cancer | Colon Cancer | Tara Leslie |
| PHARM 444 | Y3 | Fall | 2023-09-07 | Seminar/case session | Seminar #1 - Oncology Basics Module/Quiz | Oncology Introduction Case Oncology Basics Modules and Quiz | Tara Leslie |
| PHARM 444 | Y3 | Fall | 2023-09-12 | Lecture | Radiotherapy and Breast Cancer 1 | Radiotherapy | Tara Leslie |
| PHARM 444 | Y3 | Fall | 2023-09-14 | Lecture | Breast Cancer 2 | Breast Cancer | Tara Leslie |
| PHARM 444 | Y3 | Fall | 2023-09-19 | Lecture | Supportive Care 1 - AINV, Hand&Foot, Mucositis, etc | Supportive Care 1 (AINV) | Tara Leslie |
| PHARM 444 | Y3 | Fall | 2023-09-21 | Lecture | Lung Cancer 1 | Lung Cancer | Tara Leslie |
| PHARM 444 | Y3 | Fall | 2023-09-21 | Seminar/case session | Seminar 2 - Breast Cancer and Supportive Care Seminar | Breast Cancer with Supportive Care Seminar | Tara Leslie |
| PHARM 444 | Y3 | Fall | 2023-09-26 | Lecture | Lung Cancer 2 and Supportive Care 2 (Other Chemotherapy Toxicitiies) | Supportive Care 2 (Hand/Foot, mucositis, clots, cardiotoxicity hair loss) | Tara Leslie |
| PHARM 444 | Y3 | Fall | 2023-09-28 | Lecture | Prostate Cancer | Prostate Cancer | Tara Leslie |
| PHARM 444 | Y3 | Fall | 2023-10-03 | Lecture | Hematologic Malignancy Part 1 (Lymphoma and Multiple Myeloma) | Hematology (Lymphoma and Multiple Myeloma include hypercalcemia) | Tara Leslie |
| PHARM 444 | Y3 | Fall | 2023-10-05 | Lecture | Hematologic Malignancy Part 2 (Leukemias) and Supportive Care 4 (TLS) | Hematology (Leukemias) + Supportive Care 4 (TLS) | Tara Leslie |
| PHARM 444 | Y3 | Fall | 2023-10-05 | Seminar/case session | Seminar #3 - Drug Interactions and Survive and Thrive | Drug Interactions Seminar and Survive and Thrive | Tara Leslie |
| PHARM 444 | Y3 | Fall | 2023-10-12 | Lecture | Palliative Care | Palliative Care | Vincent Ha |
| PHARM 444 | Y3 | Fall | 2023-10-17 | Lecture | Supportive Care 3 (Myelosuppression and FN) | Supportive Care #3 (Myelosuppression and FN) | Tara Leslie |
| PHARM 444 | Y3 | Fall | 2023-10-19 | Lecture | Peripheral Neuropathies | Supportive Care 5 (FN and myelosuppression) | Sherif Mahmoud |
| PHARM 444 | Y3 | Fall | 2023-10-26 | Lecture | Seizures and Epilepsy 1 | Seizures and Epilepsy 1 | Sherif Mahmoud |
| PHARM 444 | Y3 | Fall | 2023-10-31 | Lecture | Seizures and Epilepsy 2 | Seizures and Epilepsy 2 | Sherif Mahmoud |
| PHARM 444 | Y3 | Fall | 2023-11-02 | Lecture | Seizures and Epilepsy 3 | Seizures and Epilepsy 3 | Sherif Mahmoud |
| PHARM 444 | Y3 | Fall | 2023-11-02 | Seminar/case session | Seminar 4 - Seizures and Epilepsy | Seizures and Epilepsy Seminar | Sherif Mahmoud |
| PHARM 444 | Y3 | Fall | 2023-11-07 | Lecture | Headache Disorders 1 | Headache Disorders 1 | Sherif Mahmoud |
| PHARM 444 | Y3 | Fall | 2023-11-09 | Lecture | Headache Disorders 2 | Headache Disorders 2 | Sherif Mahmoud |
| PHARM 444 | Y3 | Fall | 2023-11-16 | Lecture | Multiple Sclerosis | Multiple Sclerosis | Penny Smyth |
| PHARM 444 | Y3 | Fall | 2023-11-16 | Seminar/case session | Seminar 5 - Headache Seminar | Headache Seminar | Sherif Mahmoud |
| PHARM 444 | Y3 | Fall | 2023-11-21 | Lecture | Movement Disorders 1 | Movement Disorders 1 | Cheryl Sadowski |
| PHARM 444 | Y3 | Fall | 2023-11-21 | Lecture | Movement Disorders 2 | Movement Disorders 2 | Cheryl Sadowski |
| PHARM 444 | Y3 | Fall | 2023-11-28 | Lecture | Cognitive Impairment 1 | Dementia | Cheryl Sadowski |
| PHARM 444 | Y3 | Fall | 2023-11-30 | Lecture | Cognitive Impairment 2 | Delirium and behavioral disorders | Cheryl Sadowski |
| PHARM 444 | Y3 | Fall | 2023-11-30 | Seminar/case session | Seminar 6 - A day in the life of a neurology pharmacist | A day in the life of a Neurology Pharmacist | Sherif Mahmoud |
| PHARM 444 | Y3 | Fall | 2023-12-05 | Lecture | Dizziness | Dizziness | Cheryl Sadowski |
| PHARM 444 | Y3 | Fall | 2023-12-07 | Lecture | Traumatic Brain Injury /Course Review | Traumatic Brain Injury /Course Review | Sherif Mahmoud |
| PHARM 445 | Y3 | Fall | 2023-09-06 | Lecture | Course Intro, Pain Types, General Pain Assessment | Pain types, Pain management strategies | Nathan Beahm |
| PHARM 445 | Y3 | Fall | 2023-09-06 | Lecture | General Pain Assessment | Pain types, pain assessment strategies, pain assessment tools | Nathan Beahm |
| PHARM 445 | Y3 | Fall | 2023-09-11 | Lecture | Opioid Management | Initiating, titrating, rotating, weaning, and monitoring of opioids | Nathan Beahm |
| PHARM 445 | Y3 | Fall | 2023-09-13 | Lecture | Opioid Management | Initiating, titrating, rotating, weaning, and monitoring of opioids | Nathan Beahm |
| PHARM 445 | Y3 | Fall | 2023-09-15 | Lecture | Acute Pain | Pathophysiology, epidemiology, patient assessment, and management strategies | Nathan Beahm |
| PHARM 445 | Y3 | Fall | 2023-09-18 | Lecture | Acute Pain | Pathophysiology, epidemiology, patient assessment, and management strategies | Nathan Beahm |
| PHARM 445 | Y3 | Fall | 2023-09-18 | Seminar/case session | Seminar 1: Acute Pain | Seminar 1: Acute Pain | Nathan Beahm |
| PHARM 445 | Y3 | Fall | 2023-09-20 | Lecture | Cannabinoids | Pharmacology, drug interactions, clinical evidence, and clinical use of cannabinoids for pain | Nathan Beahm |
| PHARM 445 | Y3 | Fall | 2023-09-21 | Lecture | Chronic Pain | Pathophysiology, epidemiology, patient assessment, and management strategies | Nathan Beahm |
| PHARM 445 | Y3 | Fall | 2023-09-25 | Lecture | Chronic Pain | Pathophysiology, epidemiology, patient assessment, and management strategies | Nathan Beahm |
| PHARM 445 | Y3 | Fall | 2023-09-27 | Lecture | Pain Management in Palliative Care | Pathophysiology, epidemiology, patient assessment, and management strategies | Serena Rix |
| PHARM 445 | Y3 | Fall | 2023-09-29 | Lecture | Pain Management in Palliative Care | Pathophysiology, epidemiology, patient assessment, and management strategies | Serena Rix |
| PHARM 445 | Y3 | Fall | 2023-10-02 | Lecture | Methadone for Pain Management | Pharmacology, drug interactions, initiating, titrating, rotating (to/from), and monitoring of methadone | Serena Rix |
| PHARM 445 | Y3 | Fall | 2023-10-02 | Seminar/case session | Seminar 2: Chronic Pain and Palliative | Chronic Pain and Palliative | Nathan Beahm |
| PHARM 445 | Y3 | Fall | 2023-10-04 | Lecture | Neuropathic Pain | Pathophysiology, epidemiology, patient assessment, and management strategies | Nathan Beahm |
| PHARM 445 | Y3 | Fall | 2023-10-06 | Lecture | Neuropathic Pain | Pathophysiology, epidemiology, patient assessment, and management strategies | Nathan Beahm |
| PHARM 445 | Y3 | Fall | 2023-10-11 | Lecture | Mental Health Intro | Introduction to mental health module; epidemiology and population impact of mental health disorders | Dylan Moulton |
| PHARM 445 | Y3 | Fall | 2023-10-13 | Lecture | Major Depressive Disorder | Major Depressive Disorder | Dylan Moulton |
| PHARM 445 | Y3 | Fall | 2023-10-16 | Lecture | Major Depressive Disorder | Major Depressive Disorder, epidemiology, assessment, management strategies | Dylan Moulton |
| PHARM 445 | Y3 | Fall | 2023-10-18 | Lecture | Psychotropic Drugs I | epidemiology, assessment, management strategies | Dylan Moulton |
| PHARM 445 | Y3 | Fall | 2023-10-20 | Lecture | Anxiety Disorders | Anxiety Disorders | Dylan Moulton |
| PHARM 445 | Y3 | Fall | 2023-10-23 | Lecture | Anxiety Disorders | epidemiology, assessment, management strategies | Dylan Moulton |
| PHARM 445 | Y3 | Fall | 2023-10-23 | Seminar/case session | Seminar 3: Major Depressive Disorder | Major Depressive Disorder | Dylan Moulton |
| PHARM 445 | Y3 | Fall | 2023-10-25 | Lecture | Other Mental Disorders | Panic Disorder/OCD/PTSD | Dylan Moulton |
| PHARM 445 | Y3 | Fall | 2023-10-27 | Lecture | Sleep-Wake Disorders | Sleep Disorders | Dylan Moulton |
| PHARM 445 | Y3 | Fall | 2023-11-01 | Lecture | Bipolar disorder | Bipolar disorder | TBD |
| PHARM 445 | Y3 | Fall | 2023-11-03 | Lecture | Bipolar Disorder | Bipolar disorder | TBD |
| PHARM 445 | Y3 | Fall | 2023-11-06 | Lecture | Psychotropic Drugs II | Antipsychotics- monitoring and safety considerations | TBD |
| PHARM 445 | Y3 | Fall | 2023-11-06 | Seminar/case session | Seminar 4: Bipolar Disorder Seminar | Seminar 4: Bipolar Disorder Seminar | TBD |
| PHARM 445 | Y3 | Fall | 2023-11-08 | Lecture | Attention-Deficit/Hyperactivity Disorder | Attention-Deficit/Hyperactivity Disorder | Dylan Moulton |
| PHARM 445 | Y3 | Fall | 2023-11-10 | Lecture | Attention-Deficit/Hyperactivity Disorder | Attention-Deficit/Hyperactivity Disorder | Dylan Moulton |
| PHARM 445 | Y3 | Fall | 2023-11-15 | Lecture | Substance Use Disorders Intro | Substance Use Disorders [introduction, pathophysiology] | Essi Salokangas |
| PHARM 445 | Y3 | Fall | 2023-11-17 | Lecture | Opioid Use Disorder | Substance Use Disorders [opioid use disorder] | Essi Salokangas |
| PHARM 445 | Y3 | Fall | 2023-11-20 | Lecture | Opioid Use Disorder | Substance Use Disorders [opioid use disorder] | Essi Salokangas |
| PHARM 445 | Y3 | Fall | 2023-11-22 | Lecture | Alcohol Use Disorder | Substance Use Disorders [alcohol use disorder] | Essi Salokagas |
| PHARM 445 | Y3 | Fall | 2023-11-23 | Seminar/case session | Seminar 6: TBD | Seminar 6: TBD | TBD |
| PHARM 445 | Y3 | Fall | 2023-11-24 | Lecture | Alcohol Use Disorder | Substance Use Disorders [alcohol use disorder] | Essi Salokangas |
| PHARM 445 | Y3 | Fall | 2023-11-27 | Lecture | Lived Experience | Substance Use Disorders [lived experience] | Essi Salokangas |
| PHARM 445 | Y3 | Fall | 2023-11-27 | Seminar/case session | Seminar 5: Complex Applied Case (pain, mental health disorders, substance use disorders, ID) | Complex Applied Case (pain, mental health disorders, substance use disorders, ID) | Nathan Beahm, Essi Salokangas |
| PHARM 445 | Y3 | Fall | 2023-11-29 | Lecture | Schizophrenia | Schizophrenia | Chris Evernden |
| PHARM 445 | Y3 | Fall | 2023-12-01 | Lecture | Schizophrenia | Schizophrenia | Chris Evernden |
| PHARM 445 | Y3 | Fall | 2023-12-04 | Lecture | Psychotropic Drugs III | Schizophrenia | Chris Evernden |
| PHARM 445 | Y3 | Fall | 2023-12-06 | Lecture | Pharmacogenomics and the Management of Analgesics and Psychotropics | Pharmacogenomics and the Management of Psychotropics, PGx and management of analgesics | Dalia Hamdy |
| PHARM 445 | Y3 | Fall | 2023-12-08 | Final exam | Mental Health Application / Final Exam Review | Pharmacogenomics | Dylan Moulton / Nathan Beahm |
| PHARM 446 | Y3 | Winter | 2024-01-09 | Lecture | Lecture 1 (Course introduction Public Health and the Canadian Immunization System) | Course introduction Public Health and the Canadian Immunization System | Dr. Tony Kiang, Mr. Pierre Danis |
| PHARM 446 | Y3 | Winter | 2024-01-11 | Lecture | Lecture 2 (Immunology overview and types of immunizing agents) | Immunology Overview and types of immunizing agents | Mr. Pierre Danis |
| PHARM 446 | Y3 | Winter | 2024-01-16 | Lecture | Lecture 3 (Vaccine Preventable Diseases) | Vaccine Preventable Diseases | Mr. Pierre Danis |
| PHARM 446 | Y3 | Winter | 2024-01-18 | Lecture | Lecture 4 (Vaccine Preventable Diseases) | Vaccine Preventable Diseases | Mr. Pierre Danis |
| PHARM 446 | Y3 | Winter | 2024-01-23 | Lecture | Lecture 5 (Vaccine Preventable Diseases Vaccine Assessment & Screening) | Vaccine Preventable Diseases Vaccine Assessment & Screening | Mr. Pierre Danis |
| PHARM 446 | Y3 | Winter | 2024-01-23 | Seminar/case session | Seminar 1 (Vaccination Cases) | Vaccination cases | Mr. Pierre Danis |
| PHARM 446 | Y3 | Winter | 2024-01-25 | Lecture | Lecture 6 (Pharmacy-Based Immunization program: adverse events, documentation, storage and handling) | Pharmacy-Based Immunization program: adverse events, documentation, storage and handling | Mr. Pierre Danis |
| PHARM 446 | Y3 | Winter | 2024-01-30 | Lecture | Lecture 7 (Virology introduction: structure of viruses, classification, and replication) | Virology introduction: structure of viruses, classification, and replication | Ruwandi Kariyawasam |
| PHARM 446 | Y3 | Winter | 2024-02-01 | Lecture | Lecture 8 (Herpes Zoster Virus: Therapeutics) | Herpes Simplex Viruses: Therapeutics | Dr. Christine Hughes |
| PHARM 446 | Y3 | Winter | 2024-02-06 | Lecture | Lecture 9 (Herpes Simplex Viruses: Therapeutics) | Herpes Simplex Viruses: Therapeutics | Dr. Christine Hughes |
| PHARM 446 | Y3 | Winter | 2024-02-06 | Seminar/case session | Seminar 2 (Herpes Zoster Case) | Herpes Zoster Case | Dr. Christine Hughes |
| PHARM 446 | Y3 | Winter | 2024-02-08 | Lecture | Lecture 10 (Viral Hepatitis: Therapeutics) | Viral Hepatitis: Therapeutics | Dr. Christine Hughes |
| PHARM 446 | Y3 | Winter | 2024-02-13 | Lecture | Lecture 11 (HIV) | HIV | Dr. Christine Hughes |
| PHARM 446 | Y3 | Winter | 2024-02-15 | Lecture | Lecture 12 (HIV) | HIV | Dr. Christine Hughes |
| PHARM 446 | Y3 | Winter | 2024-02-27 | Lecture | Lecture 13 (HIV and opportunistic infections) | Opportunistic infections in HIV | Dr. Christine Hughes, Ms. Caitlin Olatunbosun |
| PHARM 446 | Y3 | Winter | 2024-02-27 | Seminar/case session | Seminar 3 (Viral Hepatitis Case) | Viral Hepatitis | Dr. Christine Hughes |
| PHARM 446 | Y3 | Winter | 2024-02-29 | Lecture | Lecture 14 (Influenza: Therapeutics) | Influenza: Therapeutics | Jackson Stewart |
| PHARM 446 | Y3 | Winter | 2024-03-05 | Lecture | Lecture 15 Sexually transmitted infections | Sexually transmitted infections | Jackson Stewart |
| PHARM 446 | Y3 | Winter | 2024-03-07 | Lecture | Lecture 16 (Sexually transmitted infections) | Sexually transmitted infections | Mr. Jackson Stewart |
| PHARM 446 | Y3 | Winter | 2024-03-12 | Lecture | Lecture 17 (Vaginal candidiasis: Therapeutics) | Vaginal candidiasis: Therapeutics | Ms. Eleanor Leoni |
| PHARM 446 | Y3 | Winter | 2024-03-12 | Seminar/case session | Seminar 4 (HIV case) | HIV | Dr. Christine Hughes, Ms. Caitlin Olatunbosun |
| PHARM 446 | Y3 | Winter | 2024-03-14 | Lecture | Lecture 18 (Dermatophytoses) | Dermatophytoses (Athlete’s foot, Jock itch, Ringworm, Fungal Nail Infections): Therapeutics Course evaluations Review and final exam preparation | Dr. Tony Kiang, Ms. Eleanor Leoni |
| PHARM 446 | Y3 | Winter | 2024-03-19 | Lecture | Lecture 19 (Systemic fungal infections: Therapeutics) | Systemic fungal infections: Therapeutics | Mr. Jackson Stewart |
| PHARM 446 | Y3 | Winter | 2024-03-21 | Seminar/case session | Seminar 5 (Organ donation and transplantation) | Transplant Seminar – Transplant Team (lecture theatre) | Dr. Tony Kiang |
| PHARM 446 | Y3 | Winter | 2024-03-26 | Lecture | Lecture 20 (Traveller's Health) | Traveller’s Health | Mr. Pierre Denis |
| PHARM 446 | Y3 | Winter | 2024-03-28 | Lecture | Lecture 21 (Traveller’s Health / COVID-19 pharmacotherapy, Pinworms: Therapeutics (pre-recorded)) | Traveller's Health, Pinworms: therapeutics | Dr. Christine Hughes, Mr. Pierre Denis |
| PHARM 446 | Y3 | Winter | 2024-04-02 | Lecture | Lecture 22 (history on transplantation; key concepts; mechanisms of rejection) | history on transplantation; key concepts; mechanisms of rejection | Dr. Tony Kiang |
| PHARM 446 | Y3 | Winter | 2024-04-04 | Lecture | Lecture 23 (Pharmacology/ pharmacokinetics of immunosuppressants) | Pharmacology/ pharmacokinetics of immunosuppressants (small molecule drugs 1) | Dr. Tony Kiang |
| PHARM 446 | Y3 | Winter | 2024-04-09 | Lecture | Lecture 24 (Pharmacology/Pharmacokinetics of immunosuppressants (small molecule drugs) | Pharmacology/Pharmacokinetics of immunosuppressants (small molecule drugs 2) | Dr. Tony Kiang |
| PHARM 446 | Y3 | Winter | 2024-04-09 | Seminar/case session | Seminar 6 (Renal transplant cases) | Renal Transplant cases | Dr. Tony Kiang |
| PHARM 446 | Y3 | Winter | 2024-04-11 | Lecture | Lecture 25 (Opportunistic infections in transplant) | Opportunistic infections in transplant | Dr. Tony Kiang |
| PHARM 448 | Y3 | Winter | 2024-01-09 | Lecture | Course Introduction - Advanced Therapeutics Principles I | Practice Integrated Case(s) | Sherif Mahmoud |
| PHARM 448 | Y3 | Winter | 2024-01-11 | Lecture | Advanced Therapeutics Principles II | Dealing with Complex Patients | Sherif Mahmoud |
| PHARM 448 | Y3 | Winter | 2024-01-16 | Lecture | Advanced Therapeutics - Practice Cases | Advanced Therapeutics - Practice Cases | Sherif Mahmoud |
| PHARM 448 | Y3 | Winter | 2024-01-16 | Seminar/case session | Case 1 | Case 1 | Sherif Mahmoud, Cheryl Sadowski |
| PHARM 448 | Y3 | Winter | 2024-01-18 | Lecture | Case 1 - Debrief | Case debrief | Sherif Mahmoud, Cheryl Sadowski |
| PHARM 448 | Y3 | Winter | 2024-01-23 | Lecture | Advanced Therapeutics Principles III | Decision making with no or limited evidence | Sherif Mahmoud |
| PHARM 448 | Y3 | Winter | 2024-01-25 | Lecture | Geriatrics - Part 1 | Changes with aging and implications for medication use and safety , Challenges in care delivery | Cheryl Sadowski |
| PHARM 448 | Y3 | Winter | 2024-01-30 | Lecture | Geriatrics - Part 2 | Geriatric Syndromes , Medication related problems encountered in older adults | Cheryl Sadowski |
| PHARM 448 | Y3 | Winter | 2024-02-02 | Lecture | Case 2 - Pediatrics (Acute care) | Pediatric case: acute care, Documentation: note to MD on hospital chart | Cheryl Sadowski / Pediatrics Team (D Dersch-Mills, M Romanick, J Wichart, A Chan |
| PHARM 448 | Y3 | Winter | 2024-02-09 | Lecture | Case 3 - Primary Care | Middle aged man, Comorbidities: HTN; Chronic Pain; Constipation, Documentation: Care Plan | Sherif Mahmoud |
| PHARM 448 | Y3 | Winter | 2024-02-13 | Lecture | Case 3 - Geriatrics | A geriatric patient case • Documentation: Clinic Note for NetCare | Cheryl Sadowski |
| PHARM 448 | Y3 | Winter | 2024-02-14 | Lecture | Case 3 - Debrief | Case 3 - Debrief | Sherif Mahmoud |
| PHARM 448 | Y3 | Winter | 2024-02-28 | Lecture | Case 4 - Acute Care | Middle aged woman, Comorbidities: depression; DM2; Osteoporosis; Headache. Documentation: Pharmacist discharge plan | Sherif Mahmoud/ Cheryl Sadowski |
| PHARM 448 | Y3 | Winter | 2024-02-28 | Seminar/case session | Seminar 4: A day in a life of a hospital pharmacist | Prioritizing in hospital pharmacy practice, Providing care in a complex and busy environment | Sherif Mahmoud |
| PHARM 448 | Y3 | Winter | 2024-03-02 | Lecture | Case 4 Debrief | Debrief | Sherif Mahmoud |
| PHARM 448 | Y3 | Winter | 2024-03-12 | Lecture | Pediatrics - Introduction | Pediatrics - Principles and Process of Care | Cheryl Sadowski / Pediatrics Team (D Dersch-Mills, M Romanick, J Wichart, A Chan |
| PHARM 448 | Y3 | Winter | 2024-03-14 | Lecture | Elder Abuse | Workshop/Case discussions | Cheryl Sadowski / Kitty Choi |
| PHARM 448 | Y3 | Winter | 2024-03-14 | Lecture | Pediatrics - Lecture 2 | Pediatric Therapeutics | Bharti Thomas |
| PHARM 448 | Y3 | Winter | 2024-03-14 | Seminar/case session | Seminar 5: Psychosocial Issues in Older Adults | Communication and ageism , Geriatrics Toolbox for Challenging Cases (hot topics, debates) | Cheryl Sadowski/ Sheree Kwong-See |
| PHARM 448 | Y3 | Winter | 2024-03-16 | Lecture | Case 5 - Geriatrics | Geriatric Syndromes -supportive living, Documentation: Assessment note to MD | Cheryl Sadowski |
| PHARM 448 | Y3 | Winter | 2024-03-16 | Lecture | Case 5 - Geriatrics (Acute Care) | Geriatric Syndromes, Documentation: Assessment note to MD | Cheryl Sadowski |
| PHARM 448 | Y3 | Winter | 2024-03-19 | Lecture | Case 5 - Pediatrics | Pediatric case | Bharti Thomas/ Cheryl Sadowski |
| PHARM 448 | Y3 | Winter | 2024-03-19 | Lecture | Pediatrics - Lecture 1 | Introduction to age groups, newborn care, prematurity | Cheryl Sadowski / Deonne Dersch-Mills |
| PHARM 448 | Y3 | Winter | 2024-03-21 | Lecture | Case 5 - Debrief | Debrief | Cheryl Sadowski/Bharti Thomas |
| PHARM 448 | Y3 | Winter | 2024-03-21 | Lecture | Case 5 - debrief | Introduction to age groups, classification; Newborn care, Prematurity and implications | Bharti Thomas/ Cheryl Sadowski |
| PHARM 448 | Y3 | Winter | 2024-03-28 | Lecture | Case 6 debrief | Debrief | Cheryl Sadowski |
| PHARM 448 | Y3 | Winter | 2024-03-28 | Seminar/case session | Child Maltreatment | Child Maltreatment | Jillian Poppel / Cheryl Sadowski |
| PHARM 448 | Y3 | Winter | 2024-03-28 | Seminar/case session | Seminar 6: A day in a life of Pharmacist in a correctional facility | Approach to Pediatric Care | Stewart MacLennan Correctional facility team |
| PHARM 448 | Y3 | Winter | 2024-03-30 | Lecture | Case 7 - Correctional Facility Care | Middle aged adult in incarceration, Comorbidities: COPD; Epilepsy; GERD; Liver; Anxiety. Documentation: summary note given to patient | Stewart MacLennan/Correctional facility team |
| PHARM 448 | Y3 | Winter | 2024-04-04 | Lecture | Case 7 Debrief | Debrief | Stewart MacLennan Correctional facility team |
| PHARM 448 | Y3 | Winter | 2024-04-09 | Lecture | Autism Spectrum Disorder | Care, complications and case studies | Lonnie Zwaigenbaum |
| PHARM 448 | Y3 | Winter | 2024-04-11 | Lecture | Critical Care | Case 8 - ICU • Documentation: DAP note | Sherif Mahmoud |
Assessment Information
| PHARM 243 | Y1 | Health Aisle Assignment | Assignment/written work | 12.0% | — |
| PHARM 243 | Y1 | Final | Final exam | 40.0% | — |
| PHARM 243 | Y1 | Midterm | Midterm exam | 30.0% | — |
| PHARM 243 | Y1 | Lecture, Assigned Readings, and Seminar Quizzes | Quiz | 18.0% | — |
| PHARM 343 | Y2 | Final | Final exam | 55.0% | — |
| PHARM 343 | Y2 | Midterm | Midterm exam | 30.0% | — |
| PHARM 343 | Y2 | Pre-Seminar Quiz #1: Fluid & Electrolyte Conditions | Quiz | 2.5% | — |
| PHARM 343 | Y2 | Pre-Seminar Quiz #2: Laboratory Values & Acid/Base Conditions | Quiz | 2.5% | — |
| PHARM 343 | Y2 | Pre-Seminar Quiz #3: Chronic Kidney Disease & Drug Dosing in Renal Impairment | Quiz | 2.5% | — |
| PHARM 343 | Y2 | Pre-Seminar Quiz #4: Acute Kidney Injury | Quiz | 2.5% | — |
| PHARM 343 | Y2 | Pre-Seminar Quiz #5: Insulin Management | Quiz | 2.5% | — |
| PHARM 343 | Y2 | Pre-Seminar Quiz #6: Type 2 Diabetes Management | Quiz | 2.5% | — |
| PHARM 344 | Y2 | BP Screening Clinic Assignment | Assignment/written work | 3.0% | — |
| PHARM 344 | Y2 | Care Plan and Peer Review Assignment | Assignment/written work | 5.0% | — |
| PHARM 344 | Y2 | Pharmacogenomics Assignment | Assignment/written work | 5.0% | — |
| PHARM 344 | Y2 | Final | Final exam | 50.0% | — |
| PHARM 344 | Y2 | Midterm | Midterm exam | 25.0% | — |
| PHARM 344 | Y2 | Pre-Seminar Quizzes | Quiz | 12.0% | — |
| PHARM 345 | Y2 | Final Exam | Final exam | 50.0% | — |
| PHARM 345 | Y2 | Midterm Exam | Midterm exam | 33.0% | — |
| PHARM 345 | Y2 | Participation | Participation/professionalism | 5.0% | — |
| PHARM 345 | Y2 | Seminar 4 Quiz | Quiz | 3.0% | — |
| PHARM 345 | Y2 | Seminar Quiz 1 | Quiz | 3.0% | — |
| PHARM 345 | Y2 | Seminar Quiz 2 | Quiz | 3.0% | — |
| PHARM 345 | Y2 | Seminar Quiz 5 | Quiz | 3.0% | — |
| PHARM 346 | Y2 | Seminar Assignments | Assignment/written work | 6.0% | — |
| PHARM 346 | Y2 | Weekly Learning Posts | Assignment/written work | 6.0% | — |
| PHARM 346 | Y2 | Final Exam | Final exam | 47.0% | — |
| PHARM 346 | Y2 | Midterm Exam | Midterm exam | 37.0% | — |
| PHARM 346 | Y2 | Quizzes | Quiz | 4.0% | — |
| PHARM 443 | Y3 | Final | Final exam | 50.0% | — |
| PHARM 443 | Y3 | Midterm | Midterm exam | 35.0% | — |
| PHARM 443 | Y3 | Seminar #1 | Quiz | 5.0% | — |
| PHARM 443 | Y3 | Seminar #2 | Quiz | 5.0% | — |
| PHARM 443 | Y3 | Seminar #4 | Quiz | 3.0% | — |
| PHARM 443 | Y3 | Seminar #5 | Quiz | 5.0% | — |
| PHARM 444 | Y3 | Rare Neurologic Disorders Assignment | Assignment/written work | 5.0% | — |
| PHARM 444 | Y3 | Survive and Thrive Documentary Reflection Assignment | Assignment/written work | 4.0% | — |
| PHARM 444 | Y3 | FINAL | Final exam | 40.0% | — |
| PHARM 444 | Y3 | Midterm | Midterm exam | 40.0% | — |
| PHARM 444 | Y3 | Seminar Participation | Participation/professionalism | 4.0% | — |
| PHARM 444 | Y3 | Oncology Basics Quiz | Quiz | 4.0% | — |
| PHARM 444 | Y3 | Rare Neurologic Disorders Quiz | Quiz | 3.0% | — |
| PHARM 445 | Y3 | Seminar Assignments | Assignment/written work | 7.5% | — |
| PHARM 445 | Y3 | Final Exam | Final exam | 45.0% | — |
| PHARM 445 | Y3 | Midterm Exam | Midterm exam | 35.0% | — |
| PHARM 445 | Y3 | Pre-Class Review Quizzes | Quiz | 7.5% | — |
| PHARM 445 | Y3 | Seminar Quizzes | Quiz | 5.0% | — |
| PHARM 446 | Y3 | Final | Final exam | 40.0% | — |
| PHARM 446 | Y3 | Midterm | Midterm exam | 30.0% | — |
| PHARM 446 | Y3 | Pre-Seminar Quizs | Quiz | 30.0% | — |
| PHARM 448 | Y3 | Case Presentations (Group) | Assignment/written work | 5.0% | — |
| PHARM 448 | Y3 | Documentation (Group) | Assignment/written work | 30.0% | — |
| PHARM 448 | Y3 | Final Exam | Final exam | 25.0% | — |
| PHARM 448 | Y3 | Midterm Exam | Midterm exam | 25.0% | — |
| PHARM 448 | Y3 | Case-related Quizzes | Quiz | 15.0% | — |
Use these searchable records to verify the course, session and assessment evidence behind the curriculum portrait. The browser supports inspection and verification rather than additional curriculum analysis.
Course Information
| PHARM 243 — PHARM 243 - Pharmacotherapy I | Y1 | Winter | 37 | 6 | 0 | Assignment/written work (1); Final exam (1); Midterm exam (1); Quiz (1) | 3 (fi 6) (second term, 3-1s-0) This is the first in a series of courses delivered over three years of the program that provides students with the required knowledge and skills to manage patients’ medication therapy. Topics covered include complementary and alternative medicine, as well as principles of drug therapy for common self-care and pulmonary conditions. Students will develop their critical thinking and self-directed learning skills as they learn to incorporate principles of evidence-based therapeutic decision-making into the patient care process framework. (Restricted to Pharmacy students). |
| PHARM 343 — PHARM 343 - Pharmacotherapy 2 | Y2 | Fall | 35 | 6 | 2 | Final exam (1); Midterm exam (1); Quiz (6) | 3 (fi 6) (first term, 3-1S-0) Students will develop fundamental knowledge of fluid/electrolyte imbalances and laboratory values, as well as renal, urinary tract, and endocrine conditions. They will apply therapeutic and pharmaceutical science knowledge to various patient care scenarios. Students will further develop their critical thinking and self-directed learning skills, along with their breadth and depth of therapeutic knowledge, as they incorporate principles of evidence-based therapeutic decision making within the patient care process framework. (Restricted to Pharmacy students.) |
| PHARM 344 — Pharmacotherapy 3 (Cardiovascular & Hematology) | Y2 | Winter | 36 | 8 | 0 | Assignment/written work (1); Final exam (1); Midterm exam (1); Participation/professionalism (1); Quiz (1) | Students will develop fundamental knowledge of cardiovascular and hematology conditions and will apply therapeutic and pharmaceutical science knowledge to various patient care scenarios. Students will further develop their critical thinking and self-directed learning skills, along with their breadth and depth of therapeutic knowledge, as they incorporate principles of evidence-based therapeutic decision making within the patient care process framework. (Restricted to Pharmacy students.) |
| PHARM 345 — PHARMACOTHERAPY 4 | Y2 | Winter | 39 | 4 | 0 | Final exam (1); Midterm exam (1); Participation/professionalism (1); Quiz (1) | ★ 3 (fi 6) (second term, 3-1s-0) Students will develop the necessary knowledge related to gastrointestinal, nutritional, dermatologic, and ophthalmic conditions and will apply therapeutic and pharmaceutical science knowledge to various patient care scenarios. Students will further develop their critical thinking and self-directed learning skills, along with their breadth and depth of therapeutic knowledge, as they incorporate principles of evidence-based therapeutic decision-making within the patient care process framework. (Restricted to Pharmacy students.) |
| PHARM 346 — Pharmacotherapy 5: Infectious Diseases I | Y2 | Winter | 35 | 6 | 0 | Assignment/written work (2); Final exam (1); Midterm exam (1); Quiz (1) | Students will develop knowledge related to bacterial infections and will apply therapeutic and pharmaceutical science knowledge to various patient care scenarios. Students will further develop their critical thinking and self-directed learning skills building breadth and depth of therapeutic knowledge as they incorporate principles of evidence-based therapeutic decision making within the patient care process framework. (Restricted to Pharmacy students.) |
| PHARM 443 — PHARMACOTHERAPY 6 Sexual and Reproductive Health and Musculoskeletal | Y3 | Fall | 23 | 12 | 0 | Final exam (1); Midterm exam (1); Participation/professionalism (1); Quiz (5) | ★ 3 (fi 6) (first term, 3-1s-0) Students will develop fundamental knowledge in the areas of sexual and reproductive health, as well as musculoskeletal/joint conditions and will apply therapeutic and pharmaceutical science knowledge to various patient care scenarios, with increasing complexity. Students will further develop their critical thinking and self-directed learning skills, along with their breadth and depth of therapeutic knowledge, as they incorporate principles of evidence-based therapeutic decision making within the patient care process framework. (Restricted to Pharmacy students.) |
| PHARM 444 — Pharmacotherapy 7 (Neurology and Oncology) | Y3 | Fall | 25 | 6 | 0 | Assignment/written work (2); Final exam (1); Midterm exam (1); Participation/professionalism (1); Quiz (3) | ★ 3 (fi 6) (first term, 3-1s-0) Students will develop knowledge of various types of neurologic and oncologic conditions and complications and will apply therapeutic and pharmaceutical science knowledge to various patient care scenarios. Students will further develop their critical thinking and self-directed learning skills, along with their breadth and depth of therapeutic knowledge, as they incorporate principles of evidence-based therapeutic decision making within the patient care process framework. (Restricted to Pharmacy students.) |
| PHARM 445 — Pharmacotherapy 8: Pain & Mental Health | Y3 | Fall | 37 | 5 | 1 | Assignment/written work (1); Final exam (1); Midterm exam (1); Participation/professionalism (1); Quiz (2) | Students will develop knowledge in the areas of pain and mental health conditions and will apply therapeutic and pharmaceutical science knowledge to patient care scenarios, with added complexity. Students will further develop their critical thinking and self-directed learning skills, along with their breadth and depth of therapeutic knowledge, as they incorporate principles of evidence-based therapeutic decision making within the patient care process framework. (Restricted to Pharmacy students.) |
| PHARM 446 — Pharmacotherapy 9 (ID & Transplant) | Y3 | Winter | 24 | 6 | 0 | Final exam (1); Midterm exam (1); Quiz (6) | ★ 3 (fi 6) (second term, 3-1s-0) Students will develop foundational knowledge related to select fungal, viral, and protozoal infections, as well as in the area of transplant. In addition, this course will provide students with foundational knowledge and skills (patient assessment) in disease prevention through the delivery of immunizations and traveller’s health services. Students will further develop their critical thinking and self-directed learning skills, along with their breadth and depth of therapeutic knowledge, as they incorporate principles of evidence-based therapeutic decision making within the patient care process framework. |
| PHARM 448 — Pharmacotherapy 10 (Winter 2025) (Special Populations and Advanced Therapeutics) | Y3 | Winter | 33 | 0 | 0 | Assignment/written work (2); Final exam (1); Midterm exam (1); Quiz (1) | ★ 3 (fi 6) (second term, 3-1s-0) Students will expand their knowledge and skills in order to provide care to various patient populations. Students will engage in active learning and focus on using evidence, applying the biopsychosocial model, making decisions, monitoring outcomes, and adjusting drug therapy for complex patients across the age spectrum. Students will further develop their critical thinking and advocacy skills in the provision of care. (Restricted to Pharmacy students.) |
Session Information
| PHARM 243 | Y1 | Winter | 2026-01-05 | Lecture | CAM 1 | Course overview, Introduction to CAM, Modalities and Providers Part 1 | Pawan Gill, Damion Barnes |
| PHARM 243 | Y1 | Winter | 2026-01-07 | Lecture | CAM 2 | Modalities and providers: Part II | Damion Barnes |
| PHARM 243 | Y1 | Winter | 2026-01-09 | Lecture | CAM 3 | Natural Health Products Regulations and Resources for drug information; Role of pharmacists in recommendations/referrals and collaboration | Damion Barnes |
| PHARM 243 | Y1 | Winter | 2026-01-12 | Lecture | Eye | Introduction to patient assessment; Eye Conditions; Dry Eye Disease | Damion Barnes |
| PHARM 243 | Y1 | Winter | 2026-01-14 | Lecture | Ear | Otitis Externa (swimmer’s ear); Minor Ear Pain; Impacted Ear Wax | Damion Barnes |
| PHARM 243 | Y1 | Winter | 2026-01-16 | Lecture | GI 1 | Hemorrhoids; Gastrointestinal Gas | Damion Barnes |
| PHARM 243 | Y1 | Winter | 2026-01-19 | Lecture | Dental 1 | Teething; Canker Sores (Oral Aphthous Ulcers) | Damion Barnes |
| PHARM 243 | Y1 | Winter | 2026-01-19 | Lecture | GI 2 | Heartburn (Dyspepsia and GERD) | Damion Barnes |
| PHARM 243 | Y1 | Winter | 2026-01-20 | Seminar/case session | Eye/Ear | “Over-the-counter Products related to Eyes, Ears and NHP” presentation; Eye/Ear | Damion Barnes |
| PHARM 243 | Y1 | Winter | 2026-01-21 | Lecture | Dental 2 | Dry Mouth (Xerostomia); Case Reviews | Damion Barnes |
| PHARM 243 | Y1 | Winter | 2026-01-23 | Lecture | Derm 1 | Intro to Derm Physical Assessment Hair, Skin, Nails | Ravina Sangera |
| PHARM 243 | Y1 | Winter | 2026-01-26 | Lecture | Derm 2 | Lice & Scabies | Damion Barnes |
| PHARM 243 | Y1 | Winter | 2026-01-28 | Lecture | Derm 3 | Corns / Calluses / Warts | Damion Barnes |
| PHARM 243 | Y1 | Winter | 2026-01-30 | Lecture | Derm 4 | Sun Safety Measures; Dry Skin (Xerosis); Overview of Dermatitis; Dandruff/Seborrheic Dermatitis; Diaper Dermatitis | Dr. Perry Grewal |
| PHARM 243 | Y1 | Winter | 2026-02-02 | Lecture | Derm 5 | Dermatitis topics cont'd | Ravina Sangera |
| PHARM 243 | Y1 | Winter | 2026-02-03 | Seminar/case session | Dental & GI | Dental & GI | Damion Barnes |
| PHARM 243 | Y1 | Winter | 2026-02-04 | Lecture | Derm 6 | Minor Cuts and Wounds; Burns; Insect bites and stings | Ravina Sangera |
| PHARM 243 | Y1 | Winter | 2026-02-06 | Lecture | Derm 7 | Acne | Ravina Sanghera |
| PHARM 243 | Y1 | Winter | 2026-02-09 | Lecture | Derm 8 | Acne | Ravina Sangera |
| PHARM 243 | Y1 | Winter | 2026-02-11 | Lecture | Acute Pain | MSK Injuries: Sprains, strains, and Lower Back Pain; Tension-Type Headaches | Damion Barnes |
| PHARM 243 | Y1 | Winter | 2026-02-13 | Midterm exam | Midterm | Midterm | — |
| PHARM 243 | Y1 | Winter | 2026-02-23 | Lecture | Acute Pain | MSK Injuries: Sprains, strains, and Lower Back Pain; Tension-Type Headaches | Damion Barnes |
| PHARM 243 | Y1 | Winter | 2026-02-24 | Seminar/case session | Derm | Dermatology | Ravina Sanghera |
| PHARM 243 | Y1 | Winter | 2026-02-25 | Lecture | Cough and Cold | Assessment; Nonpharmacological management | Damion Barnes |
| PHARM 243 | Y1 | Winter | 2026-02-27 | Lecture | Cough and Cold | Pharmacological management; Follow-up & Monitoring | Damion Barnes |
| PHARM 243 | Y1 | Winter | 2026-03-02 | Lecture | Allergic Rhinitis | Assessment; Nonpharmacological management | Damion Barnes |
| PHARM 243 | Y1 | Winter | 2026-03-04 | Lecture | Allergic Rhinitis | Pharmacotherapy; Monitoring & Follow-up | Damion Barnes |
| PHARM 243 | Y1 | Winter | 2026-03-05 | Lecture | Asthma 1 | Pathophysiology, signs and symptoms; Epidemiology Risk factors, triggers, and comorbidities; Diagnosis | Pawan Gill |
| PHARM 243 | Y1 | Winter | 2026-03-06 | Lecture | Asthma 2 | Asthma management (Education and nonpharmacological approaches) | Pawan Gill |
| PHARM 243 | Y1 | Winter | 2026-03-09 | Lecture | Asthma 3 | Pharmacotherapy; Inhaled delivery devices | Pawan Gill |
| PHARM 243 | Y1 | Winter | 2026-03-10 | Seminar/case session | Cough and Cold; Pain | Cough and Cold; Pain | Damion Barnes |
| PHARM 243 | Y1 | Winter | 2026-03-11 | Lecture | Asthma 4 | Pharmacotherapy; Inhaled delivery devices | Pawan Gill |
| PHARM 243 | Y1 | Winter | 2026-03-16 | Lecture | Asthma 5 | Asthma exacerbations; Management of asthma exacerbations; Special populations (pediatric, pregnancy) | Pawan Gill |
| PHARM 243 | Y1 | Winter | 2026-03-18 | Lecture | COPD 1 | Definition, Pathophysiology, Risk factors, and diagnosis; non-pharmacological | Pawan Gill |
| PHARM 243 | Y1 | Winter | 2026-03-19 | Lecture | COPD 2 | Therapeutic approach | Pawan Gill |
| PHARM 243 | Y1 | Winter | 2026-03-20 | Lecture | COPD 3 | Follow-up, Acute exacerbations, antiinflammatories, COPD Action Plan, Comparison between Asthma & COPD | Pawan Gill |
| PHARM 243 | Y1 | Winter | 2026-03-23 | Lecture | Pulmonary | Pulmonary considerations for practice | Pawan Gill |
| PHARM 243 | Y1 | Winter | 2026-03-24 | Seminar/case session | Asthma and Allergic Rhinitis | Asthma and Allergic Rhinitis | Damion Barnes and Pawan Gill |
| PHARM 243 | Y1 | Winter | 2026-03-25 | Lecture | Pulmonary | Review | Pawan Gill |
| PHARM 243 | Y1 | Winter | 2026-03-27 | Lecture | Tobacco Cessation 1 | Assessment, NRT | Pawan Gill |
| PHARM 243 | Y1 | Winter | 2026-03-30 | Lecture | Tobacco Cessation 2 | Pharmacotherapy | Pawan Gill |
| PHARM 243 | Y1 | Winter | 2026-04-01 | Lecture | Tobacco Cessation 3 | Pharmacotherapy and Alternate Products | Pawan Gill |
| PHARM 243 | Y1 | Winter | 2026-04-07 | Seminar/case session | COPD | COPD | Pawan Gill; Dr. Jagdeep Gill (Internal Medicine) |
| PHARM 243 | Y1 | Winter | 2026-04-08 | Lecture | Pulmonary | Vaccinations | Pawan Gill |
| PHARM 243 | Y1 | Winter | 2026-04-10 | Final exam | Final Review / Final Exam | Final Review; Final Exam (listed in schedule) | Pawan Gill |
| PHARM 243 | Y1 | Winter | — | Other exam/test | Exam Review | Exam Review | Damion Barnes |
| PHARM 343 | Y2 | Fall | 2025-09-03 | Lecture | Course Overview and Condition of Fluid Imbalance | Course Overview and Condition of Fluid Imbalance | Forugh Sanaee |
| PHARM 343 | Y2 | Fall | 2025-09-05 | Lecture | Conditions of Sodium Imbalance | Conditions of Sodium Imbalance | Forugh Sanaee |
| PHARM 343 | Y2 | Fall | 2025-09-08 | Lecture | Conditions of Potassium and Magnesium Imbalance | Conditions of Potassium and Magnesium Imbalance | Forugh Sanaee |
| PHARM 343 | Y2 | Fall | 2025-09-10 | Other exam/test | Laboratory Test Stewardship | Laboratory Test Stewardship | Forugh Sanaee |
| PHARM 343 | Y2 | Fall | 2025-09-11 | Seminar/case session | Fluid and Electrolyte Conditions | Fluid and Electrolyte Conditions | Forugh Sanaee |
| PHARM 343 | Y2 | Fall | 2025-09-12 | Laboratory | Endocrine and Cardiovascular Laboratory Values | Endocrine and Cardiovascular Laboratory Values | Forugh Sanaee |
| PHARM 343 | Y2 | Fall | 2025-09-15 | Laboratory | Hematology, Liver, & GI Laboratory Values | Hematology, Liver, & GI Laboratory Values | Forugh Sanaee |
| PHARM 343 | Y2 | Fall | 2025-09-17 | Lecture | Acid/Base Disorders | Acid/Base Disorders | Joey Ton |
| PHARM 343 | Y2 | Fall | 2025-09-19 | Other exam/test | Introduction to Kidney Diseases & Renal Laboratory Tests | Introduction to Kidney Diseases & Renal Laboratory Tests | Rene Breault |
| PHARM 343 | Y2 | Fall | 2025-09-22 | Lecture | Chronic Kidney Disease-1 | Chronic Kidney Disease-1 | Rupam Arora |
| PHARM 343 | Y2 | Fall | 2025-09-24 | Lecture | Chronic Kidney Disease-2 | Chronic Kidney Disease-2 | Rupam Arora |
| PHARM 343 | Y2 | Fall | 2025-09-25 | Seminar/case session | Laboratory Values and Acid/Base Disorders | Laboratory Values and Acid/Base Disorders | Joey Ton |
| PHARM 343 | Y2 | Fall | 2025-09-26 | Lecture | Chronic Kidney Disease-Management of Complications 1 | Chronic Kidney Disease-Management of Complications 1 | Peter Yoeun |
| PHARM 343 | Y2 | Fall | 2025-09-29 | Lecture | Chronic Kidney Disease-Management of Complications 2 | Chronic Kidney Disease-Management of Complications 2 | Peter Yoeun |
| PHARM 343 | Y2 | Fall | 2025-10-01 | Lecture | Drug Dosing in Renal Impairment | Drug Dosing in Renal Impairment | Rupam Arora |
| PHARM 343 | Y2 | Fall | 2025-10-03 | Lecture | Acute Kidney Injury-1 | Acute Kidney Injury-1 | Rene Breault |
| PHARM 343 | Y2 | Fall | 2025-10-06 | Lecture | Acute Kidney Injury-2 | Acute Kidney Injury-2 | Rene Breault |
| PHARM 343 | Y2 | Fall | 2025-10-08 | Lecture | Lower Urinary Tract Symptoms: Introduction | Lower Urinary Tract Symptoms: Introduction | William Gibson |
| PHARM 343 | Y2 | Fall | 2025-10-09 | Seminar/case session | Chronic Kidney Disease and Drug Dosing in Renal Impairment | Chronic Kidney Disease and Drug Dosing in Renal Impairment | Rupam Arora |
| PHARM 343 | Y2 | Fall | 2025-10-10 | Lecture | Lower Urinary Tract Symptoms: Non-pharmacologic | Lower Urinary Tract Symptoms: Non-pharmacologic | William Gibson |
| PHARM 343 | Y2 | Fall | 2025-10-15 | Lecture | Lower Urinary Tract Symptoms: Pharmacologic | Lower Urinary Tract Symptoms: Pharmacologic | William Gibson |
| PHARM 343 | Y2 | Fall | 2025-10-17 | Lecture | Lower Urinary Tract Symptoms: Case Studies | Lower Urinary Tract Symptoms: Case Studies | William Gibson |
| PHARM 343 | Y2 | Fall | 2025-10-20 | Lecture | Calcium Metabolism/PTH/Vit D | Calcium Metabolism/PTH/Vit D | Michael Doschak |
| PHARM 343 | Y2 | Fall | 2025-10-21 | Seminar/case session | Acute Kidney Injury (8:50-10:50, Location PBL Rooms &MSB 2-27) | Acute Kidney Injury (8:50-10:50, Location PBL Rooms &MSB 2-27) | Rene Breault |
| PHARM 343 | Y2 | Fall | 2025-10-22 | Lecture | Renal Replacement Therapies | Renal Replacement Therapies | Peter Yoeun |
| PHARM 343 | Y2 | Fall | 2025-10-24 | Lecture | Diabetes Epidemiology | Diabetes Epidemiology | Scot Simpson |
| PHARM 343 | Y2 | Fall | 2025-10-27 | Lecture | Type 1 Diabetes - Clinical Presentation & Rationale for Insulin Administration | Type 1 Diabetes - Clinical Presentation & Rationale for Insulin Administration | Scot Simpson |
| PHARM 343 | Y2 | Fall | 2025-10-29 | Midterm exam | MIDTERM | MIDTERM | — |
| PHARM 343 | Y2 | Fall | 2025-10-31 | Lecture | Treatment of Type 1 Diabetes | Treatment of Type 1 Diabetes | Scot Simpson |
| PHARM 343 | Y2 | Fall | 2025-11-03 | Lecture | Acute Complications of Diabetes | Acute Complications of Diabetes | Scot Simpson |
| PHARM 343 | Y2 | Fall | 2025-11-05 | Lecture | Type 2 Diabetes - Prevention | Type 2 Diabetes - Prevention | Dean Eurich |
| PHARM 343 | Y2 | Fall | 2025-11-06 | Seminar/case session | Insulin Management | Insulin Management | Scot Simpson |
| PHARM 343 | Y2 | Fall | 2025-11-07 | Lecture | Type 2 Diabetes - Initial Oral Therapy | Type 2 Diabetes - Initial Oral Therapy | Dean Eurich |
| PHARM 343 | Y2 | Fall | 2025-11-17 | Lecture | Type 2 Diabetes - Treatment Intensification Pt 1 | Type 2 Diabetes - Treatment Intensification Pt 1 | Scot Simpson |
| PHARM 343 | Y2 | Fall | 2025-11-18 | Lecture | Type 2 Diabetes - Treatment Intensification Pt 2. (9:00-9:50, Location MSB 2-27) | Type 2 Diabetes - Treatment Intensification Pt 2. (9:00-9:50, Location MSB 2-27) | Scot Simpson |
| PHARM 343 | Y2 | Fall | 2025-11-19 | Lecture | Microvascular Complications of Diabetes | Microvascular Complications of Diabetes | Scot Simpson |
| PHARM 343 | Y2 | Fall | 2025-11-21 | Lecture | Macrovascular Complications of Diabetes | Macrovascular Complications of Diabetes | Scot Simpson |
| PHARM 343 | Y2 | Fall | 2025-11-24 | Lecture | Current Issues in Diabetes Management | Current Issues in Diabetes Management | Syed Hameed |
| PHARM 343 | Y2 | Fall | 2025-11-26 | Lecture | Diabetes and Pregnancy | Diabetes and Pregnancy | TBD |
| PHARM 343 | Y2 | Fall | 2025-11-27 | Seminar/case session | Treatment of Type 2 Diabetes | Treatment of Type 2 Diabetes | Ayush Chadha |
| PHARM 343 | Y2 | Fall | 2025-11-28 | Lecture | Pragmatic Tips for Diabetes Management | Pragmatic Tips for Diabetes Management | Ayush Chadha |
| PHARM 343 | Y2 | Fall | 2025-12-01 | Lecture | Hypothalamus-Pituitary-Adrenal Axis Conditions | Hypothalamus-Pituitary-Adrenal Axis Conditions | TBD |
| PHARM 343 | Y2 | Fall | 2025-12-03 | Lecture | Thyroid Conditions-1: Hypothyroidism | Thyroid Conditions-1: Hypothyroidism | Christine Hughes |
| PHARM 343 | Y2 | Fall | 2025-12-05 | Lecture | Thyroid Conditions-2: Hyperthyroidism | Thyroid Conditions-2: Hyperthyroidism | Christine Hughes |
| PHARM 343 | Y2 | Fall | 2025-12-08 | Lecture | Natural Health Products for Diabetes & Course Review | Natural Health Products for Diabetes & Course Review | Forugh Sanaee |
| PHARM 343 | Y2 | Fall | 2025-12-12 | Lecture | FINAL | FINAL | — |
| PHARM 344 | Y2 | Winter | 2026-01-05 | Lecture | Overview of CVD (posted in Canvas) Dyslipidemia | Overview of CVD (posted in Canvas) Dyslipidemia | Dr G. Pearson |
| PHARM 344 | Y2 | Winter | 2026-01-07 | Lecture | Dyslipidemia | Dyslipidemia | Dr G. Pearson |
| PHARM 344 | Y2 | Winter | 2026-01-09 | Lecture | Dyslipidemia | Dyslipidemia | Dr G. Pearson |
| PHARM 344 | Y2 | Winter | 2026-01-12 | Lecture | Hypertension | Hypertension | Dr A. Thompson |
| PHARM 344 | Y2 | Winter | 2026-01-14 | Lecture | Hypertension | Hypertension | Dr A. Thompson |
| PHARM 344 | Y2 | Winter | 2026-01-15 | Seminar/case session | Sem 1: Risk Assessment & Primary Prevention | Sem 1: Risk Assessment & Primary Prevention | Dr A. Thompson, Dr G. Pearson |
| PHARM 344 | Y2 | Winter | 2026-01-16 | Lecture | Hypertension | Hypertension | Dr A. Thompson |
| PHARM 344 | Y2 | Winter | 2026-01-19 | Lecture | Hypertension | Hypertension | Dr A. Thompson |
| PHARM 344 | Y2 | Winter | 2026-01-20 | Lecture | Patient Assessment – Chest Pain | Patient Assessment – Chest Pain | Dr S. Koshman |
| PHARM 344 | Y2 | Winter | 2026-01-21 | Lecture | Stable Ischemic Heart Disease/Stable Angina | Stable Ischemic Heart Disease/Stable Angina | Dr A Thompson |
| PHARM 344 | Y2 | Winter | 2026-01-23 | Lecture | Stable Ischemic Heart Disease/Stable Angina | Stable Ischemic Heart Disease/Stable Angina | Dr A Thompson |
| PHARM 344 | Y2 | Winter | 2026-01-26 | Lecture | Acute Coronary Syndromes | Acute Coronary Syndromes | Ms. June Chen |
| PHARM 344 | Y2 | Winter | 2026-01-28 | Lecture | Acute Coronary Syndromes | Acute Coronary Syndromes | Ms. June Chen |
| PHARM 344 | Y2 | Winter | 2026-01-29 | Seminar/case session | Sem 2 Hypertension | Sem 2 Hypertension | Dr A. Thompson |
| PHARM 344 | Y2 | Winter | 2026-01-30 | Lecture | Acute Coronary Syndromes | Acute Coronary Syndromes | Ms. June Chen |
| PHARM 344 | Y2 | Winter | 2026-02-02 | Lecture | BP Screening Clinic Training | BP Screening Clinic Training | Dr. Ryan Chan |
| PHARM 344 | Y2 | Winter | 2026-02-04 | Lecture | Heart failure | Heart failure | Dr S. Koshman |
| PHARM 344 | Y2 | Winter | 2026-02-06 | Lecture | Heart failure | Heart failure | Dr S. Koshman |
| PHARM 344 | Y2 | Winter | 2026-02-09 | Lecture | Heart Failure | Heart Failure | Dr S. Koshman |
| PHARM 344 | Y2 | Winter | 2026-02-11 | Lecture | Heart Failure | Heart Failure | Dr S. Koshman |
| PHARM 344 | Y2 | Winter | 2026-02-12 | Seminar/case session | Sem 3 ACS | Sem 3 ACS | Dr A. Thompson, Ms. June Chen |
| PHARM 344 | Y2 | Winter | 2026-02-13 | Lecture | Patient Assessment – HF | Patient Assessment – HF | Dr S. Koshman |
| PHARM 344 | Y2 | Winter | 2026-02-16 | No class | READING WEEK | READING WEEK | — |
| PHARM 344 | Y2 | Winter | 2026-02-23 | Seminar/case session | Topics 1-13 (including seminar 3) | Topics 1-13 (including seminar 3) | Dr A. Thompson |
| PHARM 344 | Y2 | Winter | 2026-02-25 | Lecture | Patient Perspective: from Heart Failure to Heart Transplant and Beyond | Patient Perspective: from Heart Failure to Heart Transplant and Beyond | Marc Bains |
| PHARM 344 | Y2 | Winter | 2026-02-27 | Lecture | Thromboembolism | Thromboembolism | Dr T. Bungard |
| PHARM 344 | Y2 | Winter | 2026-03-02 | Lecture | Thromboembolism | Thromboembolism | Dr T. Bungard |
| PHARM 344 | Y2 | Winter | 2026-03-04 | Lecture | Thromboembolism | Thromboembolism | Dr T. Bungard |
| PHARM 344 | Y2 | Winter | 2026-03-05 | Seminar/case session | Sem 4 Heart Failure | Sem 4 Heart Failure | Dr A. Thompson and Dr. S. Koshman |
| PHARM 344 | Y2 | Winter | 2026-03-06 | Lecture | Thromboembolism | Thromboembolism | Dr T. Bungard |
| PHARM 344 | Y2 | Winter | 2026-03-09 | Lecture | Pharmacogenomics | Pharmacogenomics | Dr A. Thompson |
| PHARM 344 | Y2 | Winter | 2026-03-11 | Lecture | Patient Assessment – Palpitations, Syncope, Presyncope | Patient Assessment – Palpitations, Syncope, Presyncope | Dr S. Koshman |
| PHARM 344 | Y2 | Winter | 2026-03-13 | Lecture | Atrial Fibrillation | Atrial Fibrillation | Dr. E. Cowley |
| PHARM 344 | Y2 | Winter | 2026-03-16 | Lecture | Atrial Fibrillation | Atrial Fibrillation | Dr. E. Cowley |
| PHARM 344 | Y2 | Winter | 2026-03-18 | Lecture | Atrial Fibrillation | Atrial Fibrillation | Dr. E. Cowley |
| PHARM 344 | Y2 | Winter | 2026-03-19 | Seminar/case session | Sem 5 VTE Seminar | Sem 5 VTE Seminar | Drs A. Thompson and T. Bungard |
| PHARM 344 | Y2 | Winter | 2026-03-20 | Lecture | Stroke | Stroke | M. Hodgson |
| PHARM 344 | Y2 | Winter | 2026-03-23 | Seminar/case session | Stroke | Stroke | M. Hodgson |
| PHARM 344 | Y2 | Winter | 2026-03-25 | Lecture | Optimizing Antiplatelets & Anticoagulants | Optimizing Antiplatelets & Anticoagulants | Dr. T. Eberhardt |
| PHARM 344 | Y2 | Winter | 2026-03-27 | Lecture | Case Debrief: Optimizing Antiplatelets & Anticoagulants | Case Debrief: Optimizing Antiplatelets & Anticoagulants | Dr. T. Eberhardt |
| PHARM 344 | Y2 | Winter | 2026-03-30 | Lecture | Anemia | Anemia | Dr C. Hughes |
| PHARM 344 | Y2 | Winter | 2026-04-01 | Lecture | Anemia | Anemia | Dr C. Hughes |
| PHARM 344 | Y2 | Winter | 2026-04-02 | Seminar/case session | Sem 6 Atrial Fibrillation & Stroke | Sem 6 Atrial Fibrillation & Stroke | Dr A. Thompson, Dr. E. Cowley and M. Hodgson |
| PHARM 344 | Y2 | Winter | 2026-04-03 | No class | Good Friday (no class) | Good Friday (no class) | — |
| PHARM 344 | Y2 | Winter | 2026-04-06 | No class | Easter Monday (no class) | Easter Monday (no class) | — |
| PHARM 344 | Y2 | Winter | 2026-04-08 | Lecture | Anemia Cases | Anemia Cases | Dr C. Hughes |
| PHARM 344 | Y2 | Winter | 2026-04-10 | Lecture | Anemia Case Debrief | Anemia Case Debrief | Dr. C. Hughes |
| PHARM 344 | Y2 | Winter | 2026-04-17 | Final exam | Cumulative Final | Cumulative Final | Dr. A Thompson |
| PHARM 345 | Y2 | Winter | 2026-01-05 | Lecture | Treatment of Constipation I | Treatment of Constipation I | Dr. Breault |
| PHARM 345 | Y2 | Winter | 2026-01-07 | Lecture | Treatment of Constipation II | Treatment of Constipation II | Dr. Breault |
| PHARM 345 | Y2 | Winter | 2026-01-09 | Lecture | Treatment of Diarrhea | Treatment of Diarrhea | Dr. Breault |
| PHARM 345 | Y2 | Winter | 2026-01-12 | Lecture | Irritable Bowel Syndrome | Irritable Bowel Syndrome | Dr. Breault |
| PHARM 345 | Y2 | Winter | 2026-01-14 | Lecture | Inflammatory Bowel Disease (IBD) I | Inflammatory Bowel Disease (IBD) I | Dr. Hall |
| PHARM 345 | Y2 | Winter | 2026-01-16 | Lecture | IBD II | IBD II | Dr. Hall |
| PHARM 345 | Y2 | Winter | 2026-01-19 | Lecture | IBD III | IBD III | Dr. Hall |
| PHARM 345 | Y2 | Winter | 2026-01-21 | Lecture | IBD IV | IBD IV | Dr. Hall |
| PHARM 345 | Y2 | Winter | 2026-01-22 | Seminar/case session | SEMINAR 1: IBD | SEMINAR 1: IBD | Dr. Hall |
| PHARM 345 | Y2 | Winter | 2026-01-23 | Lecture | Peptic Ulcer Disease | Peptic Ulcer Disease | Dr. Makowsky |
| PHARM 345 | Y2 | Winter | 2026-01-26 | Lecture | Gastroesophageal Reflux Disease (GERD) | Gastroesophageal Reflux Disease (GERD) | Dr. Makowsky |
| PHARM 345 | Y2 | Winter | 2026-01-28 | Lecture | Nausea and Vomiting 1 | Nausea and Vomiting 1 | Dr. Breault |
| PHARM 345 | Y2 | Winter | 2026-01-30 | Lecture | Nausea and Vomiting 2 | Nausea and Vomiting 2 | Dr. Breault |
| PHARM 345 | Y2 | Winter | 2026-02-02 | Lecture | Liver Disease I | Liver Disease I | Dr. Sandhu |
| PHARM 345 | Y2 | Winter | 2026-02-04 | Lecture | Liver Disease II | Liver Disease II | Dr. Sandhu |
| PHARM 345 | Y2 | Winter | 2026-02-06 | Midterm exam | Midterm | Midterm | Dr. Breault |
| PHARM 345 | Y2 | Winter | 2026-02-09 | Lecture | Canada Food Guide and Dietary Reference Intakes | Canada Food Guide and Dietary Reference Intakes | Dr. Breault |
| PHARM 345 | Y2 | Winter | 2026-02-11 | Lecture | Vitamins, Minerals & Other Supplements, Nutritional Deficiencies I | Vitamins, Minerals & Other Supplements, Nutritional Deficiencies I | Dr. Breault |
| PHARM 345 | Y2 | Winter | 2026-02-13 | Lecture | Vitamins, Minerals & Other Supplements, Nutritional Deficiencies II | Vitamins, Minerals & Other Supplements, Nutritional Deficiencies II | Dr. Breault |
| PHARM 345 | Y2 | Winter | 2026-02-23 | Lecture | Enteral Nutrition | Enteral Nutrition | K. Walters |
| PHARM 345 | Y2 | Winter | 2026-02-25 | Lecture | Parenteral Nutrition | Parenteral Nutrition | K. Walters |
| PHARM 345 | Y2 | Winter | 2026-02-27 | Lecture | Obesity 1 | Obesity 1 | Dr. Breault |
| PHARM 345 | Y2 | Winter | 2026-03-02 | Lecture | Obesity 2 | Obesity 2 | Dr. Breault |
| PHARM 345 | Y2 | Winter | 2026-03-04 | Lecture | Specialty Diets 1 | Specialty Diets 1 | Dr. Ussher |
| PHARM 345 | Y2 | Winter | 2026-03-06 | Lecture | Specialty Diets 2 | Specialty Diets 2 | Dr. Ussher |
| PHARM 345 | Y2 | Winter | 2026-03-09 | Lecture | Nutrition in Pregnancy | Nutrition in Pregnancy | Emily Fleming |
| PHARM 345 | Y2 | Winter | 2026-03-11 | Lecture | Nutrition in Pediatrics | Nutrition in Pediatrics | Dr. Sanghera |
| PHARM 345 | Y2 | Winter | 2026-03-12 | Seminar/case session | SEMINAR 2: Vitamin Def & Obesity | SEMINAR 2: Vitamin Def & Obesity | R. Breault |
| PHARM 345 | Y2 | Winter | 2026-03-13 | Lecture | Nutrition in Geriatrics/Cachexia | Nutrition in Geriatrics/Cachexia | Heather Oga |
| PHARM 345 | Y2 | Winter | 2026-03-16 | Lecture | Eye Diseases 1: Infections and inflammation | Eye Diseases 1: Infections and inflammation | Dr. Ton/Dr. Hong |
| PHARM 345 | Y2 | Winter | 2026-03-16 | Lecture | Eye Diseases 2: Infections and inflammation continued | Eye Diseases 2: Infections and inflammation continued | Dr. Ton/Dr. Hong |
| PHARM 345 | Y2 | Winter | 2026-03-18 | Lecture | Glaucoma, Cataracts | Glaucoma, Cataracts | Dr. Ton/Dr. Hong |
| PHARM 345 | Y2 | Winter | 2026-03-20 | Lecture | Age-related Macular Degeneration (AMD); Diabetic retinopathy | Age-related Macular Degeneration (AMD); Diabetic retinopathy | Dr. Ton/Dr. Hong |
| PHARM 345 | Y2 | Winter | 2026-03-23 | Lecture | Drug-Induced Skin Eruption | Drug-Induced Skin Eruption | Dr. Sanghera |
| PHARM 345 | Y2 | Winter | 2026-03-25 | Lecture | Psoriasis | Psoriasis | Dr. Sanghera |
| PHARM 345 | Y2 | Winter | 2026-03-26 | Seminar/case session | SEMINAR 3: Ophthalmology | SEMINAR 3: Ophthalmology | Dr. Ton/Dr. Hong |
| PHARM 345 | Y2 | Winter | 2026-03-27 | Lecture | Urticaria (CIU) | Urticaria (CIU) | Dr. Chehade |
| PHARM 345 | Y2 | Winter | 2026-03-30 | Lecture | Perioral Dermatitis/Rosacea | Perioral Dermatitis/Rosacea | Dr. Chehade |
| PHARM 345 | Y2 | Winter | 2026-04-01 | Lecture | Alopecia and Cosmetic Derm | Alopecia and Cosmetic Derm | Dr. Chehade |
| PHARM 345 | Y2 | Winter | 2026-04-01 | Lecture | Dermatitis | Dermatitis | Dr. Sanghera |
| PHARM 345 | Y2 | Winter | 2026-04-08 | Lecture | Derm Disease with Higher prev in skin of colour | Derm Disease with Higher prev in skin of colour | Dr. Sanghera |
| PHARM 345 | Y2 | Winter | 2026-04-09 | Seminar/case session | Seminar 4: Psoriasis + Biologic Therapy | Seminar 4: Psoriasis + Biologic Therapy | Dr. Chehade/Dr. Sanghera |
| PHARM 345 | Y2 | Winter | 2026-04-10 | Lecture | Overview of skin and nail infections | Overview of skin and nail infections | Dr. Sanghera |
| PHARM 345 | Y2 | Winter | — | Lecture | Macronutrients Overview (Asynchronous/Recorded Content) | Macronutrients Overview (Asynchronous/Recorded Content) | Dr. Ussher |
| PHARM 346 | Y2 | Winter | 2026-01-05 | Lecture | Overview of Infectious Diseases and Antimicrobial Stewardship | Overview of Infectious Diseases and Antimicrobial Stewardship | Nathan Beahm |
| PHARM 346 | Y2 | Winter | 2026-01-07 | Lecture | Microbiology 1: Bacterial Pathogens | Microbiology 1: Bacterial Pathogens | Nathan Zelyas |
| PHARM 346 | Y2 | Winter | 2026-01-09 | Lecture | Microbiology 2: Bacterial Pathogens | Microbiology 2: Bacterial Pathogens | Nathan Zelyas |
| PHARM 346 | Y2 | Winter | 2026-01-12 | Lecture | Microbiology 3: Bacterial Pathogens | Microbiology 3: Bacterial Pathogens | Nathan Zelyas |
| PHARM 346 | Y2 | Winter | 2026-01-14 | Lecture | Carbapenems, Monobactams / Macrolides, Clindamycin, Tetracyclines | Carbapenems, Monobactams / Macrolides, Clindamycin, Tetracyclines | Nathan Beahm |
| PHARM 346 | Y2 | Winter | 2026-01-14 | Lecture | Penicillins / Cephalosporins | Penicillins / Cephalosporins | Nathan Beahm |
| PHARM 346 | Y2 | Winter | 2026-01-16 | Lecture | Upper Respiratory Tract Infections 1 | Upper Respiratory Tract Infections 1 | Nathan Beahm |
| PHARM 346 | Y2 | Winter | 2026-01-19 | Lecture | Fluoroquinolones, Metronidazole / Aminoglycosides | Fluoroquinolones, Metronidazole / Aminoglycosides | Nathan Beahm |
| PHARM 346 | Y2 | Winter | 2026-01-19 | Lecture | Upper Respiratory Tract Infections 2 | Upper Respiratory Tract Infections 2 | Nathan Beahm |
| PHARM 346 | Y2 | Winter | 2026-01-21 | Other exam/test | β-lactam Cross-Sensitivity/Allergy Testing | β-lactam Cross-Sensitivity/Allergy Testing | Nathan Beahm |
| PHARM 346 | Y2 | Winter | 2026-01-22 | Seminar/case session | Seminar 1: URTI | Seminar 1: URTI | Nathan Beahm |
| PHARM 346 | Y2 | Winter | 2026-01-23 | Lecture | Antibacterial Review | Antibacterial Review | Nathan Beahm |
| PHARM 346 | Y2 | Winter | 2026-01-26 | Midterm exam | Midterm Exam 1 | Midterm Exam 1 | — |
| PHARM 346 | Y2 | Winter | 2026-01-28 | Lecture | Lower Respiratory Tract Infections 1 | Lower Respiratory Tract Infections 1 | Nathan Beahm |
| PHARM 346 | Y2 | Winter | 2026-01-30 | Other exam/test | Microbiology 4: Clinical Lab Tests | Microbiology 4: Clinical Lab Tests | Nathan Zelyas |
| PHARM 346 | Y2 | Winter | 2026-02-02 | Lecture | Lower Respiratory Tract Infections 2 | Lower Respiratory Tract Infections 2 | Nathan Beahm |
| PHARM 346 | Y2 | Winter | 2026-02-04 | Lecture | Glycopeptides | Glycopeptides | Nathan Beahm |
| PHARM 346 | Y2 | Winter | 2026-02-05 | Seminar/case session | Seminar 2: LRTI | Seminar 2: LRTI | Nathan Beahm |
| PHARM 346 | Y2 | Winter | 2026-02-06 | Lecture | PK-PD of Antimicrobials 1 | PK-PD of Antimicrobials 1 | Nathan Beahm |
| PHARM 346 | Y2 | Winter | 2026-02-09 | Lecture | PK-PD of Antimicrobials 2 | PK-PD of Antimicrobials 2 | Nathan Beahm |
| PHARM 346 | Y2 | Winter | 2026-02-11 | Lecture | Miscellaneous Antibacterials 1 | Miscellaneous Antibacterials 1 | Nathan Beahm |
| PHARM 346 | Y2 | Winter | 2026-02-13 | Lecture | Miscellaneous Antibacterials 2 | Miscellaneous Antibacterials 2 | Nathan Beahm |
| PHARM 346 | Y2 | Winter | 2026-02-23 | Lecture | Sepsis and Septic Shock | Sepsis and Septic Shock | Nathan Beahm |
| PHARM 346 | Y2 | Winter | 2026-02-25 | Lecture | Skin and Soft Tissue Infections | Skin and Soft Tissue Infections | Nathan Beahm |
| PHARM 346 | Y2 | Winter | 2026-02-26 | Seminar/case session | Seminar 3: SSTI | Seminar 3: SSTI | Nathan Beahm |
| PHARM 346 | Y2 | Winter | 2026-02-27 | Lecture | Clostridioides difficile Infection | Clostridioides difficile Infection | Nathan Beahm |
| PHARM 346 | Y2 | Winter | 2026-03-02 | Midterm exam | Midterm Exam 2 | Midterm Exam 2 | — |
| PHARM 346 | Y2 | Winter | 2026-03-04 | Lecture | Vancomycin TDM | Vancomycin TDM | Tony Kiang |
| PHARM 346 | Y2 | Winter | 2026-03-06 | Lecture | Aminoglycoside TDM | Aminoglycoside TDM | Tony Kiang |
| PHARM 346 | Y2 | Winter | 2026-03-09 | Lecture | Urinary Tract Infections 1 | Urinary Tract Infections 1 | Nathan Beahm |
| PHARM 346 | Y2 | Winter | 2026-03-11 | Lecture | Urinary Tract Infections 2 | Urinary Tract Infections 2 | Nathan Beahm |
| PHARM 346 | Y2 | Winter | 2026-03-12 | Seminar/case session | Seminar 4: UTI | Seminar 4: UTI | Nathan Beahm |
| PHARM 346 | Y2 | Winter | 2026-03-13 | Lecture | Bone & Joint Infections 1 | Bone & Joint Infections 1 | Nathan Beahm |
| PHARM 346 | Y2 | Winter | 2026-03-16 | Lecture | Bone & Joint Infections 2 | Bone & Joint Infections 2 | Nathan Beahm |
| PHARM 346 | Y2 | Winter | 2026-03-18 | Lecture | Tuberculosis and Antitubercular Agents 1 | Tuberculosis and Antitubercular Agents 1 | Donna Chua |
| PHARM 346 | Y2 | Winter | 2026-03-20 | Lecture | Tuberculosis and Antitubercular Agents 2 | Tuberculosis and Antitubercular Agents 2 | Donna Chua |
| PHARM 346 | Y2 | Winter | 2026-03-23 | Lecture | Endocarditis | Endocarditis | Teagan Zeggil |
| PHARM 346 | Y2 | Winter | 2026-03-25 | Lecture | Endocarditis Cases | Endocarditis Cases | Teagan Zeggil |
| PHARM 346 | Y2 | Winter | 2026-03-26 | Seminar/case session | Seminar 5: Bone & Joint Infections | Seminar 5: Bone & Joint Infections | Nathan Beahm |
| PHARM 346 | Y2 | Winter | 2026-03-27 | Lecture | Intra-abdominal Infections | Intra-abdominal Infections | Jackson Stewart |
| PHARM 346 | Y2 | Winter | 2026-03-30 | Lecture | Surgical Prophylaxis | Surgical Prophylaxis | Nathan Beahm |
| PHARM 346 | Y2 | Winter | 2026-04-01 | Lecture | Meningitis/Encephalitis | Meningitis/Encephalitis | Cecilia Lau |
| PHARM 346 | Y2 | Winter | 2026-04-03 | No class | No Class - Easter Friday | No Class - Easter Friday | — |
| PHARM 346 | Y2 | Winter | 2026-04-06 | No class | No Class - Easter Monday | No Class - Easter Monday | — |
| PHARM 346 | Y2 | Winter | 2026-04-08 | Lecture | Infection Prevention & Control | Infection Prevention & Control | Melody Cordoviz |
| PHARM 346 | Y2 | Winter | 2026-04-09 | Seminar/case session | Seminar 6: Meningitis | Seminar 6: Meningitis | Cecilia Lau/Nathan Beahm |
| PHARM 346 | Y2 | Winter | 2026-04-10 | Lecture | Antibacterial Review | Antibacterial Review | Nathan Beahm |
| PHARM 346 | Y2 | Winter | — | No class | Winter Break - No Class | Winter Break - No Class | — |
| PHARM 443 | Y3 | Fall | 2025-09-02 | Lecture | Introduction to Course and SRH; Contraception Part 1: General | Introduction to Course and SRH; Contraception Part 1: General | Nese Yuksel |
| PHARM 443 | Y3 | Fall | 2025-09-04 | Lecture | Contraception Part 2: Combined hormonal contraceptives | Contraception Part 2: Combined hormonal contraceptives | Nese Yuksel |
| PHARM 443 | Y3 | Fall | 2025-09-09 | Lecture | Contraception Part 2: Combined hormonal contraceptives con’t | Contraception Part 2: Combined hormonal contraceptives con’t | Nese Yuksel |
| PHARM 443 | Y3 | Fall | 2025-09-11 | Lecture | Contraception Part 3: Long Acting Reversible Contraceptives; Contraception Part 4: Progestin Only Contraceptives | Contraception Part 3: Long Acting Reversible Contraceptives; Contraception Part 4: Progestin Only Contraceptives | Nese Yuksel |
| PHARM 443 | Y3 | Fall | 2025-09-11 | Seminar/case session | Seminar 1: Gender Affirming Care | Gender Affirming Care | — |
| PHARM 443 | Y3 | Fall | 2025-09-11 | Seminar/case session | Seminar 1: Gender Affirming Care | Seminar 1: Gender Affirming Care | Dylan Moulton |
| PHARM 443 | Y3 | Fall | 2025-09-16 | Lecture | Contraception Part 4 con’t and Part 5: Non-hormonal contraceptives | Contraception Part 4 con’t and Part 5: Non-hormonal contraceptives | Nese Yuksel |
| PHARM 443 | Y3 | Fall | 2025-09-18 | Lecture | Female Sexual Dysfunction | Female Sexual Dysfunction | Nese Yuksel |
| PHARM 443 | Y3 | Fall | 2025-09-23 | Lecture | Emergency Contraception; Medical Abortion | Emergency Contraception; Medical Abortion | Nese Yuksel |
| PHARM 443 | Y3 | Fall | 2025-09-25 | Lecture | Menstrual Related Disorders (dysmenorrhea, AUB), Premenstrual syndrome/Premenstrual dysphoric disorder | Menstrual Related Disorders (dysmenorrhea, AUB), Premenstrual syndrome/Premenstrual dysphoric disorder | Nese Yuksel |
| PHARM 443 | Y3 | Fall | 2025-09-25 | Seminar/case session | Seminar 2: Contraception and LARC | Seminar 2: Contraception and LARC | Nese Yuksel |
| PHARM 443 | Y3 | Fall | 2025-09-25 | Seminar/case session | Seminar 2: Contraception: Prescribing of Hormonal Contraception and LARC Cases | Contraception and LARC Cases | — |
| PHARM 443 | Y3 | Fall | 2025-09-30 | No class | Truth and Reconciliation Day - No Class | Truth and Reconciliation Day - No Class | — |
| PHARM 443 | Y3 | Fall | 2025-10-02 | Lecture | Menopause: Part 1: Pathophysiology; Part 2: Management of Menopause and Role of Hormone Therapy | Menopause: Part 1: Pathophysiology; Part 2: Management of Menopause and Role of Hormone Therapy | Nese Yuksel |
| PHARM 443 | Y3 | Fall | 2025-10-07 | Lecture | Menopause: Part 2: Management of Menopause and Role of Hormone Therapy; Part 3: Therapeutic Options | Menopause: Part 2: Management of Menopause and Role of Hormone Therapy; Part 3: Therapeutic Options | Nese Yuksel |
| PHARM 443 | Y3 | Fall | 2025-10-09 | Lecture | Endometriosis; Polycystic Ovarian Syndrome | Endometriosis; Polycystic Ovarian Syndrome | Nese Yuksel |
| PHARM 443 | Y3 | Fall | 2025-10-09 | Seminar/case session | Seminar 3: Menopause Cases | Seminar 3: Menopause Cases | Nese Yuksel |
| PHARM 443 | Y3 | Fall | 2025-10-09 | Seminar/case session | Seminar 3: Menopause: Management of Menopause Cases | Menopause Cases | — |
| PHARM 443 | Y3 | Fall | 2025-10-14 | Lecture | Erectile Dysfunction | Erectile Dysfunction | Eleanor Leoni |
| PHARM 443 | Y3 | Fall | 2025-10-16 | Midterm exam | Midterm (focused on SRH) | Midterm (focused on SRH) | — |
| PHARM 443 | Y3 | Fall | 2025-10-21 | Lecture | Hypogonadism | Hypogonadism | Eleanor Leoni |
| PHARM 443 | Y3 | Fall | 2025-10-23 | Other exam/test | Pregnancy and Ovulation Testing; Treatment of Infertility | Pregnancy and Ovulation Testing; Treatment of Infertility | Nese Yuksel |
| PHARM 443 | Y3 | Fall | 2025-10-23 | Seminar/case session | Seminar 4: Chronic Pain | Seminar 4: Chronic Pain | Jill Hall / Nathan Beahm |
| PHARM 443 | Y3 | Fall | 2025-10-23 | Seminar/case session | Seminar 4: Chronic Pain | Chronic Pain (Self-directed activity) | — |
| PHARM 443 | Y3 | Fall | 2025-10-28 | Lecture | Gout | Gout | Jill Hall |
| PHARM 443 | Y3 | Fall | 2025-10-30 | Lecture | Osteoarthritis | Osteoarthritis | Nathan Beahm |
| PHARM 443 | Y3 | Fall | 2025-11-04 | Lecture | Physiologic Changes in Pregnancy; Drugs in Pregnancy and Lactation | Physiologic Changes in Pregnancy; Drugs in Pregnancy and Lactation | Nese Yuksel |
| PHARM 443 | Y3 | Fall | 2025-11-06 | Seminar/case session | Seminar 5: Gout / Osteoarthritis | Seminar 5: Gout / Osteoarthritis | Jill Hall |
| PHARM 443 | Y3 | Fall | 2025-11-06 | Seminar/case session | Seminar 5: Gout / Osteoarthritis | Gout / Osteoarthritis | — |
| PHARM 443 | Y3 | Fall | 2025-11-06 | Lecture | Treatment Issues in Pregnancy; Postpartum Care | Treatment Issues in Pregnancy; Postpartum Care | Nese Yuksel |
| PHARM 443 | Y3 | Fall | 2025-11-10 | Other/unspecified | Fall Break | Fall Break | — |
| PHARM 443 | Y3 | Fall | 2025-11-18 | Lecture | Rheumatoid Arthritis I | Rheumatoid Arthritis I | Jill Hall |
| PHARM 443 | Y3 | Fall | 2025-11-20 | Lecture | Rheumatoid Arthritis II | Rheumatoid Arthritis II | Jill Hall |
| PHARM 443 | Y3 | Fall | 2025-11-25 | Lecture | Osteoporosis I | Osteoporosis I | Nese Yuksel |
| PHARM 443 | Y3 | Fall | 2025-11-27 | Lecture | Osteoporosis II | Osteoporosis II | Nese Yuksel |
| PHARM 443 | Y3 | Fall | 2025-11-27 | Seminar/case session | Seminar 6: Rheumatoid Arthritis | Seminar 6: Rheumatoid Arthritis | Jill Hall |
| PHARM 443 | Y3 | Fall | 2025-11-27 | Seminar/case session | Seminar 6: Rheumatoid arthritis | Rheumatoid arthritis | — |
| PHARM 443 | Y3 | Fall | 2025-12-02 | Lecture | MSK Imaging (0900-1000); SPoT (1000 - 1020) | MSK Imaging (0900-1000); SPoT (1000 - 1020) | Alison Clifford / Suki Dillon / Jill Hall |
| PHARM 443 | Y3 | Fall | 2025-12-04 | Lecture | SpA/Lupus | SpA/Lupus | Jill Hall |
| PHARM 444 | Y3 | Fall | 2025-09-02 | Lecture | Course Introduction and Oncology Introduction Case | Course Introduction and Oncology Introduction Case | Tara Leslie; Sherif Mahmoud |
| PHARM 444 | Y3 | Fall | 2025-09-04 | Lecture | Colon Cancer | Colon Cancer | Tara Leslie |
| PHARM 444 | Y3 | Fall | 2025-09-04 | Seminar/case session | Oncology Seminar 1 | Oncology Seminar 1 | Tara Leslie |
| PHARM 444 | Y3 | Fall | 2025-09-09 | Lecture | Radiotherapy / Breast Cancer 1 | Radiotherapy; Breast Cancer 1 | Brock Debenham; Tara Leslie |
| PHARM 444 | Y3 | Fall | 2025-09-11 | Lecture | Breast Cancer 2 | Breast Cancer 2 | Tara Leslie |
| PHARM 444 | Y3 | Fall | 2025-09-16 | Lecture | Supportive Care 1 (AINV, Hand & Foot, Mucositis, etc) | Supportive Care 1 (AINV, Hand & Foot, Mucositis, etc) | Tara Leslie |
| PHARM 444 | Y3 | Fall | 2025-09-18 | Lecture | Lung Cancer 1 | Lung Cancer 1 | Tara Leslie |
| PHARM 444 | Y3 | Fall | 2025-09-18 | Seminar/case session | Oncology Seminar 2 | Oncology Seminar 2 | Tara Leslie |
| PHARM 444 | Y3 | Fall | 2025-09-23 | Lecture | Lung Cancer 2 and Supportive Care 2 (Skin Toxicities and Immunologic Toxicities and Other GI toxicities) | Lung Cancer 2 and Supportive Care 2 (Skin Toxicities and Immunologic Toxicities and Other GI toxicities) | Tara Leslie |
| PHARM 444 | Y3 | Fall | 2025-09-25 | Lecture | Hematology 1 (Lymphomas, Multiple Myeloma, Hypercalcemia) | Hematology 1 (Lymphomas, Multiple Myeloma, Hypercalcemia) | Tara Leslie |
| PHARM 444 | Y3 | Fall | 2025-10-02 | Lecture | Hematology 2 (Leukemias, TLS, BMT) | Hematology 2 (Leukemias, TLS, BMT) | Tara Leslie |
| PHARM 444 | Y3 | Fall | 2025-10-02 | Seminar/case session | Oncology Seminar 3 & Survive and Thrive | Oncology Seminar 3 & Survive and Thrive | Tara Leslie |
| PHARM 444 | Y3 | Fall | 2025-10-07 | Lecture | Palliative Care | Palliative Care | Tara Leslie |
| PHARM 444 | Y3 | Fall | 2025-10-09 | Lecture | Prostate Cancer | Prostate Cancer | Tara Leslie |
| PHARM 444 | Y3 | Fall | 2025-10-14 | Lecture | Supportive Care 3 (Myelosuppression & FN) | Supportive Care 3 (Myelosuppression & FN) | Tara Leslie |
| PHARM 444 | Y3 | Fall | 2025-10-16 | Lecture | Seizures and Epilepsy 1 | Seizures and Epilepsy 1 | Sherif Mahmoud |
| PHARM 444 | Y3 | Fall | 2025-10-21 | Midterm exam | MIDTERM | MIDTERM | Tara Leslie |
| PHARM 444 | Y3 | Fall | 2025-10-23 | Lecture | Seizures and Epilepsy 2 | Seizures and Epilepsy 2 | Sherif Mahmoud |
| PHARM 444 | Y3 | Fall | 2025-10-28 | Lecture | Seizures and Epilepsy 3 | Seizures and Epilepsy 3 | Sherif Mahmoud |
| PHARM 444 | Y3 | Fall | 2025-10-30 | Lecture | Peripheral Neuropathies | Peripheral Neuropathies | Sherif Mahmoud |
| PHARM 444 | Y3 | Fall | 2025-10-30 | Seminar/case session | Seizures and Epilepsy Seminar | Seizures and Epilepsy Seminar | Sherif Mahmoud |
| PHARM 444 | Y3 | Fall | 2025-11-04 | Lecture | Multiple Sclerosis | Multiple Sclerosis | Penny Smyth |
| PHARM 444 | Y3 | Fall | 2025-11-04 | Lecture | Traumatic Brain Injury | Traumatic Brain Injury | Sherif Mahmoud |
| PHARM 444 | Y3 | Fall | 2025-11-06 | Lecture | Dizziness | Dizziness | Lisa Tate |
| PHARM 444 | Y3 | Fall | 2025-11-18 | Lecture | Headache Disorders 1 | Headache Disorders 1 | Sherif Mahmoud |
| PHARM 444 | Y3 | Fall | 2025-11-20 | Lecture | Headache Disorders 2 | Headache Disorders 2 | Sherif Mahmoud |
| PHARM 444 | Y3 | Fall | 2025-11-20 | Seminar/case session | Headache Seminar | Headache Seminar | Sherif Mahmoud |
| PHARM 444 | Y3 | Fall | 2025-11-25 | Lecture | Movement Disorders 1 | Movement Disorders 1 | Lisa Tate |
| PHARM 444 | Y3 | Fall | 2025-11-27 | Lecture | Movement Disorders 2 | Movement Disorders 2 | Lisa Tate |
| PHARM 444 | Y3 | Fall | 2025-12-02 | Lecture | Cognitive Impairment 1 | Cognitive Impairment 1 | Lisa Tate |
| PHARM 444 | Y3 | Fall | 2025-12-04 | Seminar/case session | A day in the life of a Neurology Pharmacist/Course evaluation | A day in the life of a Neurology Pharmacist / Course evaluation | Sherif Mahmoud |
| PHARM 444 | Y3 | Fall | 2025-12-04 | Lecture | Cognitive Impairment 2 | Cognitive Impairment 2 | Lisa Tate |
| PHARM 444 | Y3 | Fall | — | Final exam | FINAL EXAM | FINAL EXAM | Sherif Mahmoud |
| PHARM 445 | Y3 | Fall | 2025-09-01 | Laboratory | No Class – Labour Day | No Class – Labour Day | — |
| PHARM 445 | Y3 | Fall | 2025-09-03 | Lecture | Course Intro, Pain Types, General Pain Assessment | Course Intro, Pain Types, General Pain Assessment | Nathan Beahm |
| PHARM 445 | Y3 | Fall | 2025-09-05 | Lecture | General Pain Assessment | General Pain Assessment | Nathan Beahm |
| PHARM 445 | Y3 | Fall | 2025-09-08 | Lecture | Opioid Management I | Opioid Management I | Nathan Beahm |
| PHARM 445 | Y3 | Fall | 2025-09-10 | Lecture | Opioid Management II | Opioid Management II | Nathan Beahm |
| PHARM 445 | Y3 | Fall | 2025-09-12 | Lecture | Acute Pain I | Acute Pain I | Nathan Beahm |
| PHARM 445 | Y3 | Fall | 2025-09-15 | Seminar/case session | Acute Pain | Acute Pain | Nathan Beahm |
| PHARM 445 | Y3 | Fall | 2025-09-15 | Lecture | Acute Pain II | Acute Pain II | Nathan Beahm |
| PHARM 445 | Y3 | Fall | 2025-09-17 | Lecture | Cannabinoids | Cannabinoids | Nathan Beahm |
| PHARM 445 | Y3 | Fall | 2025-09-19 | Lecture | Chronic Pain I | Chronic Pain I | Nathan Beahm |
| PHARM 445 | Y3 | Fall | 2025-09-22 | Lecture | Chronic Pain II | Chronic Pain II | Nathan Beahm |
| PHARM 445 | Y3 | Fall | 2025-09-24 | Lecture | Neuropathic Pain I | Neuropathic Pain I | Nathan Beahm |
| PHARM 445 | Y3 | Fall | 2025-09-26 | Lecture | Neuropathic Pain II | Neuropathic Pain II | Nathan Beahm |
| PHARM 445 | Y3 | Fall | 2025-09-29 | Seminar/case session | Chronic Pain | Chronic Pain | Nathan Beahm |
| PHARM 445 | Y3 | Fall | 2025-09-29 | Lecture | Pain Management in Palliative Care I | Pain Management in Palliative Care I | Serena Rix |
| PHARM 445 | Y3 | Fall | 2025-10-01 | Lecture | Pain Management in Palliative Care II | Pain Management in Palliative Care II | Serena Rix |
| PHARM 445 | Y3 | Fall | 2025-10-03 | Lecture | Methadone for Pain Management | Methadone for Pain Management | Serena Rix |
| PHARM 445 | Y3 | Fall | 2025-10-06 | Lecture | Substance Use Disorders Intro | Substance Use Disorders Intro | Essi Salokangas |
| PHARM 445 | Y3 | Fall | 2025-10-08 | Lecture | Alcohol Use Disorder | Alcohol Use Disorder | Essi Salokangas |
| PHARM 445 | Y3 | Fall | 2025-10-10 | Lecture | Opioid Use Disorder I | Opioid Use Disorder I | Essi Salokangas |
| PHARM 445 | Y3 | Fall | 2025-10-10 | Lecture | Opioid Use Disorder II | Opioid Use Disorder II | Essi Salokangas |
| PHARM 445 | Y3 | Fall | 2025-10-13 | No class | No Class - Thanksgiving Day | No Class - Thanksgiving Day | — |
| PHARM 445 | Y3 | Fall | 2025-10-15 | Lecture | Stimulant Use Disorder | Stimulant Use Disorder | Essi Salokangas |
| PHARM 445 | Y3 | Fall | 2025-10-17 | Lecture | Lived Experience | Lived Experience | Essi Salokangas |
| PHARM 445 | Y3 | Fall | 2025-10-20 | Seminar/case session | Complex Applied Case (Pain, Substance Use Disorders, Infectious Diseases) | Complex Applied Case (Pain, Substance Use Disorders, Infectious Diseases) | Essi Salokangas / Nathan Beahm |
| PHARM 445 | Y3 | Fall | 2025-10-20 | Lecture | Mental Health Introduction | Mental Health Introduction | Dylan Moulton |
| PHARM 445 | Y3 | Fall | 2025-10-22 | Lecture | Major Depressive Disorder I | Major Depressive Disorder I | Dylan Moulton |
| PHARM 445 | Y3 | Fall | 2025-10-24 | Midterm exam | Midterm Exam | Midterm Exam | — |
| PHARM 445 | Y3 | Fall | 2025-10-27 | Lecture | Major Depressive Disorder II | Major Depressive Disorder II | Dylan Moulton |
| PHARM 445 | Y3 | Fall | 2025-10-29 | Lecture | Psychotropic Drugs I | Psychotropic Drugs I | Dylan Moulton |
| PHARM 445 | Y3 | Fall | 2025-10-31 | Lecture | Anxiety Disorders I | Anxiety Disorders I | Dylan Moulton |
| PHARM 445 | Y3 | Fall | 2025-11-03 | Lecture | Anxiety Disorders II | Anxiety Disorders II | Dylan Moulton |
| PHARM 445 | Y3 | Fall | 2025-11-03 | Seminar/case session | Major Depressive Disorder / Anxiety | Major Depressive Disorder / Anxiety | Dylan Moulton |
| PHARM 445 | Y3 | Fall | 2025-11-05 | Lecture | Schizophrenia I | Schizophrenia I | Vanessa Hill |
| PHARM 445 | Y3 | Fall | 2025-11-07 | Lecture | Psychotropic Drugs II | Psychotropic Drugs II | Dylan Moulton |
| PHARM 445 | Y3 | Fall | 2025-11-11 | No class | No Class - Fall Break | No Class - Fall Break | — |
| PHARM 445 | Y3 | Fall | 2025-11-17 | Lecture | Schizophrenia II | Schizophrenia II | Vanessa Hill |
| PHARM 445 | Y3 | Fall | 2025-11-19 | Lecture | Psychotropic Drugs III | Psychotropic Drugs III | Dylan Moulton |
| PHARM 445 | Y3 | Fall | 2025-11-21 | Lecture | Bipolar Disorder I | Bipolar Disorder I | Vanessa Hill |
| PHARM 445 | Y3 | Fall | 2025-11-24 | Seminar/case session | Bipolar Disorder / Schizophrenia | Bipolar Disorder / Schizophrenia | Vanessa Hill / Dylan Moulton |
| PHARM 445 | Y3 | Fall | 2025-11-24 | Lecture | Bipolar Disorder II | Bipolar Disorder II | Vanessa Hill |
| PHARM 445 | Y3 | Fall | 2025-11-26 | Lecture | Attention-Deficit/Hyperactivity Disorder I | Attention-Deficit/Hyperactivity Disorder I | Dylan Moulton |
| PHARM 445 | Y3 | Fall | 2025-11-28 | Lecture | Attention-Deficit/Hyperactivity Disorder II | Attention-Deficit/Hyperactivity Disorder II | Dylan Moulton |
| PHARM 445 | Y3 | Fall | 2025-12-01 | Lecture | Psychotherapy for Pain and Mental Health | Psychotherapy for Pain and Mental Health | Justin Long |
| PHARM 445 | Y3 | Fall | 2025-12-03 | Lecture | Sleep-Wake Disorders | Sleep-Wake Disorders | Dylan Moulton |
| PHARM 445 | Y3 | Fall | 2025-12-05 | Lecture | Other Mental Disorders | Other Mental Disorders | Dylan Moulton |
| PHARM 445 | Y3 | Fall | 2025-12-08 | Final exam | Mental Health Application / Final Exam Review | Mental Health Application / Final Exam Review | Essi Salokangas / Nathan Beahm |
| PHARM 446 | Y3 | Winter | 2026-01-06 | Lecture | Course Introduction; Public Health and the Canadian Immunization System | Course Introduction; Public Health and the Canadian Immunization System | Damion Barnes; Pierre Danis |
| PHARM 446 | Y3 | Winter | 2026-01-08 | Lecture | Immunology Overview and Types of Immunizing Agents | Immunology Overview and Types of Immunizing Agents | Pierre Danis |
| PHARM 446 | Y3 | Winter | 2026-01-13 | Lecture | Vaccine Preventable Diseases: Part I | Vaccine Preventable Diseases: Part I | Pierre Danis |
| PHARM 446 | Y3 | Winter | 2026-01-15 | Lecture | Vaccine Preventable Diseases: Part II | Vaccine Preventable Diseases: Part II | Pierre Danis |
| PHARM 446 | Y3 | Winter | 2026-01-20 | Lecture | Pharmacy-Based Immunization Program: Adverse events, documentation, storage and handling | Pharmacy-Based Immunization Program: Adverse events, documentation, storage and handling | Pierre Danis |
| PHARM 446 | Y3 | Winter | 2026-01-20 | Lecture | Traveller’s Health Assessment in relation to vaccines | Traveller’s Health Assessment in relation to vaccines | Pierre Danis |
| PHARM 446 | Y3 | Winter | 2026-01-22 | Seminar/case session | SEMINAR 1: Travel Health and Vaccine Assessment | SEMINAR 1: Travel Health and Vaccine Assessment | Pierre Danis |
| PHARM 446 | Y3 | Winter | 2026-01-27 | Lecture | Traveller’s Health: Health Sicknesses | Traveller’s Health: Health Sicknesses | Pierre Danis |
| PHARM 446 | Y3 | Winter | 2026-01-29 | Lecture | Virology Introduction: Structure of viruses, classification, and replication | Virology Introduction: Structure of viruses, classification, and replication | Carmen Charlton |
| PHARM 446 | Y3 | Winter | 2026-02-03 | Lecture | Herpes Zoster Virus | Herpes Zoster Virus | Damion Barnes |
| PHARM 446 | Y3 | Winter | 2026-02-03 | Seminar/case session | SEMINAR 2: Herpes Zoster Virus | SEMINAR 2: Herpes Zoster Virus | Damion Barnes |
| PHARM 446 | Y3 | Winter | 2026-02-05 | Lecture | Herpes Simplex Viruses | Herpes Simplex Viruses | Damion Barnes |
| PHARM 446 | Y3 | Winter | 2026-02-10 | Midterm exam | MIDTERM (up to and including Herpes Zoster Virus) | MIDTERM (up to and including Herpes Zoster Virus) | — |
| PHARM 446 | Y3 | Winter | 2026-02-12 | Lecture | Viral Hepatitis | Viral Hepatitis | Christine Hughes |
| PHARM 446 | Y3 | Winter | 2026-02-16 | No class | Reading Week (Mon Feb 16 – Fri Feb 20) | Reading Week (Mon Feb 16 – Fri Feb 20) | — |
| PHARM 446 | Y3 | Winter | 2026-02-24 | Lecture | HIV: Part I | HIV: Part I | Christine Hughes |
| PHARM 446 | Y3 | Winter | 2026-02-24 | Seminar/case session | SEMINAR 3: Viral Hepatitis | SEMINAR 3: Viral Hepatitis | Damion Barnes |
| PHARM 446 | Y3 | Winter | 2026-02-26 | Lecture | HIV: Part II | HIV: Part II | Christine Hughes |
| PHARM 446 | Y3 | Winter | 2026-03-03 | Lecture | HIV and Opportunistic Infections | HIV and Opportunistic Infections | Caitlin Olatunbosun |
| PHARM 446 | Y3 | Winter | 2026-03-05 | Lecture | Influenza; COVID-19 | Influenza; COVID-19 | Jackson Stewart; Nathan Beahm |
| PHARM 446 | Y3 | Winter | 2026-03-10 | Seminar/case session | SEMINAR 4: HIV | SEMINAR 4: HIV | Christine Hughes; Caitlin Olatunbosun |
| PHARM 446 | Y3 | Winter | 2026-03-10 | Lecture | Sexually Transmitted Infections: Part I | Sexually Transmitted Infections: Part I | Jackson Stewart |
| PHARM 446 | Y3 | Winter | 2026-03-12 | Lecture | Sexually Transmitted Infections: Part II | Sexually Transmitted Infections: Part II | Jackson Stewart |
| PHARM 446 | Y3 | Winter | 2026-03-17 | Lecture | Transplant: Part I | Transplant: Part I | Tony Kiang |
| PHARM 446 | Y3 | Winter | 2026-03-19 | Lecture | Transplant: Part II | Transplant: Part II | Tony Kiang |
| PHARM 446 | Y3 | Winter | 2026-03-24 | Seminar/case session | SEMINAR 5: Organ Donation and Transplantation | SEMINAR 5: Organ Donation and Transplantation | Darlene Jagusic |
| PHARM 446 | Y3 | Winter | 2026-03-24 | Lecture | Transplant: Part III | Transplant: Part III | Tony Kiang |
| PHARM 446 | Y3 | Winter | 2026-03-26 | Lecture | Transplant: Part IV | Transplant: Part IV | Tony Kiang |
| PHARM 446 | Y3 | Winter | 2026-03-31 | Lecture | Pinworms; Therapeutic Case Reviews | Pinworms; Therapeutic Case Reviews | Damion Barnes |
| PHARM 446 | Y3 | Winter | 2026-04-02 | Lecture | Systemic Fungal Infections | Systemic Fungal Infections | Jackson Stewart |
| PHARM 446 | Y3 | Winter | 2026-04-07 | Seminar/case session | SEMINAR 6: Renal Transplant | SEMINAR 6: Renal Transplant | Tony Kiang |
| PHARM 446 | Y3 | Winter | 2026-04-07 | Lecture | Vaginal Candidiasis | Vaginal Candidiasis | Ellie Leoni |
| PHARM 446 | Y3 | Winter | 2026-04-09 | Final exam | Dermatophytoses; Course Evaluations and Final Exam Preparation | Dermatophytoses; Course Evaluations and Final Exam Preparation | Ellie Leoni; Damion Barnes |
| PHARM 446 | Y3 | Winter | 2026-04-20 | Final exam | FINAL EXAM | FINAL EXAM | — |
| PHARM 448 | Y3 | Winter | 2025-01-07 | Lecture | Course Introduction; Advanced Therapeutics Principles I | Practice Integrated Case(s) | Cheryl Sadowski; Sherif Mahmoud |
| PHARM 448 | Y3 | Winter | 2025-01-09 | Lecture | Advanced Therapeutics Principles II | Dealing with Complex Patients | Sherif Mahmoud |
| PHARM 448 | Y3 | Winter | 2025-01-14 | Lecture | Integrated Case 1 | Community/ Ambulatory care | Sherif Mahmoud; Cheryl Sadowski |
| PHARM 448 | Y3 | Winter | 2025-01-14 | Lecture | Practice Case | Introduction to case process; Introduction to EHR | Sherif Mahmoud |
| PHARM 448 | Y3 | Winter | 2025-01-16 | Lecture | Case 1 Debriefing | Group presentations; Expert facilitation debriefing | Sherif Mahmoud; Cheryl Sadowski |
| PHARM 448 | Y3 | Winter | 2025-01-21 | Lecture | Advanced Therapeutics Principles III | Decision making with no or limited evidence | Sherif Mahmoud |
| PHARM 448 | Y3 | Winter | 2025-01-23 | Lecture | Geriatrics – Part I | Multimorbidity | Cheryl Sadowski |
| PHARM 448 | Y3 | Winter | 2025-01-28 | Lecture | Geriatrics - Part II | Medication related problems encountered in older adults | Cheryl Sadowski |
| PHARM 448 | Y3 | Winter | 2025-01-28 | Lecture | Integrated Case 2 | Geriatrics Case; Supportive living | Cheryl Sadowski; Daxesh Dalal; Olga Nikolaev |
| PHARM 448 | Y3 | Winter | 2025-01-30 | Lecture | Case 2 Debriefing | Group presentations; Expert facilitation debriefing | Cheryl Sadowski; Daxesh Dalal; Olga Nikolaev |
| PHARM 448 | Y3 | Winter | 2025-02-04 | Lecture | Geriatrics – Part III | Geriatric Syndromes; Care delivery and the implications of aging | Cheryl Sadowski |
| PHARM 448 | Y3 | Winter | 2025-02-06 | Lecture | Elder Abuse | Classification of abuse, interventions, and role of the pharmacist | Seniors Protection Partnership |
| PHARM 448 | Y3 | Winter | 2025-02-11 | Lecture | Geriatrics – Part IV | Debates and Practice cases | Cheryl Sadowski |
| PHARM 448 | Y3 | Winter | 2025-02-11 | Lecture | Integrated Case 3 | Geriatrics Case; Outpatient Clinic | Cheryl Sadowski |
| PHARM 448 | Y3 | Winter | 2025-02-13 | Midterm exam | MIDTERM EXAM | Material covered from Jan 9 – Feb 11 | Assessment Team; Cheryl Sadowski |
| PHARM 448 | Y3 | Winter | 2025-02-17 | Lecture | SPRING Break (Mon Feb 17 – Fri Feb 21) | SPRING Break (Mon Feb 17 – Fri Feb 21) | — |
| PHARM 448 | Y3 | Winter | 2025-02-25 | Lecture | Hospital Care | A day in the life of a hospital pharmacist | Sherif Mahmoud |
| PHARM 448 | Y3 | Winter | 2025-02-27 | Lecture | Case 3 debriefing | Group presentations; Expert facilitation debriefing | Cheryl Sadowski |
| PHARM 448 | Y3 | Winter | 2025-03-03 | Lecture | Incarceration – Introduction | A day in the life of a patient who is incarcerated; A day in the life of a pharmacist working in incarceration | Incarceration Team |
| PHARM 448 | Y3 | Winter | 2025-03-04 | Lecture | Critical Care | A day in the life of a critical care pharmacist | Sherif Mahmoud |
| PHARM 448 | Y3 | Winter | 2025-03-04 | Lecture | Integrated Case 4 | Incarceration | Ayush Chadha; Kim Taube; Sofiya Terekhovska; Cheryl Sadowski |
| PHARM 448 | Y3 | Winter | 2025-03-06 | Lecture | Case 4 debriefing | Group presentations; Expert facilitation debriefing | Ayush Chadha; Kim Taube; Sofiya Terekhovska; Cheryl Sadowski |
| PHARM 448 | Y3 | Winter | 2025-03-11 | Lecture | Pediatrics – Part I | Age groups; Developmental classification; Neonatal care | Bharti Thomas |
| PHARM 448 | Y3 | Winter | 2025-03-13 | Lecture | Pediatrics – Part II | Therapeutics | Bharti Thomas |
| PHARM 448 | Y3 | Winter | 2025-03-18 | Lecture | Integrated Case 5 | Pediatrics | Bharti Thomas; Cheryl Sadowski |
| PHARM 448 | Y3 | Winter | 2025-03-18 | Lecture | Pediatrics – Part III | Therapeutics | Bharti Thomas |
| PHARM 448 | Y3 | Winter | 2025-03-20 | Lecture | Case 5 debriefing | Group presentations; Expert facilitation debriefing | Bharti Thomas |
| PHARM 448 | Y3 | Winter | 2025-03-25 | Lecture | Pediatrics – Part IV | Cases | Bharti Thomas |
| PHARM 448 | Y3 | Winter | 2025-03-27 | Lecture | Child Maltreatment | Case studies regarding child abuse and pharmacist role and intervention | Jillian Poppel |
| PHARM 448 | Y3 | Winter | 2025-04-01 | Lecture | Autism | Care of people with autism spectrum disorder across life stages | Lonnie Zwaigenbaum |
| PHARM 448 | Y3 | Winter | 2025-04-01 | Lecture | Integrated Case 6 | Pediatrics | Bharti Thomas; Cheryl Sadowski |
| PHARM 448 | Y3 | Winter | 2025-04-03 | Lecture | Case 6 debriefing | Group presentations; Expert facilitation debriefing | Bharti Thomas |
| PHARM 448 | Y3 | Winter | 2025-04-08 | Lecture | Course SPOT surveys | Course SPOT surveys | Assessment Team |
| PHARM 448 | Y3 | Winter | 2025-04-08 | Lecture | Newcomers | Exploring the Potential Role of Pharmacists in Supporting Newcomers' Access to Healthcare | Heba Aref |
| PHARM 448 | Y3 | Winter | 2025-04-11 | Final exam | FINAL EXAM | Material covered Feb 25 PM – Apr 8 | Assessment Team; Cheryl Sadowski |
Assessment Information
| PHARM 243 | Y1 | Care Plan Critique | Assignment/written work | 10.0% | Group assignment: draft, peer feedback, final submission; AI prohibited; rubric on Canvas. |
| PHARM 243 | Y1 | Final | Final exam | 42.0% | Final exam non-cumulative; written and MCQ; closed-book, proctored, computer-based; covers Lectures 16-39 and Seminars 3-6. |
| PHARM 243 | Y1 | Midterm | Midterm exam | 30.0% | Written and MCQ midterm; computer-based, closed book, proctored; covers Lectures 1-15 and Seminars 1-2. |
| PHARM 243 | Y1 | Lecture, Assigned Readings, and Seminar Quizzes | Quiz | 18.0% | Multiple quiz dates listed; pre-seminar assignment and attendance mandatory to receive quiz credit; formats include MCQ, matching, T/F, short and long answer; time allowance multiplied by factor of 3. |
| PHARM 343 | Y2 | Final | Final exam | 55.0% | Closed-book computer-based cumulative exam (1h50m); multiple choice, select-all-that-apply, and short answer; ~20% pre-midterm, ~80% post-midterm. |
| PHARM 343 | Y2 | Midterm | Midterm exam | 30.0% | Closed-book computer-based exam (50 min) covering Lectures 1-21; multiple choice, select-all-that-apply, and short answer; format details on Canvas. |
| PHARM 343 | Y2 | Pre-Seminar Quiz #1: Fluid & Electrolyte Conditions | Quiz | 2.5% | Computer-based MC and short answer (10-20 Q); opens Monday at noon, closes 30 min before seminar; 20 min to complete; no repeat attempts; on Canvas. |
| PHARM 343 | Y2 | Pre-Seminar Quiz #2: Laboratory Values & Acid/Base Conditions | Quiz | 2.5% | Computer-based MC and short answer (10-20 Q); opens Monday at noon, closes 30 min before seminar; 20 min to complete; no repeat attempts; on Canvas. |
| PHARM 343 | Y2 | Pre-Seminar Quiz #3: Chronic Kidney Disease & Drug Dosing in Renal Impairment | Quiz | 2.5% | Computer-based MC and short answer (10-20 Q); opens Monday at noon, closes 30 min before seminar; 20 min to complete; no repeat attempts; on Canvas. |
| PHARM 343 | Y2 | Pre-Seminar Quiz #4: Acute Kidney Injury | Quiz | 2.5% | Computer-based MC and short answer (10-20 Q); opens Monday at noon, closes 30 min before seminar; 20 min to complete; no repeat attempts; on Canvas. |
| PHARM 343 | Y2 | Pre-Seminar Quiz #5: Insulin Management | Quiz | 2.5% | Computer-based MC and short answer (10-20 Q); opens Monday at noon, closes 30 min before seminar; 20 min to complete; no repeat attempts; on Canvas. |
| PHARM 343 | Y2 | Pre-Seminar Quiz #6: Type 2 Diabetes Management | Quiz | 2.5% | Computer-based MC and short answer (10-20 Q); opens Monday at noon, closes 30 min before seminar; 20 min to complete; no repeat attempts; on Canvas. |
| PHARM 344 | Y2 | Care Plan and Peer Review Assignment | Assignment/written work | 5.0% | Individual care plan due Jan 26 @1200; peer feedback due Feb 6 @1700. Grade based on completion of components; templates on Canvas. |
| PHARM 344 | Y2 | Final | Final exam | 50.0% | Closed-book cumulative final on Apr 17 (time TBD); ~80% post-midterm material, ~20% pre-midterm; MCQ and short answer. |
| PHARM 344 | Y2 | Midterm | Midterm exam | 35.0% | Closed-book midterm on Feb 23 @1100; multiple choice +/- written questions covering sessions up to Jan 30 and seminar 3. |
| PHARM 344 | Y2 | BP Screening Clinic | Participation/professionalism | 4.0% | 1% for attending Feb 2 preparatory lecture, 2% for attending one 2-hour clinic, 1% for post-clinic assignment; participation mandatory. |
| PHARM 344 | Y2 | Pre-seminar quizzes | Quiz | 6.0% | Six 1% open-book, 5-MCQ quizzes (15 minutes each) administered online within 24h prior to each seminar; single attempt. |
| PHARM 345 | Y2 | Final Exam | Final exam | 50.0% | Computer-based MCQ/short answer final exam covering Nutrition, Ophthalmology, Dermatology (lectures 15-39, seminars 2-4); non-cumulative. |
| PHARM 345 | Y2 | Midterm Exam | Midterm exam | 40.0% | 50-minute computer-based closed-book exam covering GI module (lectures 1-14, seminars 1-2); multiple choice +/- short answer. |
| PHARM 345 | Y2 | Participation | Participation/professionalism | 5.0% | Weekly formative/participation quizzes; completion-based rubric with percentage tiers (10+ = 5%, 7-9 = 3.75%, 4-6 = 2.5%, 1-3 = 1%). |
| PHARM 345 | Y2 | Seminar Quizzes | Quiz | 5.0% | Four pre-seminar online quizzes (each 1.25%); specific open and due dates listed; instructions on Canvas. |
| PHARM 346 | Y2 | Seminar Assignments | Assignment/written work | 6.0% | One 1% assignment during each seminar (instructions on Canvas); guidance provided about missed work and contacting instructor for extenuating circumstances. |
| PHARM 346 | Y2 | Weekly Learning Posts | Assignment/written work | 6.0% | Brief written posts at end of eligible weeks (may skip one of 13 eligible weeks); details on Canvas. |
| PHARM 346 | Y2 | Final Exam | Final exam | 38.0% | Final exam (38%) multiple choice and short answer; cumulative with greater focus on post-midterm material; details to follow. |
| PHARM 346 | Y2 | Midterm Exams | Midterm exam | 46.0% | Two midterms (23% each) composed of multiple choice and short answer; content cutoffs specified; more details to be provided. |
| PHARM 346 | Y2 | Quizzes | Quiz | 4.0% | Two quizzes (2% each) occurring prior to LRTI and UTI seminars; quizzes are multiple choice; instructions on Canvas; contact instructor for extenuating circumstances. |
| PHARM 443 | Y3 | Final Exam | Final exam | 48.0% | 2-hour closed-book in-person computer-based exam; focuses on post-midterm material but is cumulative. |
| PHARM 443 | Y3 | Midterm Exam | Midterm exam | 32.0% | 80-minute, closed-book, in-person computer-based exam covering material up to Oct 9, 2025. |
| PHARM 443 | Y3 | Participation and Engagement | Participation/professionalism | 5.0% | Weekly formative activities due Tue 08:00; ≥80% completion for full marks; 50% minimum for any marks. |
| PHARM 443 | Y3 | Seminar 2: Contraception | Quiz | 3.0% | Seminar quizzes are MCQ +/- short answer, computer-based; absence policy transfers mark to midterm/final if excused. |
| PHARM 443 | Y3 | Seminar 3: Menopause | Quiz | 3.0% | Seminar quizzes are MCQ +/- short answer, computer-based; absence policy transfers mark to midterm/final if excused. |
| PHARM 443 | Y3 | Seminar 4: Fibromyalgia | Quiz | 3.0% | Self-directed group assignment plus quiz: collaborate to summarize evidence; grade from quiz and seminar task completion; groups ~8. |
| PHARM 443 | Y3 | Seminar 5: Gout/OA | Quiz | 3.0% | Seminar quizzes are MCQ +/- short answer, computer-based; absence policy transfers mark to midterm/final if excused. |
| PHARM 443 | Y3 | Seminar 6: RA | Quiz | 3.0% | Seminar quizzes are MCQ +/- short answer, computer-based; absence policy transfers mark to midterm/final if excused. |
| PHARM 444 | Y3 | Rare Neurologic Disorders Assignment | Assignment/written work | 5.0% | Group-produced summary information sheet; rubric in Appendix 2; worth 5%. |
| PHARM 444 | Y3 | Survive and Thrive Documentary Reflection Assignment | Assignment/written work | 5.0% | Two-part online forum: original post due Oct 4 and response due Oct 8; rubric provided; AI use prohibited. |
| PHARM 444 | Y3 | Final | Final exam | 40.0% | Proctored computer-based MC and short-answer closed-book final; non-cumulative; date TBD. |
| PHARM 444 | Y3 | Midterm | Midterm exam | 35.0% | Proctored computer-based MC and short-answer closed-book exam covering content up to Oct 14. |
| PHARM 444 | Y3 | Seminar Participation | Participation/professionalism | 4.0% | Four seminar case submissions graded complete/not-complete; each complete = 1% (max 4%). |
| PHARM 444 | Y3 | Cancer Quizzes | Quiz | 5.0% | Six closed-book 20-minute MC quizzes; highest 5 averaged to make 5% of course grade; missed quizzes receive zero. |
| PHARM 444 | Y3 | Oncology Basics Quiz | Quiz | 3.0% | 15 MC questions from CAPhO Module 1 and Module 2 (pages 1-30); available Sept 2 13:00–Sept 7 22:00; open book; independent completion required. |
| PHARM 444 | Y3 | Rare Neurologic Disorders Quiz | Quiz | 3.0% | Seminar-related MC quiz after Seminar 6; worth 3%. |
| PHARM 445 | Y3 | Seminar Assignments | Assignment/written work | 10.0% | Five seminar assignments (2% each), completed and submitted before or during seminars; rubrics posted on Canvas. |
| PHARM 445 | Y3 | Final Exam | Final exam | 40.0% | Final: MC and short answer; cumulative exam with greater focus on post-midterm material. |
| PHARM 445 | Y3 | Midterm Exam | Midterm exam | 30.0% | Midterm: MC and short answer; covers content up to and including major depressive disorder. |
| PHARM 445 | Y3 | Seminar Peer Evaluations | Participation/professionalism | 5.0% | Five peer evaluations (1% each); grade is the average of peer scores. Failure to complete evaluation results in 1% penalty to seminar assignment grade. |
| PHARM 445 | Y3 | End of Section Quizzes | Quiz | 10.0% | Three end-of-section open-book MC quizzes (two worth 4% and one 2%), completed individually on Canvas; generally open on last day of section and close on day of next class. |
| PHARM 445 | Y3 | Pre-class Review Quizzes | Quiz | 5.0% | Five individual open-book multiple-choice quizzes on Canvas, 1% each; generally open noon day before and close at start of class on due date. |
| PHARM 446 | Y3 | Final Exam | Final exam | 40.0% | 2-hour exam; MC and short-answer case-based questions; primary focus on post-midterm material. |
| PHARM 446 | Y3 | Midterm Exam | Midterm exam | 30.0% | 80-minute exam; MC and short-answer case-based questions; covers material up to Feb 3, 2026. |
| PHARM 446 | Y3 | Seminar 1 Quiz | Quiz | 5.0% | Seminar quiz (~10 Qs), computer-based MC/short answer, 3-day window, duration x3, attendance required; excused absence redistributes weight to midterm/final. |
| PHARM 446 | Y3 | Seminar 2 Quiz | Quiz | 5.0% | Seminar quiz (~10 Qs), computer-based MC/short answer, 3-day window, duration x3, attendance required; excused absence redistributes weight to midterm/final. |
| PHARM 446 | Y3 | Seminar 3 Quiz | Quiz | 5.0% | Seminar quiz (~10 Qs), computer-based MC/short answer, 3-day window, duration x3, attendance required; excused absence redistributes weight to midterm/final. |
| PHARM 446 | Y3 | Seminar 4 Quiz | Quiz | 5.0% | Seminar quiz (~10 Qs), computer-based MC/short answer, 3-day window, duration x3, attendance required; excused absence redistributes weight to midterm/final. |
| PHARM 446 | Y3 | Seminar 5 Quiz | Quiz | 5.0% | Seminar quiz (~10 Qs), computer-based MC/short answer, 3-day window, duration x3, attendance required; excused absence redistributes weight to midterm/final. |
| PHARM 446 | Y3 | Seminar 6 Quiz | Quiz | 5.0% | Seminar quiz (~10 Qs), computer-based MC/short answer, 3-day window, duration x3, attendance required; excused absence redistributes weight to midterm/final. |
| PHARM 448 | Y3 | Case Presentations (Group) | Assignment/written work | 5.0% | 5-7 minute group presentations during debrief sessions; each presentation = 5% of final grade; schedule posted in eClass. |
| PHARM 448 | Y3 | Documentation (5% x 6) (Group) | Assignment/written work | 30.0% | Six group documentation submissions (care plans, DAP notes, communications) due on listed dates; each worth 5% (total 30%); upload to eClass. |
| PHARM 448 | Y3 | Final Exam | Final exam | 25.0% | Open-book, computer-based multiple-choice and short answer exam; explicitly non-cumulative; details on eClass. |
| PHARM 448 | Y3 | Midterm Exam | Midterm exam | 25.0% | Open-book, computer-based exam with multiple-choice and short answer questions. Further details posted in eClass. |
| PHARM 448 | Y3 | Case-related Quizzes (2.5% each x 6) | Quiz | 15.0% | Quizzes are multiple choice or short answer and are due the midnight before the group discussion for each case. |
About this Evidence
Where did this information come from, and how was it prepared?
What information is included
This curriculum portrait brings together the curriculum records available for the selected stream and academic cycle. These include course information and learning outcomes, documented sessions and topics, assessment information, and links to the CCAPP and AFPC curriculum frameworks.
The amount of descriptive detail varies across academic cycles because the underlying source material is not identical. Current-cycle records are drawn largely from syllabus information, while some earlier-cycle records come from legacy curriculum data that contain less narrative detail. Missing information is left visible rather than filled in.
How topics are connected to curriculum frameworks
Documented curriculum topics are matched to CCAPP curriculum categories with OpenAI assistance. A topic can be matched to more than one CCAPP category when it clearly relates to more than one area.
CCAPP categories are linked to AFPC professional roles. Those links are used to show the AFPC role patterns in the curriculum portrait. These profiles describe where curriculum content is documented. They do not show instructional time, student achievement, or preparedness for practice.
How the charts and percentages are calculated
The values in the charts are calculated directly from the curriculum records. AI-generated text does not calculate these numbers. Each chart is based on a different type of evidence, so percentages from different charts should not be compared as though they use the same starting point.
- Learning outcomes
- Shows the share of classified learning outcomes identified as Knowledge, Skills or Attitudes.
- AFPC roles
- Shows the share of all curriculum links to AFPC professional roles.
- CCAPP topics
- Shows the share of all curriculum links to CCAPP topic categories. One documented topic can contribute to more than one category.
- Delivery
- Uses instructional hours when session-duration information is complete enough for comparison. Otherwise it shows the number of documented sessions.
- Assessment
- Uses assessment weight when comparable weighting information is complete enough. Otherwise it shows the number of documented assessments.
The year-by-year profiles are descriptive comparisons. A visible difference between years does not, by itself, mean that an educationally important change occurred.
How the written summaries are created
The written summaries are built in steps so that broad descriptions remain connected to the underlying curriculum records. Detailed session and assessment information is first organized into summaries for each stream and program year. Those summaries are then used to create the overall stream descriptions shown to reviewers.
AI-assisted writing is used to help produce concise reviewer-facing descriptions from these prepared evidence summaries. It does not calculate the charts or decide whether the curriculum is good, coherent, effective, or whether students have achieved the intended outcomes.
The written summaries are prepared before the report is displayed. Opening or browsing this report does not send a new request to an AI service.
How missing or incomplete information is shown
When the available records are incomplete, the report shows that limitation rather than making an assumption. Examples include missing session duration, incomplete assessment weighting, and older course or assessment records that do not contain the same descriptive detail as newer syllabus-derived records.
For relationships between streams, the same evidence rule is applied from either direction. If there is not enough information to describe a relationship for a particular year and cycle, both stream views show that limitation consistently.